<PAGE>   1
================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                 ---------------
                                 AMENDMENT NO. 2
                                       TO
                                   FORM 10-KSB

(Mark One)

    [X]   ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
          EXCHANGE ACT OF 1934

                   FOR THE FISCAL YEAR ENDED DECEMBER 31, 1997
                                       OR
    [ ]   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
          EXCHANGE ACT OF 1934

                           COMMISSION FILE NO. 0-11933

                                   AXCESS INC.
                         (formerly Lasertechnics, Inc.)
              (Exact name of Small Business Issuer in Its charter)

            DELAWARE                                     85-0294536
  (State or other jurisdiction of           (I.R.S. employer identification no.)
   incorporation or organization)

3208 COMMANDER DRIVE, CARROLLTON, TEXAS                    75006
(Address of principal executive offices)                 (Zip Code)

                                 (972) 407-6080
                (Issuer's Telephone Number, Including Area Code)

        Securities registered pursuant to Section 12(b) of the Act: NONE

           Securities Registered Pursuant to Section 12(g) of the Act:

COMMON STOCK, PAR VALUE $.01 PER SHARE                        46,634,964
          (Title of Class)                         (Number of Shares Outstanding
                                                         as of March 20, 1998)

   Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. YES [X] NO [ ]

   Indicate by check mark if disclosure of delinquent filers pursuant to Item
405 of Regulation S-B is not contained herein, and will not be contained, to the
best of registrant's knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-KSB or any amendment to
this Form 10-KSB. [ ]

   Issuer's revenues for the fiscal year ended December 31, 1997 were
$11,118,339. There were 2,249,842 shares of non-voting Common Stock outstanding
as of March 20, 1998.

   The aggregate market value of voting and non-voting Common Stock held by
nonaffiliates of the Issuer is approximately $9,367,409. This amount was
calculated by reducing the total number of shares of the Issuer's Common Stock
outstanding by the total number of shares of Common Stock held by officers,
directors and stockholders owning in excess of 5% of the Issuer's Common Stock,
and multiplying the remainder by the average of the bid and asked price for the
Issuer's Common Stock on March 20, 1998, as reported on the over-the-counter
Nasdaq SmallCap Market. The information provided shall in no way be construed as
an admission that any officer, director or more than 5% stockholder of the
Issuer may be deemed an affiliate of the Issuer or that such person is the
beneficial owner of shares reported as being held by such person, and any such
inference is hereby disclaimed.

Transitional Small Business Disclosure Format (check one):
Yes      No  X
   -----   -----


================================================================================

<PAGE>   2

                        1997 ANNUAL REPORT ON FORM 10-KSB
                                Table of Contents

<TABLE>
<CAPTION>
                                                                                   Page
                                                                                   ----
<S>                 <C>                                                             <C>
PART I                                                                             
         ITEM 1.    BUSINESS........................................................  1
         ITEM 2.    PROPERTIES...................................................... 13
         ITEM 3.    LEGAL PROCEEDINGS............................................... 14
         ITEM 4.    SUBMISSION OF MATTERS TO A VOTE OF SECURITY                    
                    HOLDERS......................................................... 15
                                                                                   
PART II                                                                            
         ITEM 5.    MARKET FOR LASERTECHNICS COMMON                                
                    EQUITY AND RELATED STOCKHOLDER MATTERS.......................... 16
         ITEM 6.    MANAGEMENT'S DISCUSSION AND ANALYSIS OF                        
                    FINANCIAL CONDITION AND RESULTS OF OPERATIONS................... 20
         ITEM 7.    FINANCIAL STATEMENTS............................................ 28
         ITEM 8.    CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS                  
                    ON ACCOUNTING AND FINANCIAL DISCLOSURE.......................... 28
                                                                                   
PART III                                                                           
         ITEM 9.    DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND                   
                    CONTROL PERSONS; COMPLIANCE WITH SECTION 16(a)                 
                    OF THE EXCHANGE ACT............................................. 29
         ITEM 10.   EXECUTIVE COMPENSATION.......................................... 31
         ITEM 11.   SECURITY OWNERSHIP OF CERTAIN BENEFICIAL                       
                    OWNERS AND MANAGEMENT........................................... 34
         ITEM 12.   CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS.................. 37
         ITEM 13.   EXHIBITS AND REPORTS ON FORM 8K................................. 40
                                                                                   
SIGNATURES.......................................................................... 45
</TABLE>



                                      - i -
<PAGE>   3

                                     PART I

ITEM 1.  BUSINESS.

THE COMPANY

AXCESS Inc., a Delaware corporation ("AXCESS" or the "Company"), was formed in
October 1981. In early 1995, the Company became a holding company with two
separate operating units, Sandia Imaging Systems Corporation ("Sandia") and
Lasertechnics Marking Corporation ("LMC"), both Delaware corporations. With the
application of its personalized color ID card printing and production
experience, Sandia is developing and marketing secure access control products
that will provide organizations with a low-cost method for controlling access to
facilities. See "Business -- Access Control Business." LMC designs, manufactures
and sells high speed date marking equipment used by manufacturers on various
food products and other date sensitive consumer goods and industrial products to
facilitate inventory control. See "Business -- Marking Business." Each of Sandia
and LMC is run by its own management team, produces different products and
serves different markets. References to AXCESS or the Company mean the Company
and its subsidiaries taken as a whole, unless the context requires otherwise.

The Company's principal offices are located at 3208 Commander Drive, Carrollton,
Texas 75006, and its telephone number is (972) 407-6080.

PRODUCT LINES AND SERVICES

ACCESS CONTROL BUSINESS

Sandia, a 96% owned subsidiary of the Company, operates and manages its access
control business through two divisions: imaging and technology. The imaging
division is principally engaged in the businesses of distributing and reselling
high-end and mid-range dye-sublimation card printers and printer consumables, as
well as production of customized, high quality, fraud resistant, personalized
color ID cards. Sandia is leveraging this experience to design corporate access
control systems based on card-mounted biometric and other verification for
corporate security applications. See "Business -- Imaging Division." The
technology division is principally engaged in the development and
commercialization of imaging component products such as the new document reader,
digital camera and dithering technology (the "XLV Technology") the Company is in
the process of acquiring from XL Vision, Inc., a Safeguard Scientifics
partnership company ("XLV") for use in card readers and other digital
image-acquisition applications. In January 1998, the Company and XLV entered
into the Intellectual Property Transfer Agreement (the "Technology Development
Agreement") which provides the Company with options to acquire the XLV
Technology from XLV. See "Business -- Technology Division." The acquisition of
the XLV Technology is subject to certain conditions, including (1) the approval
of a reverse stock split proposal by the Company's stockholders and (2) the
receipt of any other stockholder approval required by law or by the rules of
Nasdaq. See "1998 Changes in Capital Stock."


                                      - 1 -

<PAGE>   4




Imaging Division

Sandia's imaging business accounted for approximately 39% of the Company's 1997
consolidated sales, down from 47% in 1996 and 23% in 1995. Sandia sells its
goods and services in several foreign countries to organizations such as
national and local government agencies. Sandia's plastic card printers
accommodate any type of PVC-based card meeting the International Standards
Organization ("ISO") plastic card requirements, including plain,
magnetic-striped, "smart" (i.e., with on-card microprocessors) and optical
storage cards. These assorted plastic cards are used to issue, among other
things, drivers' licenses, border crossing cards, identification cards and
health care cards.

In December 1997, the Company launched its IDCard Services program. IDCard
Services provides an outsourcing option to companies, associations and
universities that do not want to make a capital investment in a printer. It is a
turnkey service providing color, personalized ID cards with edge-to-edge thermal
printing and encoding. IDCard Services employs the latest complex security
technologies such as hologram, optical card chip and magnetic stripe encoding.
In addition, IDCard Services is marketing its cards as keepsakes to the retail
marketplace.

Technology Division

The technology division is attempting to develop technology for use with access
control products marketed by the imaging division and to other imaging reader
integrators. To date, the Company has not recognized any sales revenue from its
operation of the technology division.

Dataglyphs(TM). Sandia is designing imaging component products which embed in a
card database symbology originally developed by Xerox Corporation ("Xerox").
This information based card system is being marketed by Sandia under the trade
name Dataglyphs(TM). In 1995, Xerox granted Sandia the sole worldwide right to
sell DataGlyphs(TM) for use in the secure access industry. A plastic card
utilizing DataGlyphs(TM) costs no more than a magnetic-striped card but offers
40 times more data storage (which is storage comparable to a computer chip
card). The Technology Division intends to develop a customized DataGlyphs(TM)
reader, to serve as the reading device for DataGlyphs(TM) applications. The
Company and Xerox recently resolved a dispute concerning the applicability of
the products and services provided under the Dataglyphs(TM) license and the
payments due Xerox under the license. See "Legal Proceedings."

The Dataglyph(TM) Verification System. Sandia is pairing Glyphit(TM) software
and glyph readers with third party biometric verification software systems, to
develop a total card security system for use in a variety of applications.
Sandia has begun marketing these systems directly to end-users and through
re-seller arrangements under the name The Dataglyphs(TM) verification system.
The combination of The Dataglyph(TM) verification system and Sandia's plastic
card printer family offers an integrated solution for the printing, encoding,
securing and verifying needs of numerous plastic card identification
applications.

The XLV Technology. Sandia recently entered into the Technology Development
Agreement with XLV for the development and commercialization of the XLV
Technology, which consists of both hardware and software technology. The Company
believes that its secure card industry experience and the XLV Technology will
enable it to develop and market a low cost fraud resistant access control
system. This


                                      - 2 -

<PAGE>   5




system would combine the portable card embedded database with nontransferable
personal information, such as finger prints, to permit access only by the
authorized card holder.

Under the terms of the Technology Development Agreement, XLV will continue to
devote personnel, services and project management for the enhancement and
commercialization of the XLV Technology. The Company will fund the enhancement
of the XLV Technology. In January 1998, the Company paid XLV $500,000 and will
make additional payments to XLV in the aggregate amount of $4.1 million for
further development expenses, payable in several installments over the
development period. Such funds will be used to fund technology enhancement
activities by XLV with respect to the XLV Technology, with the goal of making
such technology market-ready, as determined by mutual agreement of the Company
and XLV. Of the $4.1 million earmarked for development expenses, the Company
may, at its option, accelerate funding the development of the XLV Technology.
All payments made prior to the development of a working model, including the
costs of acquiring the options under the Technology Development Agreement, will
be expensed as research and development costs.

The Company does not currently have any binding commitment in place to finance
such development expenses, but intends to seek the necessary funding through the
issuance of additional debt or equity securities. See "Management's Discussion
and Analysis of Financial Condition and Results of Operation --Liquidity and
Capital Resources." The Company has the option to cease funding the development
of the XLV Technology at any time without further liability in its reasonable
business judgment or for the failure of XLV to meet the development schedule.
If, however, the Company terminates such funding, the License Option, the
Exclusive License Option and the Assignment Option (each described below), to
the extent not previously exercised, will terminate automatically. See
"Acquisition of XLV Technology" below. All technology and intellectual property
rights developed pursuant to these joint efforts will initially be the property
of XLV, subject to the License Option, the Exclusive License Option and the
Assignment Option.

Acquisition of XLV Technology. Subject to the Company's receipt of stockholder
approval relating to the issuance by the Company of the maximum number of shares
of its common stock, $0.01 par value (the "Common Stock") to XLV under the terms
of the Technology Development Agreement, the Company will have the option (the
"License Option") for six months commencing 30 days after the Company's 1998
annual meeting of stockholders, to acquire a non-exclusive perpetual license to
the XLV Technology in exchange for 200,000 shares of Common Stock (as in effect
following the Reverse Stock Split Proposal). See "Proposed 1998 Changes in
Capital Stock." If the Company exercises the License Option, then, for 90 days
beginning on the date on which payment of all development funds contemplated by
the Technology Development Agreement has been made in full, the Company will
have the further option, in exchange for an additional 300,000 post-reverse
split shares of Common Stock, to acquire an exclusive perpetual license to the
XLV Technology (the "Exclusive License Option"). If the Company exercises the
Exclusive License Option, then, for 90 days beginning on the earlier of April 1,
1999, and the date on which payment of all development funds has been made in
full by the Company, the Company will have the further option to acquire
outright ownership of the XLV Technology in exchange for an additional 300,000
post-split shares of Common Stock (the "Assignment Option"). If the Company
exercises the License Option, XLV will indemnify the Company against any claims
of intellectual property infringement by a third party relating to the XLV
Technology. If the Company exercises the Assignment Option, it will grant to XLV
an exclusive license to the XLV Technology within a specified field of use.


                                      - 3 -

<PAGE>   6




Under the terms of the Technology Development Agreement, neither the Exclusive
License Option nor the Assignment Option may be exercised by the Company until
the Company has received stockholder approval of the issuance by the Company of
the maximum number of shares of Common Stock issuable under the Technology
Development Agreement. Accordingly, the Company will seek stockholder approval
of the issuance by the Company of the maximum number of shares of Common Stock
issuable under the Technology Development Agreement at its 1998 annual meeting
of stockholders, which is currently expected to be held in June 1998. To the
extent that the Technology Development Agreement may result in the issuance of
shares of Common Stock constituting in the aggregate more than 20% of the number
of shares of Common Stock outstanding prior to such issuance, the Technology
Development Agreement may require stockholder approval under the Nasdaq Listing
Requirements that went into effect on February 23, 1998 (the "New Nasdaq Listing
Requirements").

Spot/Mag Provision. XLV and Spot/Mag, Inc., a corporation organized under the
laws of Taiwan ("Spot/Mag"), are currently engaged in discussions regarding the
possibility of entering into an agreement (the "Spot/Mag Agreement") under which
Spot/Mag would receive certain intellectual property rights relating to the XLV
Technology, for certain limited uses, in exchange for an obligation to pay
royalties and other remuneration to XLV. If the Spot/Mag Agreement is executed
within three years after the effective date of the Technology Development
Agreement, and if the Company exercises the Assignment Option, XLV will assign
its rights and obligations under the Spot/Mag Agreement to the Company,
including the right to receive all royalties and amounts payable under the
Spot/Mag Agreement. In consideration for the assignment of the Spot/Mag
Agreement, the Company has agreed to pay to XLV on a quarterly basis one share
of Common Stock for each ten dollars ($10.00) of royalty actually received by
the Company from Spot/Mag under the Spot Mag Agreement, up to a maximum of
200,000 shares of Common Stock (in each case, based on the Common Stock
outstanding after the Reverse Stock Split). See "1998 Changes in Capital Stock."
Thereafter, any additional royalties would inure solely to the benefit of the
Company.

The development of the XLV Technology is currently proceeding and the Company
anticipates having demonstration models available in June 1998, as well as a
pre-production prototype available in September 1998. The Company currently
anticipates that it will begin producing marketable products by the end of the
first quarter of 1999. Regarding the Company's Dataglyph technology, the Company
is currently evaluating different biometrics for application to its reader
technology. The Company anticipates that the development of this technology will
progress steadily now that the Company has reached a settlement with Xerox
Corporation. See "Legal Proceedings." There can be no assurances, however, that
the development of the XLV Technology and related products will continue to
progress as planned.

MARKING BUSINESS

Laser Markers. LMC designs, manufactures and markets laser marking systems which
are used by manufacturers for the in-plant placement of lot numbers, freshness
dates and other information on consumer and industrial products and packaging
materials. LMC's marking business accounted for 61% of the Company's 1997
consolidated sales, up from 53% in 1996 and 77% in 1995. Since inception, LMC
has provided CO2 (carbon dioxide) gas laser markers that are easily integrated
into a wide range of sophisticated and demanding high-speed product packaging
facilities. To that end, LMC has created the Blazer 6000CE(TM), a water-cooled,
CO2 pulsed, gas laser system used in the on-line marking of industrial and
consumer products. In the last quarter of 1995, after more than one year of
development, LMC introduced a test version


                                      - 4 -

<PAGE>   7




of its BlazerJet(TM) dot-matrix coder at a major packaging industry show. See
"Product Development" below. As compared to the Blazer 6000CE(TM), the
BlazerJet(TM) product offers a higher degree of programmability to meet a
greater number of packaging needs and allows a larger number of codes to be
stored and called up for use with a few simple keystrokes. The BlazerJet(TM)
system is transportable among packaging lines, allows for maximum code
flexibility and provides marking quality and operating performance superior to
inkjet markers of similar capacity. LMC shipped fully functional BlazerJet(TM)
systems to customers throughout the second half of 1997.

LMC's marking systems typically solve problems related to four main product
identification needs:

         Perishables. Perishables such as beverage, food and dairy products
         require a variety of date information to provide accurate product
         freshness information. These products are manufactured in extremely
         clean facilities and are characterized by extremes in temperature and
         stringent wash-down requirements. LMC's products can tolerate a wide
         range of temperature conditions. Further, they are enclosed in a rugged
         stainless steel enclosure with smooth, easily-cleaned surfaces,
         allowing them to handle the harshest demands of wash-down routines.
         Date information is dependably marked using either the Blazer
         6000CE(TM) or the BlazerJet(TM).

         Traceability. Product traceability concerns, especially in the medical
         and pharmaceutical industries, require variable batch information to
         meet ever-increasing government regulations and enhance a
         manufacturer's ability to limit and defend against liability in
         consumer product liability claims. In such packaging environments,
         reliability of the marker products is especially important. Product
         identification marking in the form of batch numbers, serialized part
         numbers, logos or corporate names are easily handled by LMC's products.
         In addition, laser marks are permanent because they burn the mark into
         a thin surface layer of the product or package.

         High Throughput. High speed packaging lines cannot use the slower
         contact methods for identifying products. LMC's Blazer 6000CE(TM) can
         operate at speeds exceeding 1,800 marks per minute and easily provide
         legible information on fragile and/or thin materials with irregular
         surfaces or limited space. The Blazer 6000CE(TM) marks so fast (about
         one-millionth of a second per mark) that it operates at speeds required
         by high speed packaging equipment manufacturers with whom LMC has
         integrated the Blazer system. High speed packaging lines are
         accommodated by the computer-based controller of the Blazer 6000CE(TM)
         that interfaces with packaging line control equipment. While current
         models of the BlazerJet(TM) are better suited for more moderate speed
         production lines, the new BlazerJet(TM) marker system is expected to
         operate at speeds comparable to that needed in most Blazer 6000CE(TM)
         applications.

         Environmental Concerns. Packagers seeking a product identification
         system that eliminates the problems inherent in the use of expensive
         and hazardous inks and solvents are increasingly using lasers. The
         solvents used in many industrial inkjet coders are potentially harmful
         to the environment, as well as to the health of personnel who handle
         them. In addition, many inks used in marking contain solvents which are
         classified as hazardous substances by the Environmental Protection
         Agency (the "EPA") and, as such, are becoming more and more expensive
         to handle as government regulations become more stringent. LMC's
         products do not use hazardous substances as they consume only
         electricity, water and non-toxic CO(2) laser gas. Thus the Blazer
         6000CE(TM) and

                                      - 5 -

<PAGE>   8




         BlazerJet(TM) offer a safe, environmentally clean and highly reliable
         product marking alternative to inkjet marking.

Dependence on Sales to Major Customer. LMC's largest customer is Anheuser-Busch.
LMC recorded sales of system upgrades, spare parts and training to
Anheuser-Busch in the amount of $1,139,187, $3,153,000 and $2,171,000 in 1997,
1996 and 1995, respectively. Sales to Anheuser-Busch accounted for 17%, 34% and
21% of LMC's total sales in 1997, 1996 and 1995, respectively. Although this
arrangement may be terminated by either party at any time, the Company believes
it has a good relationship with Anheuser-Busch and continues to enhance this
relationship. The loss of this customer would have a material adverse effect on
the Company's results of operations.

Product Development. In November 1994, LMC introduced a prototype of its new
BlazerJet(TM) marking system utilizing technology which was previously licensed
from United Technology Optical Systems and is currently licensed, on a
non-exclusive basis, from DeMaria ElectroOptic Systems. The Company's new laser
marker emulates the action of an inkjet system by forming dot matrix characters
to mark a moving product, such as a consumer good moving along a production
line, and is the first single-laser system of this type to bring the laser tube
to the mark point. LMC shipped fully functional BlazerJet(TM) systems to
customers in the second half of 1997.

RESEARCH AND DEVELOPMENT EXPENDITURES

Research and development expenditures by the Company were $2,572,848, $2,848,767
and $3,040,830 for the years 1997, 1996 and 1995 respectively. The research and
development expenses were incurred primarily for the development of new
manufacturing systems, DataGlyphs(TM) software, hardware and software upgrades
to Sandia's high speed plastic card printers and additional enhancements to
LMC's Blazerjet(TM) dot-matrix coder. The access control and laser marking
industries are undergoing, and are expected to continue to undergo, rapid and
significant technological change. There can be no assurance that the Company's
research and development programs will enable it to compete effectively in the
future. The development by others of new or improved processes or products may
make the Company's research and its products obsolete.

COMPETITION

Access Control Business. Sandia competes with a variety of manufacturers and
resellers of plastic card printers that incorporate a non-proprietary dye
sublimation process as well as with hardware and software companies that have
similar printer and software technologies. DataGlyphs(TM) products compete with
alternative data encryption technologies used with plastic cards, such as bar
codes, magnetic stripes, optical data and smart chips. Sandia competes in the
data encryption and plastic card printer market through the development of
relationships with corporations that are prime contractors and technology
providers in the plastic card printing and secure card markets. In addition to
Dataglyph, the Company is currently evaluating other symbologies to use on a
single card. Accordingly, the Company competes with other alternative data
encryption technologies that may effect the Company's Dataglyph and other
product developments.

Laser Marking. The Company's Marking business faces competition not only from
other laser marking companies, but from companies using other marking
technologies in widespread use such as inkjet (currently the dominant technology
in the packaging industry), embossing and hot stamping. LMC competes in the

                                     - 6 -

<PAGE>   9




product marking market by marketing directly to end users through full service
distributors and independent manufacturer representatives.

The access control and laser marking industries are highly competitive in all
aspects, including research and development and marketing, and competition is
expected to intensify in both industries as technological advances are made and
become more widely known. The Company believes that the major competitive
advantages in both of its businesses include customer service, price, technical
support, speed and reliability. Because of the increase in competition, no
assurance can be given that the Company will compete successfully with respect
to the factors discussed above. Also, the Company would be adversely affected if
its competitors were to offer their products and systems at significantly lower
prices. Many of the Company's competitors have considerably greater financial,
technical and marketing resources than the Company.

MANUFACTURING AND SUPPLIERS

Approximately one-third of LMC's employees are engaged in manufacturing
activities. Sandia out-sources its manufacturing and does not have any
manufacturing employees.

Both companies depend upon a number of outside suppliers for components for
their products. Sandia arranges for the manufacture of all its plastic card
printers by a single source, Polyprint S.A. There are currently no alternative
sources of supply to manufacture Sandia's plastic card printers. Generally,
these supply arrangements may be terminated by either party at any time, but the
Company has entered into them with the expectation that these arrangements will
lead to long-term relationships or contracts with those suppliers. Although to
date the Company has generally been able to obtain adequate supplies of these
products, the inability of the Company in the future to obtain sufficient sole
or limited source products, or to develop alternative sources, could result in
delays in product introductions or shipments and could have material adverse
effects on the Company's results of operations. There are currently no formal
agreements between the Company and its suppliers.

MARKETING

Access Control Business. Marketing and sales and service functions of the access
control business are performed directly by Sandia as well as through the use of
Distributors, Value Added Resellers ("VARs") and systems integrators. Sandia has
created strategic product marketing alliances with several system integrators
and technology companies in the secure card market. The Company currently has
strategic product marketing alliances in the secure card marketplace with
Olivetti, ACE and Information Spectrum, each an integrator with a prime
contractor relationship with the end user. The Company has also established
alliances with technology companies such as XLV. The Company continues to
leverage its relationships with these alliances to create new alliances and
increase sales. Because Sandia's high speed printer systems can support
edge-to-edge color printing and data encoding requirements of any card-mounted,
digitized security technology, the Company believes Sandia's products represent
the most complete and cost-effective alternative in the high volume plastic card
printing market.

Laser Marking. LMC derives the major portion of its revenues from the sale of
laser marking systems and related spare parts. LMC currently markets and sells
its products in the United States, through independent

                                      - 7 -

<PAGE>   10




sales representatives who are paid on a commission basis. Sales in the rest of
the Americas, Western Europe and the Pacific Rim are made through full service
distributors who have OEM pricing arrangements. LMC uses demonstrations at trade
shows and conventions, direct mailings of sales brochures and advertisements in
trade journals to advertise its products.

PATENTS AND PROPRIETARY TECHNOLOGY

The Company relies on a combination of patents, technology licenses, trade
secrets and other intellectual property rights, nondisclosure agreements and
other protective measures to preserve its rights pertaining to its products. The
Company is licensed under certain patents related to the lasers used in its
markers and owns three patents, which have a broad range of medical and
industrial laser marking applications. These patents expire at various dates
through 2005. The Company also owns and has the worldwide distribution rights to
three French patents covering the mechanical parts and assembly of Sandia's
plastic card printer family of dye sublimation, photographically-customized
identification/security card printers. The Company's rights under such patents
do not preclude the manufacture of competitive products by others. However,
pursuant to its license agreement with Xerox, the Company does have sole rights
to the DataGlyphs(TM) technology for use with security and identification media.
See "Legal Proceedings."

The Company has registered or is in the process of registering the following
trade and service marks: "AXCESS Inc. (logo)"(TM), "The Clean Ones"(TM),
"Inkless Inkjet"(TM), Blazer 6000CE(TM) and "BlazerJet"(TM).

Much of the Company's ability to compete in the laser marking and access control
industries depends on trade secrets, know-how and proprietary technical
knowledge that is unprotected by patents. Although the Company continues to
implement protective measures and intends to defend its proprietary rights
vigorously, there can be no assurance that these efforts will be successful.
Such protections may not preclude competitors from developing products similar
to the Company's. In addition, the laws of certain foreign countries do not
protect intellectual property rights to the same extent as do the laws of the
United States. There can also be no assurance that third parties will not assert
intellectual property infringement claims against the Company. Any such
infringement claim could result in protracted and costly litigation and could
have a material adverse effect on the Company's results of operations regardless
of its outcome.

EMPLOYEES

As of December 31, 1997, the Company employed 82 people. Of this total, Sandia
employed 37, Sandia-Europe employed 11, LMC employed 32 and the holding company
employed 2. Because of the specialized nature of its businesses, the Company is
dependent upon the efforts of its current officers, consultants, and engineers
and upon its ability to attract and retain technologically qualified personnel,
particularly engineers and software designers highly qualified in the areas of
access control and laser technology. There is intense competition for qualified
personnel in the access control and marking industries, including competition
from companies with substantially greater resources than AXCESS. Although the
Company has been successful to date in recruiting adequate numbers of qualified
personnel, there is no assurance that it will be successful in the future in
recruiting or retaining personnel of the requisite scientific caliber or in the
requisite numbers to enable the Company to compete effectively.


                                      - 8 -

<PAGE>   11




GOVERNMENT REGULATION

All laser manufacturers in the United States, including LMC are subject to the
Laser Radiation Safety Regulations of the Center for Devices and Radiological
Health ("CDRH") of the United States Food and Drug Administration.

As a company with international sales, AXCESS is subject to the federal Export
Administrative Regulations, which govern exports from the United States of
non-military goods, technology, software and technical services. The regulations
prohibit, or require prior approval for, exports of certain items depending upon
the characteristics of the item to be exported, the country of destination, the
ultimate end-use and ultimate end-user of the export. AXCESS' products are not
currently considered sensitive for export control purposes and may be exported
to almost all locations without prior government approval. It should be noted,
however, that the export controls applicable to a particular item can be changed
without prior notice, subject only to public notification in the Federal
Register. In recent years, AXCESS' products have been subjected to several such
changes.

AXCESS is also subject to the regulations promulgated by the foreign governments
in the countries in which it sells products and provide services. These foreign
regulations vary from country to country and may be changed without prior notice
at any time.

These regulations have not had, nor are they expected to have, a material effect
on the Company's financial condition, results of operations or competitive
position.

ENVIRONMENTAL FACTORS

There has been, and it is anticipated that there will continue to be, no
material effect upon the capital expenditures, earnings, or competitive position
of Sandia or LMC due to compliance with existing provisions of federal, state
and local laws regulating the discharge of material into, or otherwise relating
to the protection of, the environment.

YEAR 2000 COMPLIANCE

The Company has assessed all of its major software applications and determined
that such applications are Year 2000 compliant in all material respects.
Although the Company may incur some expenses in connection with making certain
minor modifications to its software applications to make them Year 2000
compliant, in the opinion of management, any such expenses related to any Year
2000 issues are not expected to have a material adverse effect on the Company's
business, operations or financial condition.

1998 CHANGES IN CAPITAL STOCK

At a special meeting of the stockholders of AXCESS held on March 31, 1998 which,
with respect to item (b) below, was adjourned to April 8, 1998 (the "Special
Meeting"), the stockholders of the Company approved the following three
proposals to amend the Company's Certificate of Incorporation: (a) a proposal to
affect a one-for-twenty reverse stock split of the outstanding Common Stock,
Non-Voting Common Stock, and Series A, B and C Convertible Preferred Stock (the
"Reverse Stock Split Proposal"); (b) a proposal to reduce

                                      - 9 -

<PAGE>   12




the number of authorized shares of the Company's Common Stock; and (c) a
proposal to change the Company's name to AXCESS Inc.

The primary purpose of the Reverse Stock Split Proposal was to combine the
outstanding shares of Common Stock so that the Common Stock outstanding after
giving effect to the Reverse Stock Split Proposal would trade at a significantly
higher price per share than the Common Stock outstanding before giving effect to
the Reverse Stock Split Proposal. During 1997, the closing bid price for the
Common Stock on the SmallCap tier of The Nasdaq Stock Market, Inc. (the "Nasdaq
SmallCap Market") ranged from $1.34 to $0.22 per share. The closing bid price
for the Common Stock on March 20, 1998, was $0.22 per share. The market price of
the Common Stock was, prior to the approval of the Reverse stock Split Proposal,
below the minimum bid price of $1.00 per share required for continued inclusion
of the Common Stock on the Nasdaq SmallCap Market pursuant to the New Nasdaq
Listing Requirements. See "Cautionary Statements--Nasdaq Listing." After giving
effect to the Reverse Stock Split Proposal, the closing bid price for the Common
Stock on April 20, 1998, was $4.69 per share, which is in excess of the minimum
bid price of $1.00 per share established by the New Nasdaq Listing Requirements.

A secondary purpose of the Reverse Stock Split Proposal was to increase the
number of authorized but unissued shares of Common Stock. Prior to the approval
of the Reverse Stock Split Proposal, the Company did not have a sufficient
number of authorized but unissued shares of Common Stock to effect the
conversion, exercise or exchange of all outstanding securities of the Company
that by their terms are convertible into, or exercisable or exchangeable for,
shares of Common Stock. The lack of available shares would have prevented the
Company from consummating any of the transactions contemplated by the Technology
Development Agreement. Unless otherwise indicated, all share and per share
amounts are as of December 31, 1997, and do not take into account the adoption
of the Reverse Stock Split Proposal.

The purpose of the authorized share proposal was to decrease the number of
authorized shares of Common Stock following effectiveness of the Reverse Stock
Split Proposal, so that the number of authorized but unissued shares of Common
Stock following the Reverse Stock Split Proposal would bear a more appropriate
relation to the total number of shares of Common Stock then authorized.

Finally, the purpose of the name change proposal was to change the corporate
name of the Company to better reflect the current primary business focus of the
Company.

CAUTIONARY STATEMENTS

Except for the historical information contained herein, this Report includes
"forward looking statements" within the meaning of Section 27A of the Securities
Act of 1933, as amended (the "Securities Act"), and Section 21E of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"). Although the
Company believes that the expectations reflected in such forward looking
statements are reasonable, it can give no assurance that such expectations will
prove to be correct. Certain important factors that could cause actual results
to differ materially from the Company's expectations ("Cautionary Statements")
are disclosed below and qualify the forward looking statements included in this
Report. All subsequent written and oral forward looking statements attributable
to the Company or persons acting on its behalf are expressly qualified in their
entirety by the Cautionary Statements.


                                     - 10 -

<PAGE>   13




ACCUMULATED LOSSES

From its incorporation in 1982 through December 31, 1997, the Company has an
accumulated loss of approximately $66,700,000 and has been profitable in only
one fiscal year during that time. There can be no assurance that the Company
will generate sufficient revenues to achieve profitability in the future.

AUDITORS' REPORT

The Company's auditors have included an explanatory paragraph in their audit
opinion with respect to the Company's consolidated financial statements related
to a significant uncertainty with respect to the Company's financial position at
December 31, 1997, which states that the Company's recurring losses from
operations and resulting continued dependence on access to external financing
raise substantial doubts about its ability to continue as a going concern. In
October 1995, March 1996, and December 1997, the Company arranged an aggregate
of $12,500,000 in additional financing. In addition, in July 1996, May 1997 and
December 1997, the Company completed a private placement of convertible
preferred stock for $8,350,000, $500,000 and $7,000,000. respectively. As a
result, there can be no assurance that the Company's future financial statements
will not include a similar explanatory paragraph if the Company is unable to
raise sufficient funds either through financing or from operations to cover the
cost of its operations. The factors leading to and the existence of the
explanatory paragraph may adversely affect the Company's relationship with
customers and suppliers and have an adverse effect on its ability to obtain
financing.

The Company is currently in discussions with a number of existing and potential
corporate, strategic and institutional investors. The Company's actual funding
needs will depend upon numerous factors, however, including actual expenditures
and revenues generated from its operations compared to its business plans. The
Company's actual funding needs will also depend on the successful development of
the new products contemplated within the XLV Technology Acquisition and other
unanticipated expenditures, none of which can be predicted with certainty. There
can be no assurance, however, that the Company will acquire the additional
funding it needs to fully pursue its business objectives.

SMALL TRADING VOLUME AND VOLATILITY OF STOCK PRICE

The weekly trading volume of the Company's Common Stock in the over-the-counter
market has varied from several thousand shares to 3 and 4 million shares, which
may tend to increase the volatility of the price. Since January 1992, the
closing bid price of Common Stock in the over-the-counter market has varied from
a low of $.22 to a high of $4.07 per share. There can be no assurance that the
price volatility will not continue in the future.

NASDAQ LISTING

The Company's Common Stock is listed on the Nasdaq SmallCap Market, which
requires maintenance of certain quantitative and other standards for continual
listing thereon. In its quarterly report on Form 10-QSB for the fiscal quarter
ended September 30, 1997, the Company reported total stockholders' equity of
approximately $1.3 million, down from approximately $5.3 million at June 30,
1997, reflecting the Company's consolidated net loss applicable to common stock
for the three month period ending September 30, 1997 of approximately $4.7
million, partially offset by conversions into Common Stock of outstanding

                                     - 11 -

<PAGE>   14




convertible notes. On November 17, 1997, Nasdaq advised the Company that the
Company was not in compliance with the listing requirements of the Nasdaq
SmallCap Market, then in effect (the "Old Nasdaq Listing Requirements") which
required a minimum bid price of $1.00 per share or, as an alternative if the bid
price is less than $1.00, maintenance of capital and surplus of $2,000,000 and a
public float of $1,000,000. The Nasdaq's letter stated that no delisting action
with respect to the bid price deficiency would be initiated at that time and
that the Company would be provided 90 calendar days in which to regain
compliance with either the minimum bid price or the alternative stockholders'
equity/ public float requirement.

The Company believes that it is currently in compliance with the stockholders'
equity and public float provisions of the Old Nasdaq Listing Requirements.
However, on August 22, 1997, the Securities and Exchange Commission
("Commission") approved the New Nasdaq Listing Requirements (as defined below)
for continued listing on the Nasdaq SmallCap Market. In particular, the New
Nasdaq Listing Requirements require that a Company currently included in Nasdaq
meet each of the following standards to maintain its continued listing: (i)
either (A) net tangible assets (defined as total assets, minus goodwill, minus
total liabilities) of $2 million, (B) total market capitalization of $35
million, or (C) net income (in the latest fiscal year or in two of the last
three fiscal years) of $500,000; and (ii) public float of at least 500,000
shares, with a market value of at least $1 million; and (iii) minimum bid price
of $1; and (iv) at least two market makers; and (v) at least 300 round lot
beneficial shareholders; and (vi) compliance with certain corporate governance
requirements (the "New Nasdaq Listing Requirements"). As of April 2, 1998, the
first full trading day after the Company gave notice to Nasdaq that the Reverse
Stock Split Proposal was approved by its stockholders, the closing bid price of
the Common Stock was $5.00 per share, which is in excess of the minimum bid
price of $1.00 per share established by the New Nasdaq Listing Requirements.
Further, by letter dated April 15, 1998, Nasdaq advised the Company that it was
in compliance with the New Nasdaq Listing Requirements and approved the
Company's continued listing on Nasdaq. There can be no assurance, however, that
the Company's continued losses or other factors beyond the control of the
Company will not cause the Company to fail to meet such requirements. See "1998
Changes in Capital Stock."

Since December 31, 1997, Antiope Partners, L.L.C. ("Antiope Partners") and
Amphion Ventures, L.P. ("Amphion Ventures") purchased $1.9 million in shares of
a new series of Convertible Preferred Stock, Series G, $0.01 par value (the
"Series G Preferred Stock"). Additionally, Amphion Ventures committed to
purchase up to an additional $5,500,000 of Series G or a certain other new
series of preferred stock to fund the Company's operations and provide for the
continued maintenance of the Company's net tangible assets above the New Nasdaq
Listing Requirements. As of February 28, 1998, the Company's net tangible assets
were in excess of the $2 million threshold established by the New Nasdaq Listing
Requirements. Although management believes that the Company will be able to
preserve the listing of the Common Stock on the Nasdaq SmallCap Market, there
can be no assurance that the Company will be able to do so.

If the Common Stock were delisted from the Nasdaq SmallCap Market, trading, if
any, would likely be conducted in the over-the-counter market on the National
Association of Securities Dealers' OTC Bulletin Board and/or on the pink sheets
of the National Quotation Bureau. As a result, an investor may find it more
difficult to dispose of, or to obtain accurate quotations as to the price of,
the Common Stock. In addition, the Common Stock would be subject to rules
promulgated under the Exchange Act applicable to penny stocks. The Commission
has adopted regulations that generally define a "penny stock" to be an equity
security that has a market price (as determined pursuant to regulations adopted
by the Commission) or exercise price of less than $5.00 per share, subject to
certain exceptions. By virtue of being listed on the Nasdaq SmallCap

                                     - 12 -

<PAGE>   15




Market, the Common Stock will be exempt from the Definition of "penny stock."
If, however, the Common stock is removed from the Nasdaq SmallCap Market, the
Company's securities may become subject to the penny stock rules that impose
additional sales practice requirements on broker-dealers who sell penny stocks
to persons other than established customers and accredited investors.
Consequently, the penny stock rules may affect the ability of broker-dealers to
sell the Common Stock and may affect the ability of purchasers of Common Stock
to sell such securities in the secondary market.

SHARES ELIGIBLE FOR FUTURE SALE; CONVERTIBLE SECURITIES AND WARRANTS

Future sales of Common Stock in the public market by existing stockholders,
warrant holders and holders of convertible securities subsequent to the date
hereof could adversely affect the market price of the Company's Common Stock. At
December 31, 1997, an aggregate of approximately 32,722,691 shares of Common
Stock were outstanding and freely tradeable without restriction under the
Securities Act. In addition, up to 13,912,273 shares were eligible for resale in
accordance with the manner of sale and volume limitations of Rule 144
promulgated under the Securities Act.

AXCESS has reserved approximately 10,000,000 shares of Common Stock for issuance
upon the exercise of outstanding convertible securities and warrants. As of
December 31, 1997, there were 1,153,846, 1,056,338, 708,530 and 789.74 shares of
Series A, B, C and G Convertible Preferred Stock outstanding, respectively. Each
share of Series A, B and C Convertible Preferred Stock is convertible at any
time, at the option of the holder, into one share of Common Stock. The
conversion price for the Series G Convertible Preferred Stock is $0.50 per
share, subject to the Series G Reset Right. See "Recent Sale of Unregistered
Securities" below.

There are also currently 6,008,189 warrants outstanding to acquire the same
number of shares of Common Stock, as well as $535,000 of indebtedness with a
two-year maturity, convertible into Common Stock at $0.25 per share.

AXCESS has also reserved approximately 1,093,066 shares of Common Stock for
issuance to key employees, officers, directors and consultants pursuant to the
Company's benefit plans. As of December 31, 1997, there were 553,965 options
outstanding.

ITEM 2.  PROPERTIES.

ACCESS CONTROL BUSINESS

Sandia leases a 14,508 square foot facility in Carrollton, Texas used for
administrative, engineering and sales offices. This facility is rented under a
three year agreement that terminates in 2000. In addition, Sandia is the lessor
for two facilities in Paris, France comprising approximately 2,700 square feet
in the aggregate, which are used to house the administrative, engineering and
sales functions of Sandia Europe. Both of these leases expire in June 1998. The
Company's facilities are suitable and adequate to accommodate the Company's
operations. The Company does not intend to renew its leases on two facilities in
Paris, France, each of which expire in June 1998. Instead, the Company plans on
leasing one smaller facility to serve as the Company's European sales support
office. The Asia/Pacific operations are handled by Sandia's

                                     - 13 -

<PAGE>   16




consulting partner, Technology Interests Pty. Ltd in Sydney, Australia, and the
Europe/Africa operations are handled by Sandia's Paris, France office.

MARKING BUSINESS

LMC manufactures laser markers in a 20,000 square foot facility in Albuquerque,
New Mexico, which it occupies under a long-term capital-lease agreement. For
further information with respect to commitments on the properties of the
Company, reference is made to Notes 5 and 6 of the Notes to the Consolidated
Financial Statements for the years ended December 31, 1997, 1996, and 1995.

ITEM 3.  LEGAL PROCEEDINGS.

On February 28, 1996, an investor group filed suit against the Company in the
U.S. District Court for the Southern District of New York. This lawsuit arises
out of the Company's refusal to recognize the investor group's attempt to
exercise an option to purchase 1,400,000 shares of Common Stock at a price of
$.495 per share. The option had been granted to the Company's former President
and CEO, who attempted to transfer his option to the investor group on the last
day of the option term in September of 1995. On that same day, the investor
group attempted to exercise the option. The Company refused to recognize the
attempted transfer of the option to the investor group on the primary grounds
that the option was granted personally to the Company's former President and CEO
and was not transferable to third-parties. The lawsuit seeks issuance and
registration of the 1,400,000 shares upon payment of the exercise price, or in
the alternative, monetary damages which the investor group alleges to be not
less than $2,800,000. On May 1, 1996, the Company moved to dismiss the complaint
on the grounds that the court in New York lacked personal jurisdiction over the
Company. The court denied the motion to dismiss by order dated June 10, 1997.
Subsequently, the Company filed an answer, denying the material allegations of
the complaint and asserting various defenses. On December 31, 1997, plaintiffs
moved for partial summary judgment on the question of liability, as to whether
or not the option was assignable. The Company filed papers opposing this motion
on or about January 26, 1998. The Company believes the claim is without merit
and will vigorously oppose it. However, there can be no assurances that the
Company will prevail in the pending litigation, and an adverse outcome could
have a material adverse effect upon the financial position and liquidity of the
Company.

The Company has had discussions with Xerox regarding the scope of the Company's
license for DataGlyphs(TM), a 2-D symbology developed by Xerox. In 1995, the
Company was granted an exclusive license from Xerox, for an initial license fee
of $2.1 million, for the right to develop and sell products utilizing
DataGlyphs(TM) for the secured access industry. The royalty obligation was
evidenced by the Company's promissory note payable to Xerox, due in three equal
annual principal installments, plus interest, beginning December 1997. In
December 1997, the Company notified Xerox that it would not make the payment due
under the note, pending satisfactory resolution of the Company's concerns
regarding the technological applicability of the products and services provided
by Xerox to the Company pursuant to its license and the payment due in respect
thereof. Xerox then advised the Company in writing that it believed that payment
under the note was past due. To date, the Company has not recognized any sales
revenue related to the DataGlyphs(TM) Technology. The Company and Xerox have
entered into a settlement agreement pursuant to which the Company has agreed to
pay Xerox $1.47 million of the initial license fee and issue Xerox 120,000 (post
reverse-split) shares of the Company's Common Stock. Xerox has agreed not to
sell those shares until December 1999, at which time shares may be sold subject
to certain limitations. The

                                     - 14 -

<PAGE>   17




Company will fund the payment to Xerox from proceeds received from Amphion
Ventures under the terms of a two-year loan which bears interest at the rate of
10% per annum. In addition, Amphion Ventures will receive, as a loan origination
fee, (i) 15,120 (post reverse-split) shares of restricted Common Stock with a
fair value of approximately $68,040 as of the date of issuance and (ii) 3-year
warrants to purchase 14,700 (post reverse-split) shares of Common Stock with an
exercise price of $5.00 per share and with a fair market value of approximately
$25,379 as of the date of issuance.

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

None.



                                     - 15 -

<PAGE>   18




                                     PART II

ITEM 5.  MARKET FOR LASERTECHNICS COMMON EQUITY AND RELATED STOCKHOLDER MATTERS.

The Company's Common Stock trades on the Nasdaq SmallCap Market tier of the
Nasdaq Stock Market under the symbol AXSI. The table below sets forth high and
low last sale prices for the Common Stock during each of the periods indicated,
as reported by the Nasdaq. Such price quotations represent inter-dealer prices
without retail markup, markdown or commission and may not necessarily represent
actual transactions.


<TABLE>
<CAPTION>
                  1997 LAST SALE PRICES     1996 LAST SALE PRICES
                  ---------------------     ---------------------
CALENDAR PERIOD     LOW          HIGH         LOW          HIGH
---------------   --------     --------     --------     --------
<S>                <C>          <C>          <C>          <C>   
FIRST QUARTER      $ 0.47       $ 1.47       $ 1.91       $ 2.06
SECOND QUARTER       0.59         1.00         2.59         2.88
THIRD QUARTER        0.50         0.97         1.31         1.38
FOURTH QUARTER       0.22         0.66         1.00         1.19
</TABLE>

As of December 31, 1997, the Company had approximately 1,500 holders of record
of voting Common Stock and one holder of record of non-voting Common Stock. The
Company estimates that there were approximately 9,000 beneficial owners of its
Common Stock as of the same date.

The Company has not paid dividends on its Common Stock and does not anticipate
the payment of cash dividends in the foreseeable future as it contemplates
retaining all earnings to finance the continued growth of the Company's
business. In addition, certain covenants contained in the Company's financing
arrangements restrict the payment of dividends. See "Management's Discussion and
Analysis of Financial Condition and Results of Operations - Liquidity and
Capital Resources" and Notes 8 and 9 to Notes to Consolidated Financial
Statements for the years ended December 31, 1997, 1996 and 1995.

RECENT SALE OF UNREGISTERED SECURITIES

During the fourth quarter of 1997, the Company issued unregistered securities in
connection with each of the transactions described below. All references in this
section to numbers of shares and to the exercise or conversion prices of
convertible securities were determined without reference to the Reverse Stock
Split Proposal. See "1998 Changes in Capital Stock." The issuance of the
preferred stock, Common Stock, warrants and convertible debentures were exempt
from the registration requirements of the Securities Act by virtue of Section
4(2) thereof as a transaction not involving a public offering and an appropriate
restrictive legend was affixed to the certificates and warrants.

                                     - 16 -

<PAGE>   19





Transactions Involving Convertible Securities

The Company's 10% Convertible Debentures due March 1, 1999 (the "1996
Debentures"), in the original principal amount of $5,500,000, the Company's 10%
Convertible Series B Debenture due March 1, 1999 (the "Series B Debenture"), in
the principal amount of $500,000 and the Company's Series D Convertible
Preferred Stock, $0.01 par value (the "Series D Preferred Stock"), in the
original stated amount of $8,350,000, and Series E Convertible Preferred Stock,
$0.01 par value (the "Series E Preferred Stock") in the original stated amount
of $500,000 became convertible in full into Common Stock at various times during
1996 and 1997.

In May 1997, $600,000 principal amount of the 1996 Debentures was redeemed by
the Company with (i) the proceeds from the private placement to a single new
investor of the Company's Series B Convertible Debenture, due March 1999 in the
principal amount of $500,000 and (ii) $100,000 in proceeds from the private
placement of $500,000 of Series E Preferred Stock with a single new investor.
The Series E Preferred Stock was substantially identical to the terms of the
Series D Preferred Stock and the Series B Convertible Debenture had
substantially identical terms as the 1996 Debentures. In June 1997, $400,000
principal amount of Series D Preferred Stock was redeemed by the Company, upon
receipt of the holder's notice of conversion, with the remaining proceeds from
the sale of Series E Preferred Stock. See "Restructuring of Variable Price
Convertible Securities" below.

Equity Investment by Major Stockholder

In December 1997, the Company concluded an agreement with one institutional
investor with respect to the purchase of 700 shares of a Series G Preferred
Stock for an aggregate purchase price of $7,000,000. The purchase price was
payable primarily through a combination of cash and the cancellation and
exchange of existing indebtedness of the Company to the institutional investor.
In addition, the purchaser had the right to offset a portion of the purchase
price, aggregating approximately $709,000, against the Company's obligation to
pay previously accrued and unpaid cash dividends on outstanding shares of Series
A, Series B and Series C Preferred Stock of the Company held by the
institutional investor on such date, and to pay a portion of such total purchase
price, not to exceed an aggregate of $1,500,000, by delivery of an unconditional
promissory note, payable on demand, in principal amount equal to the portion of
the purchase price so paid.

As additional consideration, the Company agreed that if, at any time on or
before December 31, 1999, the Company completes a financing with third parties
raising at least $3,000,000 in new equity, the initial holders of the Series G
Preferred will have the non-assignable right (the "Series G Reset Right"), but
not the obligation, to exchange all or a portion of their shares of Series G
Preferred Stock for shares of a new series of preferred stock with substantially
the same terms and conditions offered to such third parties; provided that no
such exchange will result in an increase in the conversion price above $.50 per
share (as determined without giving effect to the Reverse Stock Split Proposal).
See "1998 Changes in Capital Stock."



                                     - 17 -

<PAGE>   20




Extension of Bridge Loans

Also in December 1997, the Company concluded an agreement (the "Extension
Agreement") with Amphion Ventures, Antiope Partners and J. P. Morgan Investment
Corporation ("JPMIC"), with respect to the extension of the Company's
obligations under the June Note Purchase Agreement by and among the Company,
Antiope Partners (formerly, Wolfensohn Partners L.P.), Amphion Ventures (by
assignment from Antiope Partners) and JPMIC, and the several Senior Promissory
Notes issued and sold by the Company pursuant to the June Note Purchase
Agreement. The Extension Agreement extended the maturity date of such promissory
notes for one year, through December 31, 1998. In addition, the agreement
provided for the base interest rate on the promissory note payable to JPMIC to
be increased from 6.64% to 10% per annum, which is the same rate originally
payable under the promissory note payable to Antiope Partners. As provided for
in the original June Note Purchase Agreement, on December 31, 1997, the holders
of such promissory notes also became entitled to receive, as a late payment fee,
(i) additional 3-year warrants to purchase 600,000 shares of Common Stock with
an exercise price of $0.25 per share and with a fair market value of
approximately $60,000 as of the date of issuance and (ii) 112,942 additional
shares of restricted Common Stock with a fair market value of approximately
$28,000 as of the date of issuance. The total value of the warrants and Common
Stock issued will be charged to interest expense during 1998, producing a total
effective interest rate of thirteen percent (13%) for 1998 on the Extension
Agreement.

Restructuring of Variable Price Convertible Securities

 In December 1997, the Company entered into negotiations with the holders of
certain outstanding convertible securities of the Company, with respect to the
restructuring and/or refinancing of such securities.

The Company originally issued the 1996 Debentures, the Series B Debentures
(collectively, the "Convertible Debentures"), the Series D Preferred Stock, and
the Series E Preferred Stock in separate private placements to institutional
investors in 1996 and 1997. In July 1997, the Company issued shares of a new
series of Convertible Preferred Stock, Series F, $0.01 par value (the "Series F
Preferred Stock"), in exchange for, and/or to finance the repurchase of, all the
outstanding shares of Series D Preferred Stock and Series E Preferred Stock, as
described below. The terms of the Series F Preferred Stock are substantially
identical to the terms of the Series D and Series E Preferred Stock, except as
necessary to reflect the terms of the Standstill Agreement described below. The
Convertible Debentures, Series D Preferred Stock, Series E Preferred Stock and
Series F Preferred Stock were all convertible into Common Stock at a conversion
price determined by formula, which was generally about 85% of the recent average
market price of the Common Stock at the time of conversion, subject to a fixed
maximum conversion price. The Convertible Debentures, Series D Preferred Stock,
Series E Preferred Stock and Series F Preferred Stock are sometimes referred to
collectively herein as the Company's "Variable Price Convertible Securities".

In July 1997, the Company and certain holders of Variable Price Convertible
Securities negotiated a gated standstill arrangement (the "Standstill
Agreement"), in which such holders agreed to refrain from converting 75% of
their holdings for a period of at least three months, with the locked-up portion
released in five equal monthly installments thereafter. The provisions of the
Standstill Agreement (which also included a reduction in the maximum conversion
price to $1.14 in the case of the Series D and Series E Preferred Stock and
$1.00 in the case of the Convertible Debentures, and the issuance of $.70
warrants to acquire 814,375 shares of Common Stock as an additional inducement
to the participating holders) were implemented by the execution of allonges to
the Convertible Debentures and by exchanging all of the outstanding shares of
Series D Preferred Stock and Series E Preferred Stock for an equal number of
shares of Series F Preferred Stock, which shares were substantially identical to
the shares exchanged, except as necessary to implement the terms

                                     - 18 -

<PAGE>   21




of the Standstill Agreement. Concurrently therewith, the Company issued 48
shares of Series F Preferred Stock to a single existing investor for $480,000 in
cash, which was used by the Company to repurchase and cancel an equal number of
shares of Series D Preferred Stock, the holder of which had declined to
participate in the Standstill Agreement. By December 14, 1997, 70% of the face
amount of the Variable Price Convertible Securities held by such holders on the
date of the Standstill Agreement were available for conversion, with the
remainder to become convertible in equal installments in January and February
1998.

In December 1997, the Company re-initiated negotiations with the holders of the
Variable Price Convertible Securities, with the intention of restructuring or
refinancing such securities to remove the variable price conversion feature. In
December 1997 and January 1998, the Company converted, redeemed or restructured
all of the Variable Price Convertible Securities that had been outstanding on
December 1, 1997, comprising in the aggregate $1,250,000 principal amount of
Convertible Debentures and 237 shares ($2,370,000 face amount) of Series F
Preferred Stock (collectively, the "December 1997 Restructuring"). Based on the
closing bid prices of the Common Stock for the applicable trading periods prior
to December 24, 1997, such Variable Price Convertible Securities, together with
accrued interest and dividends, would have been convertible on that date into an
aggregate of approximately 17 million shares of Common Stock, with further
dilution possible in the event of further declines in the market price of the
Common Stock.

To implement the December 1997 Restructuring, including all related conversions,
the Company made cash payments totaling approximately $1.3 million and issued in
the aggregate approximately: $1.1 million in non-convertible short- term
indebtedness; $535,000 of indebtedness with a two-year maturity, convertible
into Common Stock at $.25 per share (the "1997 Debentures"); 1,407,000 shares of
Common Stock, most of which are subject to certain transfer restrictions; 90
shares of Series G Preferred Stock; and warrants to purchase an additional
1,440,000 shares of Common Stock at an average exercise price in excess of $.46
per share. The fair market value of the additional securities issued, at the
time of their issuance, represents the conversion inducement. The Convertible
Debentures inducement was valued at approximately $48,000 and charged to
interest expense. The inducement for Variable Price Convertible Securities other
than the Convertible Debentures was valued at approximately $306,000 and
recorded as a preferred dividend. The Company funded the cash and short-term
debt portion of the restructuring by issuing shares of Series G Preferred Stock
as described above.


                                     - 19 -

<PAGE>   22




ITEM 6.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
         OF OPERATIONS.

BUSINESS SEGMENTS

The Company operates in two business segments: imaging and marking. Imaging
operations involve the manufacture and sale of plastic card printing systems and
related consumable products to print and encode fraud-resistant wallet-sized
plastic cards for, among other things, drivers' licenses, identification, border
crossing, financial transactions and health care services. Marking is involved
in the manufacture and sale of laser systems which mark consumer and commercial
products with a "freshness date," serial number, lot numbers, logos or bar code.

SELECTED CONSOLIDATED FINANCIAL DATA

The selected consolidated financial data set forth for each of the years 1997,
1996 and 1995 has been derived from the audited consolidated financial
statements for the years ended December 31, 1997, 1996, and 1995 and the notes
thereto. General corporate assets and expenses are allocated to the respective
business segments. Assets used by the respective segments are located at the
operating units of the respective segments and there are no general corporate
assets. General corporate expenses are allocated based on the estimated usage of
financial resources by the respective segments.

<TABLE>
<CAPTION>
                                                         IMAGING            MARKING        CONSOLIDATED
                                                         (Sandia)            (LMC)            (LASX)  
                                                       ------------      ------------      ------------
<S>                                                    <C>               <C>               <C>
YEAR ENDED DECEMBER 31, 1997
Sales ............................................     $  4,353,318      $  6,765,021      $ 11,118,339
Loss from operations .............................       (8,383,449)       (1,808,445)      (10,191,894)
Identifiable assets ..............................        8,934,768         5,750,644        14,685,412
Capital expenditures .............................          178,212          (109,953)           68,259
Depreciation .....................................          417,489            92,359           509,848

YEAR ENDED DECEMBER 31, 1996
Sales ............................................     $  8,197,639      $  9,383,801      $ 17,581,440
Loss from operations .............................       (8,642,620)         (981,376)       (9,623,996)
Identifiable assets ..............................        9,941,186         7,720,671        17,661,857
Capital expenditures .............................          654,832           128,962           783,794
Depreciation .....................................          459,860           265,999           725,859

YEAR ENDED DECEMBER 31, 1995
Sales ............................................     $  3,121,577      $ 10,308,154      $ 13,429,731
Loss from operations .............................       (7,934,839)         (195,374)       (8,130,213)
Identifiable assets ..............................        5,844,770         8,797,832        14,642,602
Capital expenditures .............................          640,528           354,990           995,518
Depreciation .....................................          133,991           218,466           352,457
</TABLE>


                                     - 20 -

<PAGE>   23




RESULTS OF OPERATIONS

CONSOLIDATED RESULTS OF OPERATIONS FOR THE FISCAL YEARS ENDED DECEMBER 31, 1997,
1996 AND 1995

Consolidated Sales. Consolidated sales decreased to $11,118,339 in 1997 from
$17,581,440 in 1996. In 1995 sales totaled $13,429,731.

   Imaging. The Company's imaging business is based largely on the sale of high
volume card printers. The price of a high volume card printer is such that
generally only governments and state agencies have ongoing card volume
production requirements sufficient to justify such a purchase. Historically, new
government customers have consisted primarily of developing nations, resulting
in highly unpredictable selling cycles and procurement demand. In the third
quarter of 1996, the Company was realizing revenue from its Australian drivers'
license project. In 1997, there was no equivalent project in process.
Additionally, revenues from the introduction of GlyphScan readers and
Glyphit(TM) software have not materialized to date, as a result, in part, of the
factors underlying the Company's dispute with Xerox regarding the DataGlyph
technology licensed by the Company. The Company's dispute with Xerox is more
fully described in Note 11 to Notes to Consolidated Financial Statements.

The Company has taken a number of actions to improve future sales. The Company
has restructured its imaging business by reorganizing it into two divisions:
imaging and technology, and expects to expand its market opportunities and
product offerings through the proposed acquisition of advanced imaging and
software technology (the "XLV Technology") from XL Vision, Inc., a Safeguard
Scientifics partnership company ("XLV"). Sandia recently entered into the
Intellectual Property Transfer Agreement (the "Technology Development
Agreement") with XLV for the development and commercialization of the XLV
Technology, which consists of both hardware and software technology. The Company
believes that its secure card industry experience and the XLV Technology will
enable it to develop and market a low cost fraud resistant access control
system. This system would combine the portable card embedded database with
nontransferable personal information, such as finger prints, to permit access
only by the authorized card holder.

Under the terms of the Technology Development Agreement, XLV will continue to
devote personnel, services and project management for the enhancement and
commercialization of the XLV Technology. The Company will fund the enhancement
of the XLV Technology. In January 1998, the Company paid XLV $500,000 and will
make additional payments to XLV in the aggregate amount of $4.1 million for
further development expenses, payable in several installments over the
development period. Such funds will be used to fund technology enhancement
activities by XLV with respect to the XLV Technology, with the goal of making
such technology market-ready, as determined by mutual agreement of the Company
and XLV. Of the $4.1 million earmarked for development expenses, the Company
may, at its option, accelerate funding the development of the XLV Technology.
All payments made prior to the development of a working model, including the
costs of acquiring the options under the Technology Development Agreement, will
be expensed as research and development costs.

The imaging division will (i) continue to resell high volume printers, including
a launch of mid-volume printers for customers with card volume requirements
below that of the Company's historical customers, (ii) market overnight delivery
of fraud-resistant wallet size ID cards to corporate badge and loyalty account
customers through its newly-developed service bureau operation, and (iii) sell
turnkey security systems utilizing biometrics and portable databases on
Company-produced and other vendor cards. The new technology division proposes to
develop and commercialize the XLV Technology to be acquired from XLV,

                                     - 21 -

<PAGE>   24




including digital camera and optical butting technologies, for use in card
readers and other digital image-acquisition applications. This new generation of
card readers is expected to accommodate a wide range of card-mounted
symbologies, including DataGlyphs(TM), at commercially attractive speeds. The
proposed acquisition of the XLV Technology is subject to stockholder approval
and certain other conditions. The Company believes that the diversification
provided by its revised business strategy will help to make its revenue stream
more predictable, and that the corporate access control market, which is
currently highly fragmented, will provide a significantly greater market size
for the Company's expanded product offerings.

The Company's ability to improve future sales may be affected by the volatility
of market demand, timing of large governmental and state agency contracts,
competition and technological innovations. These factors could significantly
effect the Company's ability to compete effectively.

Marking. The Company's marking business was adversely affected by (i) the delay
in the re-introduction of the BlazerJet(TM) marking system, which began shipment
in the summer of 1997, and (ii) the Company's announcement in the second quarter
of 1997 that it had engaged an independent financial advisor to advise on
strategic alternatives for LMC, including the possibility of a disposition or
strategic partnership. The Company believes that this announcement was a
distraction to LMC's management and other potential new employees, and resulted
in a degree of confusion and uncertainty among certain current and potential
customers, thereby delaying LMC's ability to capitalize on the launch of the
BlazerJet(TM). Since the Company's termination of the independent financial
advisor, LMC's management has stabilized relationships with current and
potential customers and key employees, allowing them to refocus on the marking
business. Additionally, significant progress has been made in the development of
strategic relationships aimed at leveraging LMC's distribution capabilities and
creating access to the newest marking technologies.

Sales to the marking business's largest customer, Anheuser-Busch, accounted for
17%, 34% and 21% of LMC's total sales in 1997, 1996 and 1995, respectively. The
loss of this customer or the inability to obtain others would have a material
adverse effect on the Company's results of operations.

Consolidated Gross Profit. Consolidated gross profit as a percentage of sales
(gross margin) remained relatively the same for 1997 at 30% compared to 31% in
1996 and 32% in 1995. In the third quarter of 1997, certain limited shelf-life
imaging business inventories (ribbons and other consumables) were written off.
These inventories had been acquired in anticipation of certain large government
contracts and were purchased in advance of the contracts being awarded to ensure
availability and to take advantage of volume purchase discounts. The related
government contracts have not been awarded and the remaining shelf-life of these
inventories rendered them unusable for the Company's intended customers,
resulting in write-offs of approximately $500,000.

Consolidated Operating Expenses. Consolidated operating expenses were
$13,557,196, $15,047,325 and $12,400,551 in 1997, 1996 and 1995 respectively. In
the third quarter of 1997, Sandia recorded significant accounts receivable
provisions related to two separate contracts. In each case the Company was
acting as a sub-contractor. In connection with one such contract, a dispute
arose between the Company and the prime contractor for the project. Although the
Company had fulfilled all contractual obligations related to revenues
recognized, the Company and the prime contractor agreed to discontinue the
relationship. The Company established $400,000 in reserves on receivables
previously recorded under this contract, considering the degree of uncertainty
as to their ultimate collectability. In connection with the other contract, a
second prime contractor has experienced delays in the launch of their publicly
announced major Asian project, of which the printers purchased from the Company
are an integral part. The Company's contract was not conditioned on the timing
of the prime contractor's project, but the prime contractor additionally
experienced delays in

                                     - 22 -

<PAGE>   25




the receipt of funding from external financing they had expected to have
available when the Company's printers were purchased. The degree of uncertainty
relating to the timing of the project launch combined with the related
uncertainty of the timing of the receipt of their external funding, caused the
Company to establish $200,000 in reserves for receivables previously recorded
under this contract.

In 1996 the Company recorded a loss on settlement of a contract as the result of
discontinuing a manufacturing agreement with its Singapore manufacturer. Sandia
recorded $1,000,000 in expenses as a cost of settling the dispute. In addition,
the imaging segment recorded a $287,000 charge in the third quarter of 1996 to
reduce on-going expenses in its international operations.

Other Income/(Expense). Other income/(expense) consisting primarily of interest
expense including the amortization of discounts and inducements in connection
with the issuance and extension of debt arrangements and securities as more
fully described in Notes 8 and 9 to Notes to Consolidated Financial Statements
was ($2,628,547) in 1997, ($1,774,999) in 1996, and ($2,016,251) in 1995.

Consolidated Net Loss. Consolidated net loss for 1997 was $12,820,441 compared
to the 1996 consolidated net loss of $11,398,995. The 1995 net loss was
$10,146,464.

The Company has restated its consolidated financial statements for the years
ended December 31, 1995 and 1996 to conform its accounting for beneficial
conversion features related to the issuance of convertible debentures in October
1995 and March 1996 and convertible preferred stock issued in July 1996 to
Emerging Issues Task Force Topic No. D-60 issued in March 1997 ("Topic D-60").
Topic No. D-60 requires that the intrinsic value of beneficial conversion
features of convertible debt securities should be recognized as interest expense
over the period from issuance to the first date that conversion can occur.
Previously, the Company was amortizing the estimated fair value of the
beneficial conversion feature to interest expense over the life of the
convertible debentures. Topic No. D-60 further states that the intrinsic value
of beneficial conversion features of convertible preferred stock should be
treated as a return to the preferred stockholder over the period from issuance
to the first date that conversion can occur. The Company had not previously
assigned a value to the beneficial conversion feature of its Series D
Convertible Preferred Stock. See Note 2 to Notes to Consolidated Financial
Statements for the years ended December 31, 1997, 1996 and 1995.

IMAGING BUSINESS RESULTS OF OPERATIONS

Imaging segment sales decreased in 1997 to $4,353,318, or approximately 53% of
1996 sales totaling $8,197,639. Imaging segment sales were $3,121,577 in 1995.
The decrease from 1996 was primarily due to the completion of the Australian
drivers' license project. Sandra did not acquire a similar size project in 1997.

The Imaging segment loss from operations in 1997 was $8,383,449 compared to
$8,642,620 in 1996 and $7,934,839 in 1995. 1996 results include the $1,000,000
loss on contract settlement and the $287,000 charge noted above.

The Imaging segment gross profit margin in 1997 improved to 29.4% compared to
17.3% and 16% in 1996 and 1995, respectively. Lower margins in 1996 were
primarily the result of Sandia's first significant drivers' license contract
(the Australian drivers' license contract) at margins that insured Sandia would
be awarded the contract. In 1995 the lower margins were the result of larger
than expected OEM sales of plastic card printers which carry a lower selling
price and lower margin than direct sales to end users, and because of the sale
of custom-designed plastic card printers which have a higher manufacturing cost
than standard models.

                                     - 23 -

<PAGE>   26




Imaging segment operating expenses decreased 4.0% in 1997 to $9,661,795. Imaging
segment operating expenses increased 19% in 1996 to $10,061,712 from the
$8,421,492 of operating expenses in 1995. The 1996 increase of $1,640,220 was
primarily the result of approximately $360,000 increase in sales and marketing
costs for the continued expansion of Sandia worldwide operations and the
$1,000,000 and $287,000 charges noted above.

Research and development expense for 1997 was $1,634,671 compared to $2,053,111
for 1996 and $1,963,537 for 1995. The research and development costs incurred in
1997, 1996 and 1995 were primarily for manufacturing development, DataGlyphs(TM)
software development and hardware and software upgrading of Sandia's high speed
plastic card printers. Research and development expenses were lower in 1997 as a
result of the completion of certain custom products in 1996.

Sales and marketing expenses increased approximately 22% in 1997 to $4,776,741
as a result of the accounts receivable provisions previously discussed, compared
to $3,737,867 in 1996 and $3,376,618 in 1995. General and administrative
expenses remained relatively constant in 1997 at $3,250,383 compared to 1996 and
1995.

MARKING BUSINESS RESULTS OF OPERATIONS

The 1997 operating loss for the Marking segment was $1,808,445 compared to the
1996 operating loss of $981,376, and the 1995 operating loss of $195,374.

Marking segment sales decreased approximately 28.0% to $6,765,021 following a
decrease of 9%, from $10,308,154 in 1995 to $9,383,801 in 1996. The decrease in
1997 was primarily due to the delay in the reintroduction of the BlazerJet(TM)
marking system and customer's reluctance to place orders while the disposition
of the Marking business was under consideration.

The 1997 gross profit percentage for the Marking segment was 31% compared to 44%
in 1996 and 37% in 1995. The decline in margin in 1997 was primarily a result of
an inventory write-down of $441,000 for slow moving inventory. Higher margin
service sales were the major contributor to the 1996 and some extent 1995
overall margins.

Marking segment operating expenses for 1997 were $3,895,401 compared to
$4,985,613 and $3,979,059 in 1996 and 1995, respectively. The 1997 decrease was
primarily the result of a $700,000 decrease in general and administrative
expenses, a $500,000 decrease in marketing expenses, and an increase of $140,000
in research and development expenses. The general and administrative decrease
resulted from reductions in bad debt expense, legal and accounting fees, and
salaries and benefits due to personnel reductions. Marketing expenses decreased
because of decreased travel. Research and development expense increased due to
continued enhancements on the BlaserJet(TM). The 1996 increase of 25% over 1995,
was primarily the result of a $610,000 increase in general and administrative
expenses, a $500,000 increase in marketing expenses and a $281,000 reduction in
research and development expenses. The reduction in research and development is
the result of narrowing the scope of research and development activities to
upgrading current marking systems only.


                                     - 24 -

<PAGE>   27




LIQUIDITY AND CAPITAL RESOURCES

Since inception, the Company has utilized the proceeds from a number of public
and private sales of its equity securities, the exercise of options and warrants
and more recently, convertible debt and short-term bridge loans from
shareholders to meet its working capital requirements.

The Company's foreign sales are generated by Sandia Europe (located in Paris,
France), Sandia and LMC. Sandia Europe sales and operating costs are primarily
denominated in French Francs. Sandia and LMC sales are in US dollars. Although
the Company funds some of its European operations out of the U.S., currency
exchange exposure is considered minimal because the majority of French franc
expenses are funded with French franc revenues.

The Company's operations continued to generate losses in 1997, primarily due to
lower than expected sales in both the imaging and marking businesses. The
Company's future working capital requirements will depend upon many factors,
including the extent and timing of the Company's product sales, the Company's
operating results and the status of competitive products. The Company
anticipates that its existing working capital resources and revenues from
operations, together with the additional financing in the aggregate amount of
$5,500,000 arranged in the first quarter of 1998. (See Note 18 to Notes to
Consolidated Financial Statements), will not be adequate to satisfy its funding
requirements in 1998. The Company is continuing discussions with a number of
existing and potential corporate, strategic and institutional investors. The
Company's actual funding needs will depend on numerous factors, including actual
expenditures and revenues generated from its operations compared to its business
plan. The Company's actual funding needs will also depend on the successful
development of the new products contemplated under the Technology Development
Agreement and other unanticipated expenditures, none of which can be predicted
with certainty. There can be no assurance, however, that the Company will
acquire the additional funding it needs to fully pursue its business objectives.
If the Company's losses continue, the Company may have to obtain sufficient
funds to meet its cash requirements through strategic or other financial
transactions with compatible entities having the resources to support its
programs, the sale of assets or securities or other financing arrangements, or
it will be required to curtail its programs or seek a merger partner. Any
additional funding may be on terms which are unfavorable to the Company or
disadvantageous to existing stockholders. In addition, no assurance may be given
that the Company will be successful in raising additional funds or entering into
business alliances.

In 1983, the City of Albuquerque, New Mexico issued 8% tax-exempt industrial
development revenue bonds in connection with a 25-year capital lease of LMC's
headquarters facility. The principal amount outstanding as of December 31, 1997
was $807,935. Pursuant to its agreement with the City of Albuquerque,
Lasertechnics is required to maintain a current ratio of at least 1 to 1. At
December 31, 1997, the Company's current ratio was less than 1 to 1 which is not
in compliance with the agreement. As a result, the full amount of the lease was
classified as a current liability on the Company's balance sheet at December 31,
1997. Failure of the Company to obtain a waiver could result in the relocation
of LMC headquarters to other facilities and the associated disruption of the
business, as well as increased difficulty in obtaining financing and credit, and
could affect the Company's ability to continue as a going concern. The Company
intends to seek a waiver of non-compliance during 1998 relating to this covenant
violation. See Note 6 to Notes to Consolidated Financial Statements.


                                     - 25 -

<PAGE>   28




OTHER

Nasdaq Listing. On August 22, 1997, the Commission approved the New Nasdaq
Listing Requirements (as defined below) for continued listing on the Nasdaq
SmallCap Market. In particular, the New Nasdaq Listing Requirements require that
a Company currently included in Nasdaq meet each of the following standards to
maintain its continued listing: (i) either (A) net tangible assets (defined as
total assets, minus goodwill, minus total liabilities) of $2 million, (B) total
market capitalization of $35 million, or (C) net income (in the latest fiscal
year or in two of the last three fiscal years) of $500,000; and (ii) public
float of at least 500,000 shares, with a market value of at least $1 million;
and (iii) minimum bid price of $1; and (iv) at least two market makers; and (v)
at least 300 round lot beneficial shareholders; and (vi) compliance with certain
corporate governance requirements (the "New Nasdaq Listing Requirements"). As of
April 2, 1998, the first full trading day after the Company gave notice to
Nasdaq that the 1-for-20 reverse stock split was approved by its stockholders,
the closing price of the Common Stock was $5.00 per share, which is in
compliance with the New Nasdaq Listing requirements. Further, by letter dated
April 15, 1998, Nasdaq advised the Company that it was in compliance with the
New Nasdaq Listing Requirements and approved the Company's continued listing on
Nasdaq. There can be no assurance, however, that the Company's continued losses
or other factors beyond the control of the Company will not cause the Company to
fail to meet such requirements. See Note 18 to Notes to Consolidated Financial
Statements.

Inflation. Inflation has not had and is not expected to have a material impact
on the operations and financial condition of the Company.

Recent Accounting Pronouncements. In February 1997, the Financial Accounting
Standards Board issued SFAS No. 129, "Disclosure of Information about Capital
Structure" ("SFAS 129"). SFAS 129 is applicable to all entities and requires
that disclosure about any entity's capital structure include a brief discussion
of rights and privileges for securities outstanding. SFAS 129 is effective for
financial statements for periods ending after December 15, 1997. The effective
adoption of SFAS No. 129 is not expected to have a material impact on the
Company's financial statements and related disclosures.

In June 1997, the Financial Accounting Standards Board issued SFAS No. 130,
"Reporting Comprehensive Income" ("SFAS 130"). SFAS 130 is effective for fiscal
years beginning after December 15, 1997. This statement establishes standards
for reporting and display of comprehensive income and its components. The
effective adoption of SFAS No. 130 is not expected to have a material impact on
the Company's financial statements and related disclosures.

In June 1997, the Financial Accounting Standards Board issued SFAS No. 131,
"Disclosure about Segments of an Enterprise and Related Information" ("SFAS
131"). SFAS 131 is effective for fiscal years beginning after December 15, 1997.
This statement establishes standards for the way that public companies report
information about segments in annual and interim finanical statements. The
effective adoption of SFAS No. 131 is not expected to have a material impact on
the Company's financial statements and related disclosures.

Caution Regarding Forward-Looking Statements. The Company occasionally makes
forward-looking statements concerning its plans, goals, product and service
offerings, and anticipated financial performance. These forward-looking
statements may generally be identified by introductions such as "outlook" for an
upcoming period of time, or words and phrases such as "should", "expect",
"hope", "plans", "projected", "believes", "forward-looking" (or variants of
those words and phrases) or similar language indicating the expression of an
opinion or view concerning the future.


                                     - 26 -

<PAGE>   29




These forward-looking statements are subject to risks and uncertainties based on
a number of factors and actual results or events may differ materially from
those anticipated by such forward-looking statements. These factors include, but
are not limited to: the ability to raise capital; the growth rate of the
Company's revenue and market share; the consummation of new, and the
non-termination of, existing relationships with customers and suppliers; the
Company's ability to effectively manage its business functions while growing the
Company's business in a rapidly changing environment; the ability of the Company
to adapt and expand its services in such an environment; the effective and
efficient development of new products; and the quality of the Company's plans
and strategies, and the ability of the Company to execute such plans and
strategies.

In addition, forward-looking statements concerning the Company's expected
revenue or earnings levels are subject to many additional uncertainties
applicable to competitors generally and to general economic conditions over
which the Company has no control. The Company does not plan to generally
publicly update prior forward-looking statements for unanticipated events or
otherwise and, accordingly, prior forward-looking statements should not be
considered to be "fresh" simply because the Company has not made additional
comments on those forward-looking statements. See "Cautionary Statements" in the
Company's Form 10-KSB for the period ended December 31, 1997.






                                     - 27 -

<PAGE>   30




ITEM 7.  FINANCIAL STATEMENTS.

<TABLE>
<CAPTION>
                                                                                                Page
                                                                                                ----
<S>                                                                                             <C>
CONSOLIDATED FINANCIAL STATEMENTS:
     Independent Auditors' Report..............................................................  F-1
     Consolidated Balance Sheets as of December 31, 1997 and 1996..............................  F-2
     Consolidated Statements of Operations for the Years
         Ended December 31, 1997, 1996 and 1995................................................  F-3
     Consolidated Statements of Stockholders' Equity for the Years
         Ended December 31, 1997, 1996 and 1995................................................  F-4
     Consolidated Statements of Cash Flows for the Years
         Ended December 31, 1997, 1996 and 1995................................................  F-5
     Notes to Consolidated Financial Statements ...............................................  F-6
</TABLE>

The following consolidated financial statement schedule of the Company is filed
as a part of this report:

FINANCIAL STATEMENT SCHEDULE

<TABLE>
<CAPTION>
                                                                                                 Page
                                                                                                 ----
<S>                                                                                              <C>
     Schedule II--Valuation and Qualifying Accounts............................................  S-1
</TABLE>

All other financial statement schedules have been omitted because they are not
applicable or the required information is shown in the consolidated financial
statements and notes thereto.


ITEM 8.  CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING
         AND FINANCIAL DISCLOSURE.

None.


                                     - 28 -

<PAGE>   31
                                    PART III

ITEM 9.  DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS;
         COMPLIANCE WITH SECTION 16(A) OF THE EXCHANGE ACT.

   The board of directors elects executive officers annually at its first
meeting following the annual meeting of stockholders. The following table sets
forth, as of March 1, 1998, the names of the directors and the executive
officers of the Company and its subsidiaries, their respective ages and their
respective positions with the Company and its subsidiaries.

<TABLE>
<CAPTION>
NAME                                     AGE                   POSITION
----                                     ---                   --------
<S>                                       <C>             <C>
Richard C.E. Morgan....................   53              Chairman of the Board of Directors and Chief
                                                          Executive Officer-- Company; Director-- LMC;
                                                          Chairman of the Board of Directors-- Sandia

Jean Pierre Arnaudo....................   53              Director-- Company; Director and Chief Executive
                                                          Officer-- Sandia

Eugene A. Bourque......................   53              Director-- Company; Director, Chairman of the
                                                          Board, President and Chief Executive Officer-- LMC

Harry S. Budow.........................   36              Director and Secretary-- Company; Director,
                                                          President and Chief Operating Officer-- Sandia

Danny G. Hair*.........................   48              Executive Vice President and Chief Financial Officer
                                                          -- Company

C. Seth Cunningham.....................   42              Director-- Company; Director-- Sandia and LMC

Richard M. Clarke......................   66              Director-- Company; Director-- Sandia and LMC

Alfred E. Paulekas.....................   66              Director-- Company; Director-- LMC

Paul J. Coleman, Jr....................   66              Director-- Company
</TABLE>

*Mr. Hair was appointed to his position by the Board on February 1, 1998.

--------------------------------------------------------------------------------

   RICHARD C.E. MORGAN is Chairman of the Board and Chief Executive Officer of
the Company. Mr. Morgan is also the Chairman of the Board of Directors of Sandia
and serves on the Board of Directors of LMC. He is a member of the executive,
compensation and stock option committees. Since 1986 Mr. Morgan has been a
managing member of Antiope Partners and Amphion Partners. Mr. Morgan became a
director and Chairman of the Board of the Company in 1985.

   JEAN-PIERRE ARNAUDO is a director of the Company and a director and Chief
Executive Officer of Sandia. From 1993 until his appointment as Chief Executive
Officer of Sandia, Mr. Arnaudo served as the President and General Manager of
Sandia Imaging Systems Europe, S.A., a subsidiary of Sandia. Mr. Arnaudo became
a director of the Company in 1995.

   EUGENE A. BOURQUE is a director of the Company and is a director, Chairman of
the Board, President and Chief Executive Officer of LMC. He is a member of the
executive committee. From 1993 to 1995, Mr. Bourque served as President of the
Company. From 1988 to 1993, Mr. Bourque served as Vice President and Chief
Financial Officer of the Company. Mr. Bourque became a director of the Company
in 1993.


                                     - 29 -

<PAGE>   32




   HARRY S. BUDOW is a director and Secretary of the Company and President and
Chief Operating Officer of Sandia. He is a member of the executive committee.
Before joining the Company, Mr. Budow was Vice President of Bell Packaging
Corporation from January 1996 to February 1997 and Senior Vice President with
SpectraVision, Inc. from March 1990 to December 1995.

   DANNY G. HAIR is Executive Vice President and Chief Financial Officer of the
Company and Sandia. Mr. Hair was chief financial officer of PC Service Source,
Inc. from January 1997 to January 1998, Bell Packaging Corporation from January
1995 to November 1996, and SpectraVision, Inc., from April 1991 to October 1995.

   C. SETH CUNNINGHAM is a director of the Company, as well as Sandia and LMC.
He is a member of the audit committee. From 1979 to mid-1996, Mr. Cunningham was
employed by J.P. Morgan, and has served as a managing director since 1991. From
1985 to mid-1996, Mr. Cunningham worked with and was a founding member of, J.P.
Morgan Capital Corporation, which makes worldwide private equity investments for
J.P. Morgan's own account. Currently, Mr. Cunningham is a private equity
investor. Mr. Cunningham became a director of the Company in 1994.

   RICHARD M. CLARKE is a director of the Company, Sandia and LMC. He is a
member of the compensation and stock option committees. Since 1992, Mr. Clarke
has been the chairman of Yankelovich Partners, Inc., a market research firm.
From 1990 to 1993 Mr. Clarke was the chairman and chief executive officer of
Akzo America Inc., a diversified international chemical and health care
corporation. Mr. Clarke is the chairman of NESC and the vice chairman of
Farleigh Dickinson University. Mr. Clarke became a director of the Company in
1988.

   ALFRED E. PAULEKAS is a director of the Company and a director of LMC. He is
a member of the compensation committee. Since 1992, Mr. Paulekas has been
President of A.T.C. Associates, a business consulting firm. Mr. Paulekas became
a director of the Company in 1994.

   PAUL J. COLEMAN, JR. is a director of the Company. He is a member of the
audit and stock option committees. He is president, chief executive officer, and
a trustee of the Universities Space Research Association, a non-profit space
research, technology and education company, and a professor of space physics at
the University of California at Los Angeles ("UCLA"). He also serves as a
director of Quantrad Sensors, Inc., One Room Systems, Inc. and Southeast
Interactive Technology, LLC. From 1993 through 1996, Dr. Coleman was the
director of the National Institute for Global Environmental Change of the U.S.
Department of Energy, and from 1989 through 1993, he was the director of the
Institute of Geophysics and Planetary Physics at UCLA. Mr. Coleman became a
director of the Company in 1982.

COMPLIANCE WITH SECTION 16(a) OF THE SECURITIES EXCHANGE ACT

   Under Section 16(a) of the Exchange Act, directors, certain officers and
beneficial owners of ten percent or more of the Company's Common Stock are
required from time to time to file with the Commission reports on Forms 3, 4 or
5, relating principally to transactions in Company securities by such persons.
Based solely upon a review of Forms 3, 4 and 5 submitted to the Company during
and with respect to 1997, and written representations received by the Company
from certain reporting persons that no Forms 5 were required from such persons,
the Company believes that all of the directors and executive officers of the
Company have timely filed their respective Forms 3, 4 or 5 required by Section
16(a) of the Securities Exchange Act during 1997, except Harry Budow, a director
and officer of the Company, who did not file timely a Form 3 when he joined the
Company in June 1997. Mr. Budow does not own any Common Stock or options to
acquire Common Stock.

                                     - 30 -

<PAGE>   33




ITEM 10.  EXECUTIVE COMPENSATION.

   The following table summarizes the compensation earned by the Company's Chief
Executive Officer and its three other most highly compensated executive officers
(whose compensation exceeded $100,000 in 1997) and two additional individuals
for whom disclosures would have been provided had the individuals been serving
as executive officers as of December 31, 1997, collectively, the "Named
Officers," for services rendered in all capacities to the Company during the
fiscal years ended December 31, 1997, 1996 and 1995.

                           SUMMARY COMPENSATION TABLE

<TABLE>
<CAPTION>
                                                                            Long-Term
                                                 Annual Compensation       Compensation
                                                 -------------------       ------------
                                                                            Securities
                                                                            Underlying
                                                                             Options/        All Other
                                                Salary          Bonus          SARs         Compensation
  Name and Principal Positions       Year         ($)           ($)             (#)             ($)
  ----------------------------     ------      ---------       -----           -----        ------------
<S>                                  <C>         <C>           <C>             <C>          <C>
Richard C.E. Morgan..............    1997        60,000          --             --             40,000
  Chief Executive Officer (A)        1996       100,000          --          60,000(E)           --
                                     1995         --             --           5,000(F)           --

Jean-Pierre Arnaudo..............    1997       180,000        40,000           --           37,956(J)
  Chief Executive Officer -          1996       180,000        50,000       162,500(F)       49,700(J)
  Sandia (B)                         1995       150,000        25,000        75,000(G)       10,840(J)

Eugene A. Bourque................    1997       140,000         5,625           --               --
  President and Chief Executive      1996       138,358          --          80,000(H)           --
  Officer - LMC (B)                  1995       125,029          --             --               --

Harry S. Budow...................    1997        87,500        22,498        50,000(F)           --
  President and Chief Operating      1996         --             --             --               --
  Officer - Sandia (C)               1995         --             --             --               --

Milo Mattorano...................    1997       122,083          --             --               --
  former Vice President and Chief    1996        93,747        10,000       111,000(I)           --
  Financial Officer of the           1995        65,000        10,000         5,000(F)           --
Company
  and Sandia (D)

Stephen C. Nesbit................    1997       117,384          --             --               --
  former Vice President and          1996       120,000        30,000        81,000(F)           --
  General Manager DataGlyphs         1995        30,000        22,500        20,000(F)           --
  Business - Sandia (D)
</TABLE>

--------------------

(A) Mr. Morgan receives an annual salary of $100,000, $60,000 of which is
    payable in cash and $40,000 of which is payable in Common Stock. The cash
    and stock portions of Mr. Morgan's 1997 salary have been accrued, but remain
    unpaid as of the date of report.

(B) Mr. Arnaudo's compensation for January to May 1995 was for his service as
    the President of the Company and the President and General Manager of Sandia
    Europe, S.A., a subsidiary of Sandia.

(C) Mr. Budow joined the Company in June 1997.

(D) Mr. Mattorano and Mr. Nesbit resigned in December 1997.

                                     - 31 -

<PAGE>   34





(E) Securities underlying options are 50,000 shares of Common Stock and 10,000
    shares of LMC Common Stock.

(F) Securities underlying options are shares of Sandia Common Stock.

(G) Securities underlying options are 50,000 shares of Common Stock and 25,000
    shares of Sandia Common Stock.

(H) Securities underlying options are shares of LMC Common Stock.

(I) Securities underlying options are 91,000 shares of Sandia Common Stock and
    20,000 shares of Common Stock.

(J) Represents the payment of transitional living expenses incurred from January
    1996 to December 1997, under Mr. Arnaudo's Employment Agreement with the
    Company. Represents the payment of (i) moving expenses incurred due to Mr.
    Arnaudo's relocation from Paris, France to Dallas, Texas and (ii)
    transitional living expenses incurred from September 1, 1995 to December 31,
    1995, pursuant to Mr. Arnaudo's Employment Agreement with the Company. See
    "Employment Contracts with Executive Officers."

OPTION GRANTS

         The Company did not grant any options to acquire the Company's Common
Stock to the Named Officers during the fiscal year ended December 31, 1997.

AGGREGATE OPTION EXERCISES IN 1997 BY THE COMPANY'S EXECUTIVE OFFICERS

   The following table provides information as to options exercised, if any, by
each of the Named Officers in 1997 and the value of options held by those
officers at year-end measured in terms of the last reported sale price for the
shares of the Company's Common Stock on December 31, 1997 ($4.40 post reverse
split as reported on Nasdaq). All share amounts reported take into account the
adoption of the Reverse Stock Split Proposal.


                AGGREGATED OPTION EXERCISES IN 1997 AND YEAR-END
                                  OPTION VALUES

<TABLE>
<CAPTION>
                                                                                                  Value of Unexercised
                                   Shares                               Number of                     in-the-Money
                                  Acquired                        Securities Underlying                Options at
                                    on           Value             Unexercised Options              December 31, 1997
                                  Exercise      Realized          at December 31, 1997(#)                (A)($)
                                  --------      --------          -----------------------         --------------------
        Name                        (#)           ($)          Exercisable    Unexercisable    Exercisable    Unexercisable
        ----                        ---           ---          -----------    -------------    -----------    -------------
<S>                               <C>           <C>            <C>            <C>              <C>            <C>
Richard C. E. Morgan                 --            --            1,875            625               --             --
                                                                10,000(B)      10,000(B)            --             --
                                                                 2,500(C)       7,500(C)            --             --
Jean-Pierre Arnaudo                  --            --            1,875            625               --             --
                                                                80,417(B)     287,500(B)            --             --
Eugene A. Bourque                    --            --            7,314             --               --             --
                                                                16,000(C)      64,000(C)            --             --
Harry S. Budow                       --            --           50,000(B)     150,000(B)            --             --
Milo Mattorano (D)                   --            --            5,000         15,000               --             --
                                                                 2,188(B)      96,000(B)            --             --
Stephen C. Nesbit (D)                --            --           20,000(B)      81,000(B)            --             --
</TABLE>

-------------------------

(A) Market value of shares covered by in-the-money options on December 31, 1997,
    less option exercise price. Options are in-the-money if the market value of
    the shares covered thereby is greater than the option exercise price.


                                     - 32 -

<PAGE>   35




(B) Securities underlying options are shares of Sandia Common Stock.

(C) Securities underlying options are shares of LMC Common Stock.

(D) In December 1997, Mr. Mattorano resigned as Vice President and Chief
    Financial Officer of the Company and Sandia, and Mr. Nesbit resigned as Vice
    President and General Manager of DataGlyphs Business. In connection with
    their resignations, all options held by Messrs. Mattorano and Nesbit have
    been cancelled.

COMPENSATION OF THE COMPANY'S DIRECTORS

    The Company's current policy is that non-employee directors of the Company
are eligible to receive an annual fee of $10,000 for preparing for and attending
meetings of directors and committees. While directors do not receive additional
compensation for attending meetings, the Company will pay ordinary and necessary
out-of-pocket expenses for directors to attend board and committee meetings.
Directors who are officers or employees of the Company receive no fees for
service on the board or committees thereof. Directors who serve on the board of
directors of Sandia or LMC are not separately or additionally compensated for
such service. Each director attended 100% of (i) the total number of meetings of
the board held during the period in which he was a director and (ii) the total
number of meetings held by all committees on which he served.

    The board of directors has adopted the Director Compensation Plan, subject
to stockholder approval at the Company's 1998 annual meeting of stockholders
(the "Annual Meeting"), under which directors who are not employees of the
Company and who do not beneficially own more than 5% of the shares of Common
Stock outstanding would receive an initial one-time grant of 4,000 options to
acquire Common Stock at an exercise price of $10.00 per share (the "Initial
Grant") and an annual grant of 2,000 options to acquire Common Stock at an
exercise price equal to the fair market value per share of the Common Stock at
the time the option is granted (the "Annual Grant"). Assuming the Director
Compensation Plan is approved by the stockholders at the Annual Meeting, the
Initial Grant and Annual Grant will take place shortly after the Annual Meeting.
The Annual Grant will customarily occur on the date of the Company's annual
meeting. All new board members will receive 3,000 options to acquire Common
Stock at an exercise price equal to the fair market value per share of the
Common Stock on the date the board member is approved by the directors. The
Company has temporarily suspended paying any cash to eligible directors for
preparing and attending meetings of directors and committees until the Company
reports quarterly net earnings. Once the Company has reported net earnings for a
fiscal quarter, the Company will reconsider paying additional cash consideration
to eligible directors.

EMPLOYMENT CONTRACTS WITH EXECUTIVE OFFICERS

    Sandia and Jean-Pierre Arnaudo are parties to an employment agreement, which
provides for the employment of Mr. Arnaudo through August 31, 2002 at a minimum
annual base salary of $160,000, subject to increase by the board of directors of
Sandia. The agreement also provides for the payment to Mr. Arnaudo of up to one
times his annual salary in the event he is terminated after a change in control
(as defined in the employment agreement) of Sandia or if he is terminated
without cause at the election of the board of directors of Sandia. The
employment agreement also contains confidentiality and non-competition
provisions.


                                     - 33 -

<PAGE>   36




ITEM 11.  SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
          MANAGEMENT.

    The following table sets forth the number of shares of (i) Common Stock,
(ii) Non-Voting Common Stock, (iii) Series A Preferred Stock, (iv) Series B
Preferred Stock, (v) Series C Preferred Stock, (vi) Series G Preferred Stock,
(vii) common stock, par value $.01 per share, of Sandia Imaging Systems
Corporation ("Sandia Common Stock") and (viii) common stock, par value $.01 per
share, of LMC ("LMC Common Stock") beneficially owned as of March 1, 1998, after
taking into account the approval of the Reverse Stock Split Proposal, by (i)
each director and director nominee who beneficially owns Common Stock and
certain of the executive officers of the Company and its subsidiaries, (ii) all
of the Company's directors and executive officers as a group and (iii) each
person known by the Company to be the beneficial owner of more than 5% of the
Company's Common Stock as of March 1, 1998. The business address of each
director and executive officer is c/o AXCESS Inc., 3208 Commander Drive,
Carrollton, Texas 75006.

    The number of shares of the Company's Common Stock and Preferred Stock
beneficially owned by each individual set forth below under the heading
"Percentage of Class" is determined under the rules of the Securities and
Exchange Commission, and the information is not necessarily indicative of
beneficial ownership for any other purpose. Under such rules, beneficial
ownership includes any shares as to which an individual has sole or shared
voting power or investment power and any shares that an individual presently, or
within 60 days, has the right to acquire through the exercise of any stock
option or warrant. However, such shares are not deemed to be outstanding for the
purpose of computing the percentage of outstanding shares beneficially owned by
any other person. Unless otherwise indicated, each individual has sole voting
and investment power (or shares such powers with their spouse) with respect to
the shares of the Company's Common Stock and Preferred Stock set forth in the
table below:


NAME OF BENEFICIAL OWNER

<TABLE>
<CAPTION>
DIRECTORS AND NOMINEES FOR DIRECTORS                                                                                 PERCENTAGE OF
(INCLUDING THOSE WHO ARE ALSO EXECUTIVE                                          NUMBER OF SHARES       PERCENTAGE      COMPANY
OFFICERS):                                              TITLE OF CLASS          BENEFICIALLY OWNED       OF CLASS     VOTING POWER
                                                        --------------          ------------------       --------     ------------
<S>                                                  <C>                        <C>                      <C>          <C>
     Richard C.E. Morgan ........................    Common Stock                   530,744(1)            21.5%          12.3%
                                                     Series A Preferred Stock        57,692(2)           100.0%           1.7%
                                                     Series B Preferred Stock        52,816(3)           100.0%           1.5%
                                                     Series C Preferred Stock        25,492(4)            72.0%           0.7%
                                                     Series G Preferred Stock           955(5)              96%          27.5%
                                                     Sandia Common Stock             10,000(6)(9)          *              n/a

     Jean-Pierre Arnaudo ........................    Common Stock                     1,875(7)             *               *
                                                     Sandia Common Stock            287,500(8)(9)         3.29%           n/a

     Eugene A. Bourque ..........................    Common Stock                     7,814(10)            *               *
                                                     LMC Common Stock                10,000(9)(11)         *              n/a
                                                     Sandia Common Stock             32,000(12)            *              n/a

     Harry S. Budow .............................    Sandia Common Stock             50,000(13)            *              n/a
</TABLE>



                                     - 34 -

<PAGE>   37

NAME OF BENEFICIAL OWNER

<TABLE>
<CAPTION>
DIRECTORS AND NOMINEES FOR DIRECTORS                                                                                  PERCENTAGE OF
(INCLUDING THOSE WHO ARE ALSO EXECUTIVE                                           NUMBER OF SHARES     PERCENTAGE        COMPANY
OFFICERS):                                             TITLE OF CLASS            BENEFICIALLY OWNED     OF CLASS      VOTING POWER
                                                       --------------            ------------------     --------      ------------
<S>                                                  <C>                         <C>                    <C>           <C>
     Richard M. Clarke ..........................    Common Stock                   13,250                 *               *
                                                     Sandia Common Stock            10,000(9)(14)          *              n/a

NAME OF BENEFICIAL OWNER

     C. Seth Cunningham .........................    Common Stock                    4,250(15)             *               *

     Paul J. Coleman, Jr ........................    Common Stock                      903(16)             *               *
                                                     Sandia Common Stock             7,500(9)(17)          *              n/a

     Alfred E. Paulekas .........................    Common Stock                    2,250(18)             *               *

EXECUTIVE OFFICERS:

     Danny G. Hair ..............................    Common Stock                    2,000                 *               *

     All Directors and Executive Officers .......    Common Stock                  559,032(19)           22.8%           19.2%

     as a group (8 individuals) .................    Sandia Common Stock           434,667(3)(20)         7.9%            4.9%

OTHER:

     Amphion Group ..............................    Common Stock                  508,452(21)           20.8%           17.7%

     590 Madison Avenue .........................    Series A Preferred Stock       57,692              100.0%            1.7%

     New York, NY 10021 (24) ....................    Series B Preferred Stock       52,816              100.0%            1.5%
                                                     Series C Preferred Stock       25,492(22)           72.0%            0.7%
                                                     Series G Preferred Stock          955                96%            27.5%

     J.P. Morgan Investment Corporation
     60 Wall Street .............................    Common Stock                  289,422(23)           11.7%           11.4%

     New York, NY 10060 .........................    Non-Voting Common Stock       112,492              100.0%            n/a
</TABLE>

------------------------------------------------------------------------
     *    Denotes percentage ownership of less than 1%.


     (1)  Includes 1,875 shares that Mr. Morgan has the right to acquire within
          60 days pursuant to options, 411,906 shares held by entities within
          the Amphion Group (defined in Note 24 below) and 92,703 shares that
          entities within the Amphion Group have the right to acquire within 60
          days pursuant to warrants. Mr. Morgan is a Managing Member of Amphion
          Partners L.L.C. ("Amphion Partners"), the sole general partner of
          Amphion Ventures. Mr. Morgan disclaims beneficial ownership as to all
          such shares beneficially owned by entities within the Amphion Group.
          See Note 24.

     (2)  All 57,692 shares are held by Amphion Ventures. See Note 1 and Note
          24.

     (3)  All 52,816 shares are held by Amphion Ventures. See Note 1 and Note
          24.

     (4)  All 25,492 shares are held by Amphion Ventures. Does not include 9,933
          shares held by Jackson Hole Investments Acquisitions, L.P., ("Jackson
          Hole"). Jackson Hole is not affiliated with Amphion Ventures. See Note
          1 and Note 24.

     (5)  Includes 905 shares held by Amphion Ventures and 50 shares held by
          Antiope Partners. See Note 1 and Note 24.

     (6)  Includes 10,000 shares that Mr. Morgan has the right to acquire within
          60 days pursuant to options.

     (7)  Includes 1,875 shares that Mr. Arnaudo has the right to acquire within
          60 days pursuant to options.

     (8)  Includes 80,417 shares that Mr. Arnaudo has the right to acquire
          within 60 days pursuant to options.

     (9)  The authorized capital stock of Sandia consists of (i) 18,000,000
          shares of Sandia Common Stock, of which 4,830,000 shares are issued
          and outstanding and held by the Company and 260,000 shares are issued
          and outstanding and held by certain individuals employed or previously
          employed by Sandia or the Company, (ii) 3,500,000 shares of Sandia
          Voting Convertible Preferred Stock, of which 3,370,925 shares are
          issued and outstanding and held by the Company.

     (10) Includes 7,314 shares that Mr. Bourque has the right to acquire within
          60 days pursuant to options.

     (11) Includes 10,000 shares that Mr. Bourque has the right to acquire
          within 60 days pursuant to options.

     (12) Includes 32,000 shares of preferred stock convertible into common
          stock that Mr. Bourque has the right to acquire within 60 days
          pursuant to options.

                                     - 35 -

<PAGE>   38




     (13) Includes 50,000 shares that Mr. Budow has the right to acquire within
          60 days pursuant to options.

     (14) Includes 10,000 shares that Mr. Clarke has the right to acquire within
          60 days pursuant to options.

     (15) Includes 1,500 shares that Mr. Cunningham has the right to acquire
          within 60 days pursuant to options.

     (16) Includes 813 shares that Mr. Coleman has the right to acquire within
          60 days pursuant to options.

     (17) Includes 7,500 shares that Mr. Coleman has the right to acquire within
          60 days pursuant to options.

     (18) Includes 1,500 shares that Mr. Paulekas may have the right to acquire
          within 60 days pursuant to options.

     (19) Includes the 14,877 shares that officers and directors have the right
          to acquire within 60 days pursuant to options, as described in Notes
          1, 7,10, 15, 16 and 18; the 92,703 shares that Amphion Ventures and
          Antiope Partners have the right to acquire pursuant to warrants; and
          the 411,906 shares held by entities within the Amphion Group (as to
          which Mr. Morgan disclaims beneficial ownership). Does not include
          shares of Voting Preferred Stock held by entities within the Amphion
          Group (as to which Mr. Morgan disclaims beneficial ownership). See
          Notes 5 and 24.

     (20) Includes the 227,584 shares that officers, former officers and
          directors have the right to acquire within 60 days pursuant to
          options, as described in Notes 6, 8, 9, 11, 13, 14 and 17.

     (21) Includes 52,203 and 40,500 shares that Amphion Ventures and Antiope
          Partners, respectively, have the right to acquire within 60 days
          pursuant to warrants. See Note 24.

     (22) Does not include 9,934 shares held by Jackson Hole. See Note 24.

     (23) Includes 22,252 shares that J. P. Morgan Investment Corporation
          ("JPMIC") has the right to acquire within 60 days pursuant to
          warrants. As a result of an agreement between JPMIC and Antiope
          Ventures L.P. ("Antiope Ventures"), Antiope Ventures agreed to vote at
          JPMIC's request for any one person designated by JPMIC to be a
          director of the Company. To the extent that agreement is binding on
          any entity in the Amphion Group, JPMIC could be deemed to have shared
          voting power with respect to all the shares of voting stock held by
          entities within the Amphion Group. If the shares held by entities
          within the Amphion Group were deemed to be beneficially owned by
          JPMIC, JPMIC would beneficially own in the aggregate voting securities
          representing approximately 52% of the Company voting power. JPMIC
          disclaims beneficial ownership of the voting stock held by entities
          within the Amphion Group.

     (24) Includes shares beneficially owned by: (i) Amphion Ventures (formerly
          known as Wolfensohn Associates II L.P.); (ii) Amphion Partners
          (formerly known as Wolfensohn Partners II L.L.C.); and (iii) Antiope
          Partners (formerly known as Wolfensohn Partners L.L.C.). Amphion
          Ventures, Amphion Partners and Antiope Partners disclaim that they
          hold any securities of the Company as a group, within the meaning of
          any applicable securities law or regulation.

          The security holdings of the Amphion Group in the Company are largely
          the result of a restructuring of Wolfensohn Associates L.P., now known
          as Antiope Ventures. As of August 19, 1997, Antiope Ventures
          transferred all of its assets and liabilities to Amphion Ventures, in
          exchange for limited partnership interests of Amphion Ventures.
          Amphion Partners is the sole general partner of Amphion Ventures, and
          Antiope Partners is the sole general partner of Antiope Ventures.
          Amphion Ventures, Amphion Partners, Antiope Ventures and Antiope
          Partners are collectively referred to herein as the "Amphion Group."

          Richard C. E. Morgan, a director and the Chairman and Chief Executive
          Officer of the Company, is a managing member of both Amphion Partners
          and Antiope Partners.

          Jackson Hole Management Co. ("JHMC") provides management services to
          Amphion Partners, Antiope Partners and the general partner of Jackson
          Hole. Richard Morgan is an employee of JHMC. Mr. Morgan disclaims
          beneficial ownership of the securities of the Company owned
          beneficially by Amphion Partners, Amphion Ventures, Antiope Partners
          and Antiope Ventures, and disclaims beneficial ownership of the
          securities of the Company owned beneficially by Jackson Hole.

          The holdings of the Amphion Group in the Company as of March 1, 1998,
are as follows:

<TABLE>
<CAPTION>
                                          SERIES A      SERIES B     SERIES C      SERIES G     COMMON         COMMON
                             COMMON       PREFERRED     PREFERRED    PREFERRED     PREFERRED     STOCK          STOCK
                             STOCK         STOCK          STOCK        STOCK         STOCK      WARRANTS       OPTIONS
                            -------       ---------     ---------    ---------     ---------    --------       -------
<S>                         <C>           <C>           <C>          <C>           <C>          <C>            <C>
Antiope Partners ....        37,492            --            --            --          50        40,500            --
Amphion Ventures ....       346,289        57,692        52,816        25,492         905        52,203         3,843
Amphion Partners ....        28,125            --            --            --          --            --            --
Total ...............       411,906        57,692        52,816        25,492         955        92,703         3,843
</TABLE>



                                     - 36 -

<PAGE>   39






ITEM 12.  CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS.

During 1996 the Company received consulting services from director nominee
Alfred E. Paulekas relating to the Company's manufacturing and production
operations. In 1996, Mr. Paulekas was Chairman of the LMC Board of Directors and
was paid a total of $15,000 per quarter (an aggregate of $10,000 per year for
his services as a director of the Company and an aggregate of $50,000 per year
for his services as the Chairman of the LMC Board of Directors) for his services
to the Company. Mr. Paulekas received the same compensation during 1997 for his
services to the Company. The Company has complete discretion over whether or not
to use the consulting services of Mr. Paulekas.

Notes Payable to Stockholders

During the first quarter of 1997, the Company obtained a commitment for a
working capital bridge loan of up to $1,000,000 from Antiope Partners. The
Company made draws of $1,000,000 under this agreement during the first and
second quarters of 1997. Borrowings bore interest at 12% and were due on demand.
The borrowings were ultimately convertible into the Company's voting common
stock. In June 1997, borrowings under this agreement were converted into an
advance under the terms of the new bridge loan financing provided to the Company
by Antiope Partners and JPMIC pursuant to a note purchase agreement dated June
25, 1997 (the "Note Purchase Agreement"). The Note Purchase Agreement provided
the Company with additional bridge financing up to a total of $3,000,000 to be
funded 60% by Antiope Partners and 40% by JPMIC. Under the Note Purchase
Agreement, the Company received additional fundings of $2,000,000 by September
1997. The Note Purchase Agreement provided for an interest rate of 10% per annum
for advances by Antiope Partners and 6.64% per annum for advances by JPMIC, with
a final maturity of December 31, 1997. In connection with the advances, the
Company issued to Antiope Partners and JPMIC an aggregate of 308,571 (15,428
post reverse split) restricted shares of the Company's common stock and warrants
to purchase 600,000 (30,000 post reverse split) shares of the Company's common
stock with a strike price of $0.70 ($14.00 post reverse split). Further,
advances under the Note Purchase Agreement were convertible into convertible
debentures with terms similar to the currently outstanding convertible
debentures, which were ultimately convertible into common stock at a discount.
See "Restructuring of Variable Price Convertible Securities" below. Advances
under the Note Purchase Agreement are secured by a pledge of all the capital
stock of the Company's LMC subsidiary held by the Company.

In December 1997, JPMIC, Antiope Partners and Amphion Ventures, extended the
maturity of the Note Purchase agreement to December 31, 1998, in exchange for
112,942 (5,647 post reverse split) restricted shares of the Company's common
stock and warrants to purchase 600,000 (30,000 post reverse split) shares of
common stock at an exercise price of $0.25 ($5.00 post reverse split).

The Company borrowed additional funds of $4,138,575 from Amphion Ventures during
late September 1997 through early December 1997 under an informal borrowing
agreement. The advances accrued interest at a rate of ten percent per annum. In
connection with these advances, the Company issued 425,681 (21,284 post reverse
split) restricted shares of the Company's common stock and warrants to purchase
827,715 (41,385 post reverse split) shares of the Company's common stock at an
exercise price of $.70 ($14.00 post reverse split). In December 1997, the
Company entered into an agreement whereby it converted the advances under this
informal borrowing agreement into shares of Series G Preferred Stock. See
"Equity Investments by Major Stockholders" below.


                                     - 37 -

<PAGE>   40




During June and July 1996, the Company obtained a 12% working capital bridge
loan totaling $1.7 million from Amphion Ventures. The loan principal and related
interest were paid in full in August 1996 with proceeds from the sale of Series
D Convertible Preferred Stock, par value $.01 per share ("Series D Preferred
Stock"). See "Restructuring of Variable Price Convertible Securities" below. In
connection with these borrowings, a five year warrant to purchase a total of
56,341 (2,817 post reverse split) shares of Common Stock was issued to Amphion
Ventures.

Series F Preferred Stock

In July 1997, the Company completed a private placement of $480,000 face amount
of Series F Preferred Stock with Antiope Partners , the proceeds of which were
used to redeem $480,000 of existing Series D Convertible Preferred Stock from a
stockholder. The Series F Preferred stock had substantially identical terms as
the Company's Series D Preferred Stock, except as necessary to reflect the terms
of the Standstill Agreement described below.

Equity Investments by Major Stockholders

On December 29, 1997, the Company concluded an agreement with Amphion Ventures
and Antiope Partners with respect to the purchase by Amphion Ventures and
Antiope Partners as of such date of 700 and 50 shares, respectively, of the
Company's Series G Preferred Stock for an aggregate purchase price of
$7,500,000. The purchase price was payable primarily through a combination of
cash and the cancellation and exchange of existing indebtedness of the Company
to Amphion Ventures. In addition, Amphion Ventures had the right to offset a
portion of the purchase price, aggregating approximately $709,000, against the
Company's obligation to pay previously accrued and unpaid cash dividends on
outstanding shares of Series A, Series B or Series C Preferred Stock of the
Company held by Amphion Ventures on such date, and to pay a portion of such
total purchase price, not to exceed an aggregate of $1,500,000, by delivery of
Amphion Ventures' unconditional promissory note, payable on demand, in principal
amount equal to the portion of the purchase price so paid.

As additional consideration to Amphion Ventures and Antiope Partners, the
Company agreed that if, at any time on or before December 31, 1999, the Company
completes a financing with third parties raising at least $3,000,000 in new
equity, the initial holders of the Series G Preferred will have the
non-assignable right, but not the obligation, to exchange all or a portion of
their shares of Series G Preferred Stock for shares of a new series of preferred
stock with substantially the same terms and conditions offered to such third
parties; provided that no such exchange will result in an increase in the
conversion price above $10.00 per share.

Restructuring of Variable Price Convertible Securities

In December 1997, the Company entered into negotiations with the holders of
certain outstanding convertible securities of the Company, with respect to the
restructuring and/or refinancing of such securities.

The Company originally issued the Convertible Debentures, the Series D Preferred
Stock, and the Series E Preferred Stock in separate private placements to
institutional investors in 1996 and 1997. In July 1997, the Company issued
shares of the Series F Preferred Stock, in exchange for, and/or to finance the
repurchase of, all the outstanding shares of Series D Preferred Stock and Series
E Preferred Stock, as described below. The Convertible Debentures, Series D
Preferred Stock, Series E Preferred Stock and Series F Preferred Stock were all
convertible into Common Stock at a conversion price determined by formula, which
was generally about 85% of the recent average market price of the Common Stock
at the time of conversion, subject to a fixed maximum conversion price. The
Convertible Debentures, Series D Preferred Stock, Series E Preferred

                                     - 38 -

<PAGE>   41




Stock and Series F Preferred Stock are sometimes referred to collectively herein
as the Company's "Variable Price Convertible Securities".

In July 1997, the Company and certain holders of Variable Price Convertible
Securities negotiated a Standstill Agreement, in which such holders agreed to
refrain from converting seventy-five percent of their holdings for a period of
at least three months, with the locked-up portion released in five equal monthly
installments thereafter. The provisions of the Standstill Agreement (which also
included a reduction in the maximum conversion price to $1.14 ($22.80 post
reverse split) in the case of the Series D and Series E Preferred Stock and
$1.00 ($20.00 post reverse split) in the case of the Convertible Debentures, and
the issuance of $.70 ($14.00 post reverse split) warrants to acquire 814,375
(271,875 post reverse split) shares of Common Stock as an additional inducement
to the participating holders) were implemented by the execution of allonges to
the Convertible Debentures and by exchanging all of the outstanding shares of
Series D Preferred Stock and Series E Preferred Stock for an equal number of
shares of Series F Preferred Stock, which shares were substantially identical to
the shares exchanged, except as necessary to implement the terms of the
Standstill Agreement. Concurrently therewith, the Company issued 48 shares of
Series F Preferred Stock to a single existing investor for $480,000 in cash,
which was used by the Company to repurchase and cancel an equal number of shares
of Series D Preferred Stock, the holder of which had declined to participate in
the Standstill Agreement. By December 14, 1997, 70% of the face amount of the
Variable Price Convertible Securities held by such holders on the date of the
Standstill Agreement were available for conversion, with the remainder to become
convertible in equal installments in January and February 1998.

In December 1997, the Company re-initiated negotiations with the holders of the
Variable Price Convertible Securities, with the intention of restructuring or
refinancing such securities to remove the variable price conversion feature. In
December 1997 and January 1998, the Company converted, redeemed or restructured
all of the Variable Price Convertible Securities that had been outstanding on
December 1, 1997, comprising in the aggregate $1,250,000 principal amount of
Convertible Debentures and 237 shares ($2,370,000 face amount) of Series F
Preferred Stock (collectively, the "December 1997 Restructuring"). Based on the
closing bid prices of the Common Stock for the applicable trading periods prior
to December 24, 1997, such Variable Price Convertible Securities, together with
accrued interest and dividends, would have been convertible on that date into an
aggregate of approximately 17 million shares of Common Stock (pre reverse
split), with further dilution possible in the event of further declines in the
market price of the Common Stock.

To implement the December 1997 Restructuring, including all related conversions,
the Company made cash payments totaling approximately $1.3 million and issued in
the aggregate approximately: $1.1 million in non-convertible short-term
indebtedness; $535,000 of indebtedness with a two-year maturity, convertible
into Common Stock at $.25 ($5.00 post reverse split) per share (the "1997
Debentures"); 1,407,000 (70,350 post reverse split) shares of Common Stock, most
of which are subject to certain transfer restrictions; 90 shares of Series G
Preferred Stock; and warrants to purchase an additional 72,000 shares of Common
Stock at an average exercise price in excess of $9.20 per share post reverse
split). The fair market value of the additional securities issued, at the time
of their issuance, represents the conversion inducement. The Company funded the
cash and short-term debt portion of the restructuring by issuing shares of
Series G Preferred Stock as described above. In connection with the December
1997 Restructuring, Antiope Partners received 50 shares of Series G Preferred
Stock and 24,889 shares of Common Stock in exchange for its $480,000 face amount
of Series F Preferred Stock plus $17,780 of accrued but unpaid dividends.



                                     - 39 -

<PAGE>   42





ITEM 13.  EXHIBITS AND REPORTS ON FORM 8-K.

(a) Exhibits

       3.1    --Certificate of Incorporation of the Company. Incorporated herein
              by reference to Exhibit 3.1 to the Company's Registration
              Statement on Form S-1 (Registration No. 2-80946).

       3.2    --By-laws of AXCESS. Incorporated herein by reference to Exhibit
              3.2 to the Company's Registration Statement on Form S-1
              (Registration No. 2- 80946).

       3.3    --First Amendment to Certificate of Incorporation of AXCESS dated
              June 6, 1986. Incorporated herein by reference to Exhibit 3.3 to
              the Company's Annual Report on Form 10-KSB for the year ended
              December 31, 1987.

       3.4    --Second Amendment to Certificate of Incorporation of AXCESS,
              dated May 27, 1987. Incorporated herein by reference to Exhibit
              3.4 to the Company's Annual Report on Form 10-KSB for the year
              ended December 31, 1987.

       3.5    --Third Amendment to Certificate of Incorporation of AXCESS, dated
              November 11, 1994. Incorporated herein by reference to Exhibit 4.4
              to the Company's Registration Statement on Form S-3 (Registration
              No. 333- 10665).

       3.6    --Fourth Amendment to Certificate of Incorporation of AXCESS,
              dated July 28, 1995. Incorporated herein by reference to Exhibit
              4.5 to the Company's Registration Statement on Form S-3
              (Registration No. 333-10665).

       3.7    --Fifth Amendment to Certificate of Incorporation of AXCESS, dated
              June 17, 1996. Incorporated herein by reference to Exhibit 4.6 to
              the Company's Registration Statement on Form S-3 (Registration No.
              333-10665).

       3.8    --Sixth Amendment to Certificate of Incorporation of AXCESS dated
              March 31, 1998. Incorporated herein by reference to Exhibit 99.1
              to the Company's Report on Form 8-K dated April 13, 1998.

       3.9    --Seventh Amendment to Certificate of Incorporation of AXCESS
              dated March 31, 1998. Incorporated herein by reference to Exhibit
              99.2 to the Company's Report on Form 8-K dated April 13, 1998.

       3.10   --Eighth Amendment to Certificate of Incorporation of AXCESS dated
              April 9, 1998. Incorporated herein by reference to Exhibit 99.3 to
              the Company's Report on Form 8-K dated April 13, 1998.

       4.1    --Certificate of Designation of the Company's Series A, B and C
              Preferred Stock, dated December 27, 1995. Incorporated herein by
              reference to Exhibit 4.7 to the Company's Registration Statement
              on Form S-3 (Registration No. 333-10665).

                                     - 40 -

<PAGE>   43

       4.2    --Certificate of Designation of the Company's Series D Preferred
              Stock. Incorporated herein by reference to Exhibit 4.1 to the
              Company's Quarterly Report on Form 10-QSB for the period ended
              June 30, 1996.

       4.3    --Certificate of Designation of the Company's Series E Preferred
              Stock. Incorporated by reference to Exhibit 4.3 to the Company's
              Quarterly Report on Form 10-QSB for the period ended September 30,
              1997.

       4.4    --Certificate of Designation of the Company's Series F Preferred
              Stock and Certificate of Correction. Incorporated by reference to
              Exhibit 4.4 to the Company's Quarterly Report on Form 10-QSB for
              the period ended September 30, 1997.

       4.5    --Certificate of Designation of AXCESS Series G Preferred Stock.
              Incorporated herein by reference to Exhibit 4.5 to the Company's
              Annual Report on Form 10-KSB for the year ended December 31, 1997.

       10.1   --License agreement, dated June 30, 1988, between the Company and
              Patlex Corporation. Incorporated herein by reference to Exhibit
              10.17 to the Company's Annual Report on Form 10-KSB for the year
              ended December 31, 1988.

       10.2   --Employment agreement dated August 31, 1989, between Louis F.
              Bieck, Jr. and AXCESS Inc. as amended. Incorporated herein by
              reference to Exhibit 10.17 the Company's Form 10-KSB for the year
              ended December 31, 1990.

       10.3   --1991 Incentive Stock Option Plan, dated August 14, 1991.
              Incorporated herein by reference to Exhibit 10.10 to
              Lasertechnics' Annual Report on Form 10-KSB for the year ended
              December 31, 1991.

       10.4   --Purchase Agreement between Sandia Europe and Jean-Luc
              Poutchnine, Alain Quilleau and Philippe Bonnevie, dated March 4,
              1994. Incorporated herein by reference to Exhibit 10.15 to the
              Company's Annual Report on Form 10-KSB for the year ended December
              31, 1994.

       10.5   --Letter confirming sale of shares of AXCESS Common Stock to
              Singapore Precision Industries PTE LTD, dated May 12, 1994.
              Incorporated herein by reference to Exhibit 10.16 to the Company's
              Annual Report on Form 10- KSB for the year ended December 31,
              1994.



                                     - 41 -

<PAGE>   44




       10.6   --Advisory and investment banking services agreement between
              AXCESS and Wolfensohn International, Inc., dated May 19, 1993.
              Incorporated herein by reference to Exhibit 10.18 to the Company's
              Annual Report on Form 10-KSB for the year ended December 31, 1994.

       10.7   --Purchase of Common Stock and Convertible Note Agreement between
              the Company and J.P. Morgan Investment Corporation, dated July 8,
              1994. Incorporated herein by reference to Exhibit 10.19 to the
              Company's Annual Report on Form 10-KSB for the year ended December
              31, 1994.

       10.8   --OEM License Agreement between Sandia and Xerox Corporation,
              dated January 6, 1995. Incorporated herein by reference to Exhibit
              10.20 to the Company's Annual Report on Form 10-KSB for the year
              ended December 31, 1994.

       10.9   --Demand Promissory Note issued to J.P. Morgan Investment
              Corporation, dated December 19, 1994. Incorporated herein by
              reference to Exhibit 10.21 to the Company's Annual Report on Form
              10-KSB for the year ended December 31, 1994.

       10.10  --Demand Promissory Note issued to J.P. Morgan Investment
              Corporation, dated December 31, 1994. Incorporated herein by
              reference to Exhibit 10.22 to the Company's Annual Report on Form
              10-KSB for the year ended December 31, 1994.

       10.11  --Amendment to the OEM License Agreement between Sandia and Xerox
              Corporation, dated December 27, 1996. Incorporated by reference to
              Exhibit 10.12 to the Company's Annual Report on Form 10-KSB for
              the year ended December 31, 1996.

       10.12  --Demand Promissory Note issued to Wolfensohn Associates L.P.,
              dated March 27, 1997. Incorporated by reference to Exhibit 10.13
              to the Company's Quarterly Report on Form 10-QSB for the period
              ended September 30, 1997.

       10.13  --Warrant to purchase shares of the Company's Common Stock issued
              to Wolfensohn Associates L.P., dated March 27, 1997. Incorporated
              by reference to Exhibit 10.14 to the Company's Quarterly Report on
              Form 10- QSB for the period ended September 30, 1997.

       10.14  --Note Purchase Agreement dated June 25, 1997, by and among
              AXCESS, J.P. Morgan Investment Corporation and Wolfensohn
              Associates L.P. Incorporated by reference to Exhibit 10.15 to the
              Company's Quarterly Report on Form 10-QSB for the period ended
              September 30, 1997.



                                     - 42 -

<PAGE>   45




       10.15  --Intellectual Property Transfer Agreement dated January 8, 1998,
              by and between XL Vision, Inc. and Sandia Imaging Systems
              Corporation. Incorporated herein by reference to Exhibit 10.15 to
              the Company's Annual Report on Form 10-KSB for the year ended
              December 31, 1997.

       10.16  --Amendment to Notes and Note Purchase Agreement dated December
              31, 1997, by and among the Company, Antiope Partners L.L.C. and
              J.P. Morgan Investment Corporation. Incorporated herein by
              reference to Exhibit 10.16 to Amendment No. 1 to the Company's
              Annual Report on Form 10-KSB for the year ended December 31, 1997.

       10.17  --Series G Preferred stock Purchase Agreement dated December 29,
              1997, by and among the Company and Amphion Ventures L.P.
              Incorporated herein by reference to Exhibit 10.17 to Amendment No.
              1 to the Company's Annual Report on Form 10-KSB for the year ended
              December 31, 1997.

       10.18  --Pledge Agreement dated August 18, 1997, by and among the
              Company, Antiope Partners L.L.C. and J.P. Morgan Investment
              Corporation. Incorporated herein by reference to Exhibit 10.18 to
              Amendment No. 1 to the Company's Annual Report on Form 10-KSB for
              the year ended December 31, 1997.

       10.19  --Preferred Stock Exchange Agreement dated January 8, 1998, by and
              among the Company, Antiope Partners L.L.C. and H.T. Ardinger.
              Incorporated herein by reference to Exhibit 10.19 to Amendment No.
              1 to the Company's Annual Report on Form 10-KSB for the year ended
              December 31, 1997.

       10.20  --Form of Warrant to purchase shares of the Company's Common Stock
              issued to Antiope Partners L.L.C. and Amphion Ventures L.P.
              Incorporated herein by reference to Exhibit 10.20 to Amendment No.
              1 to the Company's Annual Report on Form 10-KSB for the year ended
              December 31, 1997.

       10.21  --Settlement Agreement dated as of April 21, 1998, by and between
              the Company and Xerox Corporation. Incorporated herein by
              reference to Exhibit 10.21 to Amendment No. 1 to the Company's
              Annual Report on Form 10-KSB for the year ended December 31, 1997.

       21     --Subsidiaries of the Company. Incorporated herein by reference to
              Exhibit 21 to the Company's Annual Report on Form 10-KSB for the
              year ended December 31, 1997.

       23     --Consent and Report on Schedule of KPMG Peat Marwick LLP.*

       27     --Financial Data Schedule. Incorporated herein by reference to
              Exhibit 27 to the Company's Annual Report on Form 10-KSB for the
              year ended December 31, 1997.

     --------------
     *Filed herewith.


                                     - 43 -

<PAGE>   46

(b)  REPORTS ON FORM 8-K.

     No reports on Form 8-K were filed by the Company during the last quarter of
fiscal 1997.





                                     - 44 -

<PAGE>   47




                                   SIGNATURES

         Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.

Dated: June 22, 1998               AXCESS INC.


                                   By:/s/ Richard C.E. Morgan
                                      ------------------------------------------
                                      Richard C.E. Morgan, Chairman of the Board

         Pursuant to the requirements of the Securities Exchange Act of 1934,
this report has been signed below by the following persons on behalf of the
Registrant and in the capacities indicated on June 22, 1998.

<TABLE>
<CAPTION>
    SIGNATURE                     CAPACITY
    ---------                     --------
<S>                               <C>
/s/ Richard C.E. Morgan           Chairman of the Board
----------------------------
Richard C.E. Morgan


/s/ Paul J. Coleman, Jr.          Director
----------------------------
Paul J. Coleman, Jr.


/s/ Danny G. Hair                 Executive Vice President and Chief Financial Officer
----------------------------      (Principal Financial and Accounting Officer)
Danny G. Hair


                                  Director
----------------------------
C. Seth Cunningham


/s/ Jean-Pierre Arnaudo           Director and Vice Chairman of the Board
----------------------------
Jean-Pierre Arnaudo


/s/ Harry S. Budow                Director and President and Chief Executive Officer
----------------------------
Harry S. Budow

/s/ E.A. Bourque                  Director
----------------------------
E. A. Bourque


/s/ Alfred E. Paulekas            Director
----------------------------
Alfred E. Paulekas


/s/ Richard M. Clarke             Director
----------------------------
Richard M. Clarke


/s/ Gregory W. Haskell            Director
----------------------------
Gregory W. Haskell
</TABLE>

                                     - 45 -
<PAGE>   48
 
                          INDEPENDENT AUDITORS' REPORT
 
The Board of Directors and Stockholders
Lasertechnics, Inc.
 
     We have audited the accompanying consolidated balance sheets of
Lasertechnics, Inc. and subsidiaries as of December 31, 1997 and 1996, and the
related consolidated statements of operations, stockholders' equity, and cash
flows for each of the years in the three-year period ended December 31, 1997.
These consolidated financial statements are the responsibility of the Company's
management. Our responsibility is to express an opinion on these consolidated
financial statements based on our audits.
 
     We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.
 
     In our opinion, the consolidated financial statements referred to above
present fairly, in all material respects, the financial position of
Lasertechnics, Inc. and subsidiaries as of December 31, 1997 and 1996, and the
results of their operations and their cash flows for each of the years in the
three-year period ended December 31, 1997 in conformity with generally accepted
accounting principles.
 
     The accompanying consolidated financial statements have been prepared
assuming that the Company will continue as a going concern. As discussed in note
3 to the consolidated financial statements, the Company's recurring losses from
operations and resulting continued dependence upon access to additional external
financing raise substantial doubt about its ability to continue as a going
concern. Management's plans in regard to these matters are also described in
note 3. The consolidated financial statements do not include any adjustments
that might result from the outcome of this uncertainty.
 
     As discussed in note 2 to the consolidated financial statements, the
Company has restated its consolidated financial statement for the years ended
December 31, 1995 and 1996 to reflect a change in its accounting for beneficial
conversion features related to the issuance of convertible debentures and
convertible preferred stock.
 
                                            /s/  KPMG Peat Marwick LLP
 
Dallas, Texas
February 20, 1998
 
                                       F-1
<PAGE>   49
 
                       LASERTECHNICS, INC. & SUBSIDIARIES
 
                          CONSOLIDATED BALANCE SHEETS
                           DECEMBER 31, 1997 AND 1996
 
                                     ASSETS
 
<TABLE>
<CAPTION>
                                                                  1997            1996
                                                              ------------    ------------
                                                                                (NOTE 2)
<S>                                                           <C>             <C>
Current assets:
  Cash and cash equivalents.................................  $  1,687,178    $  1,598,744
  Note receivable from stockholder..........................     1,158,684              --
  Accounts receivable -- trade, less allowance for doubtful
    accounts of $380,911 in 1997 and $357,136 in 1996.......     1,864,270       3,196,943
Inventory (note 14):
  Raw materials.............................................     3,824,932       4,293,978
  Work-in-process...........................................       483,500         551,340
  Finished goods............................................       935,684       1,754,689
                                                              ------------    ------------
                                                                 5,244,116       6,600,007
Prepaid expenses............................................       130,137         230,839
Other.......................................................        50,081          67,606
                                                              ------------    ------------
         Total current assets...............................    10,134,466      11,694,139
                                                              ------------    ------------
Property, plant and equipment, net (note 5).................     2,974,725       3,334,277
Goodwill....................................................        90,473         172,510
Deferred license fee (note 11)..............................     1,400,000       2,100,000
Other assets................................................        85,748         360,931
                                                              ------------    ------------
                                                              $ 14,685,412    $ 17,661,857
                                                              ============    ============
 
                           LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
  Notes payable to stockholder (note 8).....................  $  2,931,821    $         --
  Notes payable (note 11)...................................     3,942,495         775,292
  Accounts payable..........................................     1,789,321       1,369,818
  Accrued liabilities (note 7)..............................     2,089,793       2,957,525
  Current portion of capital lease obligations (note 6).....       807,935         225,676
                                                              ------------    ------------
         Total current liabilities..........................    11,561,365       5,328,311
                                                                              ------------
Convertible debentures (note 9).............................            --       2,250,749
Capital lease obligations (note 6)..........................       114,845         927,411
Notes payable, long-term (note 11)..........................       535,205       1,400,000
Other.......................................................         4,694         149,387
                                                              ------------    ------------
         Total liabilities..................................    12,216,109      10,055,858
                                                              ------------    ------------
Stockholders' equity (notes 2, 9, 10, 11 and 12):
Convertible preferred stock, $.01 par; 7,000,000 shares
  authorized in 1997 and 1996:
    Series A: $1.30 stated value; 1,153,846 shares issued
     and outstanding in 1997 and 1996.......................     1,500,000       1,500,000
    Series B: $1.42 stated value; 1,056,338 shares issued
     and outstanding in 1997 and 1996.......................     1,500,000       1,500,000
    Series C: $1.51 stated value; 708,530 shares issued and
     outstanding in 1997 and 1996...........................     1,069,880       1,069,880
    Series D: $10,000 stated value; exchanged for Series F
     in 1997 and 585
      in 1996...............................................            --       6,049,314
    Series G: $10,000 stated value; 789.735 shares
     outstanding in 1997 and none in 1996...................     7,897,353              --
Common stock, $.01 par value; authorized 56,750,000 in 1997
  and 1996; 46,634,964 and 37,133,514 shares issued and
  outstanding in 1997 and 1996..............................       466,350         371,335
Nonvoting convertible common stock; $.01 par value
  Authorized 2,250,000 shares in 1997 and 1996; 2,249,842
  shares issued and outstanding in 1997 and 1996.
  Convertible into common stock on a share-for-share
  basis.....................................................        22,499          22,499
Paid-in capital.............................................    56,704,310      49,891,230
Accumulated deficit.........................................   (66,691,089)    (52,798,259)
                                                              ------------    ------------
         Total stockholders' equity.........................     2,469,303       7,605,999
                                                              ------------    ------------
                                                              $ 14,685,412    $ 17,661,857
                                                              ============    ============
</TABLE>
 
          See accompanying notes to consolidated financial statements.
 
                                       F-2
<PAGE>   50
 
                       LASERTECHNICS, INC. & SUBSIDIARIES
 
                     CONSOLIDATED STATEMENTS OF OPERATIONS
                  YEARS ENDED DECEMBER 31, 1997, 1996 AND 1995
 
<TABLE>
<CAPTION>
                                                        1997           1996           1995
                                                    ------------   ------------   ------------
                                                                     (NOTE 2)       (NOTE 2)
<S>                                                 <C>            <C>            <C>
Sales (notes 4 and 16)............................  $ 11,118,339   $ 17,581,440   $ 13,429,731
Cost of sales.....................................     7,753,037     12,158,111      9,159,393
                                                    ------------   ------------   ------------
          Gross profit............................     3,365,302      5,423,329      4,270,338
Expenses:
Research and development..........................     2,572,848      2,848,767      3,040,830
General and administrative........................     4,921,359      5,151,502      4,460,724
Selling and marketing.............................     6,062,989      5,760,056      4,898,997
Loss on contract settlement and other (Note 14)...            --      1,287,000             --
                                                    ------------   ------------   ------------
          Operating expenses......................    13,557,196     15,047,325     12,400,551
                                                    ------------   ------------   ------------
          Loss from operations....................   (10,191,894)    (9,623,996)    (8,130,213)
Other income (expense):
Interest income...................................        24,646        110,007         32,182
Interest expense..................................    (2,254,887)    (1,910,919)    (2,020,751)
Other.............................................      (398,306)        25,913        (27,682)
                                                    ------------   ------------   ------------
          Net other income (expense)..............    (2,628,547)    (1,774,999)    (2,016,251)
Loss before income taxes..........................   (12,820,441)   (11,398,995)   (10,146,464)
Income taxes (note 15)............................            --             --             --
                                                    ------------   ------------   ------------
          Net loss................................   (12,820,441)   (11,398,995)   (10,146,464)
Preferred stock dividend requirements (Note 10)...    (1,072,389)    (1,865,115)       (73,234)
                                                    ------------   ------------   ------------
          Net loss applicable to common stock.....  $(13,892,830)  $(13,264,110)  $(10,219,698)
                                                    ============   ============   ============
Net loss per common share.........................  $      (0.31)  $      (0.39)  $      (0.37)
                                                    ============   ============   ============
Weighted average shares of common stock
  outstanding during the year.....................    44,684,785     34,339,313     27,511,489
                                                    ============   ============   ============
</TABLE>
 
          See accompanying notes to consolidated financial statements.
 
                                       F-3
<PAGE>   51
 
                       LASERTECHNICS, INC. & SUBSIDIARIES
 
                CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
                  YEARS ENDED DECEMBER 31, 1997, 1996 AND 1995
<TABLE>
<CAPTION>
                                                                                            NONVOTING
                                           CONVERTIBLE                                     CONVERTIBLE
                                         PREFERRED STOCK           COMMON STOCK           COMMON STOCK
                                     -----------------------   ---------------------   -------------------     PAID-IN
                                      SHARES       AMOUNT        SHARES      AMOUNT     SHARES     AMOUNT      CAPITAL
                                     ---------   -----------   ----------   --------   ---------   -------   -----------
<S>                                  <C>         <C>           <C>          <C>        <C>         <C>       <C>
Balance at December 31, 1994.......         --   $        --   25,078,779   $250,788     377,684   $3,777    $30,302,473
Exercise of common stock options
  (note 12)........................         --            --      625,712      6,257          --       --        450,593
Detachable warrants issued in
  conjunction with convertible debt
  (note 9).........................         --            --           --         --          --       --        207,000
Stock issued for debt, net of
  unamortized discount and expenses
  (note 8).........................  2,521,363     3,469,880    1,383,632     13,836   1,872,158   18,722      2,804,215
Increasing rate preferred stock
  discount.........................         --      (126,446)          --         --          --       --        126,446
Discount accretion.................         --        73,234           --         --          --       --             --
Conversion feature of debentures
  issued (note 9)..................         --            --           --         --          --       --      1,235,294
Debentures converted, net of
  unamortized discount and expenses
  (note 9).........................         --            --      658,570      6,586          --       --        968,959
Issuance of convertible preferred
  stock (note 10)..................    397,351       600,000           --         --          --       --             --
Exercise of detachable warrants....         --            --      534,105      5,341          --       --        684,659
Foreign currency translation
  adjustment.......................         --            --           --         --          --       --       (109,248)
Net loss...........................         --            --           --         --          --       --             --
                                     ---------   -----------   ----------   --------   ---------   -------   -----------
Balance at December 31, 1995.......  2,918,714     4,016,668   28,280,798    282,808   2,249,842   22,499     36,670,391
Exercise of common stock options
  (note 12)........................         --            --       89,222        893          --       --        109,898
Increasing rate preferred stock
  discount (note 10)...............         --        53,212           --         --          --       --             --
Conversion feature of debentures
  and detachable warrants issued
  (note 9).........................         --            --           --         --          --       --      1,555,981
Conversion feature of Series D
  Preferred Stock (note 10)........         --    (1,198,055)          --         --          --       --      1,198,055
Debentures converted, net of
  expenses (note 9)................         --            --    6,682,561     66,825          --       --      8,796,242
Warrant discount net of related
  debenture conversions (note 9)...         --            --           --         --          --       --         53,792
Issuance of convertible preferred
  stock, net of expenses (note
  10)..............................        835     8,350,000           --         --          --       --       (762,964)
Preferred stock accretion and
  dividends (note 10)..............         --     1,455,721           --         --          --       --             --
Preferred stock converted,
  including related accretion (note
  10)..............................       (250)   (2,558,352)   2,280,933     22,809          --       --      2,535,543
Retirement of treasury stock.......         --            --     (200,000)    (2,000)         --       --       (248,000)
Foreign currency translation
  adjustment.......................         --            --           --         --          --       --        (17,708)
Net loss...........................         --            --           --         --          --       --             --
                                     ---------   -----------   ----------   --------   ---------   -------   -----------
Balance at December 31, 1996.......  2,919,299    10,119,194   37,133,514    371,335   2,249,842   22,499     49,891,230
Issuance of common stock...........         --            --       22,989        230          --       --         40,453
Issuance of common stock for
  extension of stockholder notes
  payable (note 8).................         --            --      112,942      1,129          --       --         27,107
Conversion feature of stockholder
  notes payable (note 8)...........         --            --           --         --          --       --        687,833
Conversion feature of debentures
  issued (note 9)..................         --            --           --         --          --       --         88,235
Issuance of common stock in
  connection with stockholder notes
  payable (note 8).................         --            --      734,251      7,343          --       --        383,699
Debentures converted, net of
  expenses (note 9)................         --            --    1,980,901     19,809          --       --      1,013,637
Issuance of Series G preferred
  stock, net of expenses and
  conversion of Series F Preferred
  Stock, including common stock
  issued (note 10).................    801,735     7,980,842           --         --          --       --             --
Issuance of common stock for the
  conversion of Series F to Series
  G Preferred Stock................         --            --      897,353      8,974          --       --        227,851
Preferred stock accretion and
  dividends (note 10)..............         --       231,911           --         --          --       --             --
Preferred stock converted,
  including related accretion (note
  10)..............................       (359)   (3,829,218)   5,753,014     57,530          --       --      3,771,688
Preferred stock redeemed (note
  10)..............................       (133)   (1,350,000)          --         --          --       --             --
Preferred stock converted to debt
  (note 10)........................       (106)   (1,185,496)          --         --          --       --             --
Issuance of warrants in connection
  with the stockholder notes
  payable, standstill agreement and
  December 1997 restructuring
  (notes 8, 9, and 10).............         --            --           --         --          --       --        567,593
Foreign currency translation
  adjustment.......................         --            --           --         --          --       --          4,984
Net loss...........................         --            --           --         --          --       --             --
                                     ---------   -----------   ----------   --------   ---------   -------   -----------
Balance at December 31, 1997.......  2,919,504   $11,967,233   46,634,964   $466,350   2,249,842   $22,499   $56,704,310
                                     =========   ===========   ==========   ========   =========   =======   ===========
 
<CAPTION>
 
                                     ACCUMULATED    TREASURY
                                       DEFICIT        STOCK        TOTAL
                                     ------------   ---------   ------------
<S>                                  <C>            <C>         <C>
Balance at December 31, 1994.......  $(29,314,451)  $(250,000)  $    992,587
Exercise of common stock options
  (note 12)........................           --           --        456,850
Detachable warrants issued in
  conjunction with convertible debt
  (note 9).........................           --           --        207,000
Stock issued for debt, net of
  unamortized discount and expenses
  (note 8).........................           --           --      6,306,653
Increasing rate preferred stock
  discount.........................           --           --             --
Discount accretion.................      (73,234)          --             --
Conversion feature of debentures
  issued (note 9)..................           --           --      1,235,294
Debentures converted, net of
  unamortized discount and expenses
  (note 9).........................           --           --        975,545
Issuance of convertible preferred
  stock (note 10)..................           --           --        600,000
Exercise of detachable warrants....           --           --        690,000
Foreign currency translation
  adjustment.......................           --           --       (109,248)
Net loss...........................  (10,146,464)          --    (10,146,464)
                                     ------------   ---------   ------------
Balance at December 31, 1995.......  (39,534,149)    (250,000)     1,208,217
Exercise of common stock options
  (note 12)........................           --           --        110,791
Increasing rate preferred stock
  discount (note 10)...............           --           --         53,212
Conversion feature of debentures
  and detachable warrants issued
  (note 9).........................           --           --      1,555,981
Conversion feature of Series D
  Preferred Stock (note 10)........           --           --             --
Debentures converted, net of
  expenses (note 9)................           --           --      8,863,067
Warrant discount net of related
  debenture conversions (note 9)...           --           --         53,792
Issuance of convertible preferred
  stock, net of expenses (note
  10)..............................           --           --      7,587,036
Preferred stock accretion and
  dividends (note 10)..............   (1,865,115)          --       (409,394)
Preferred stock converted,
  including related accretion (note
  10)..............................           --           --             --
Retirement of treasury stock.......           --      250,000             --
Foreign currency translation
  adjustment.......................           --           --        (17,708)
Net loss...........................  (11,398,995)          --    (11,398,995)
                                     ------------   ---------   ------------
Balance at December 31, 1996.......  (52,798,259)          --      7,605,999
Issuance of common stock...........           --           --         40,683
Issuance of common stock for
  extension of stockholder notes
  payable (note 8).................           --           --         28,236
Conversion feature of stockholder
  notes payable (note 8)...........           --           --        687,833
Conversion feature of debentures
  issued (note 9)..................           --           --         88,235
Issuance of common stock in
  connection with stockholder notes
  payable (note 8).................           --           --        391,042
Debentures converted, net of
  expenses (note 9)................           --           --      1,033,446
Issuance of Series G preferred
  stock, net of expenses and
  conversion of Series F Preferred
  Stock, including common stock
  issued (note 10).................           --           --      7,980,842
Issuance of common stock for the
  conversion of Series F to Series
  G Preferred Stock................           --           --        236,825
Preferred stock accretion and
  dividends (note 10)..............   (1,072,389)          --       (840,478)
Preferred stock converted,
  including related accretion (note
  10)..............................           --           --             --
Preferred stock redeemed (note
  10)..............................           --           --     (1,350,000)
Preferred stock converted to debt
  (note 10)........................           --           --     (1,185,496)
Issuance of warrants in connection
  with the stockholder notes
  payable, standstill agreement and
  December 1997 restructuring
  (notes 8, 9, and 10).............           --           --        567,593
Foreign currency translation
  adjustment.......................           --           --          4,984
Net loss...........................  (12,820,441)          --    (12,820,441)
                                     ------------   ---------   ------------
Balance at December 31, 1997.......  $(66,691,089)  $      --   $  2,469,303
                                     ============   =========   ============
</TABLE>
 
          See accompanying notes to consolidated financial statements.
 
                                       F-4
<PAGE>   52
 
                       LASERTECHNICS, INC. & SUBSIDIARIES
 
                     CONSOLIDATED STATEMENTS OF CASH FLOWS
                  YEARS ENDED DECEMBER 31, 1997, 1996 AND 1995
 
<TABLE>
<CAPTION>
                                                                 1997            1996            1995
                                                             ------------    ------------    ------------
                                                                                               (NOTE 2)
                                                                               (NOTE 2)
<S>                                                          <C>             <C>             <C>
Cash flows from operating activities:
  Net loss.................................................  $(12,820,441)   $(11,398,995)   $(10,146,464)
Adjustments to reconcile net loss to net cash used by
  operating activities:
  Depreciation and amortization............................     1,126,870         725,859         514,988
    Provision for losses on accounts receivable............     1,058,572         248,489         115,375
    Provision for product warranty reserve.................       382,795         639,606         338,250
    Amortization of discount and issuance costs and other
      non-cash interest and dividends......................     1,553,934       1,259,621       1,726,193
    Accrued interest not paid..............................            --         514,163              --
  (Increase) decrease in:
    Accounts receivable, trade.............................       274,101         628,243      (1,165,875)
    Inventory..............................................     1,577,165      (2,187,157)     (1,616,559)
    Prepaid expenses.......................................       100,702        (775,350)        104,779
    Other current assets...................................        17,525      (1,280,821)        163,769
    Accounts payable.......................................       419,503      (2,087,326)        (42,450)
    Accrued expenses.......................................      (842,060)       (598,871)       (890,512)
    Other..................................................       205,571         608,912              --
         Net cash used by operating activities                 (6,945,763)    (13,703,627)    (10,898,506)
Cash flows from investing activities -- Capital
  expenditures.............................................      (206,555)       (783,794)       (995,518)
Cash flows from financing activities:
    Borrowings under financing agreements..................     7,158,808       3,800,000       7,329,906
    Principal payments on financing agreements.............            --      (2,200,000)     (2,969,452)
    Proceeds from issuance of convertible debentures.......       500,000       5,500,000       7,000,000
    Convertible debenture issuance costs...................            --        (385,000)       (520,000)
    Principal payments on capital lease obligations........      (230,307)       (219,018)       (164,860)
    Net proceeds from issuance of preferred and common
      stock................................................     1,952,525       7,697,826       1,683,729
    Redemption of preferred stock..........................    (1,350,000)             --              --
    Redemption of convertible debentures...................      (650,000)             --              --
    Other..................................................      (140,274)             --              --
                                                             ------------    ------------    ------------
         Net cash provided by financing activities.........     7,240,752      14,193,808      12,359,323
         Net increase (decrease) in cash and cash
           equivalents.....................................        88,434        (293,613)        465,299
Cash and cash equivalents at beginning of year.............  $  1,598,744    $  1,892,357    $  1,427,058
                                                             ------------    ------------    ------------
Cash and cash equivalents at end of year...................  $  1,687,178    $  1,598,744    $  1,892,357
                                                             ============    ============    ============
Supplemental information:
  Cash paid during the year for interest...................         2,031         151,354         173,619
                                                             ============    ============    ============
  Conversions to common stock (notes 8, 9 and 10):
         Debentures........................................     1,000,000       9,225,000       1,025,000
         Notes payable, net of expenses....................            --              --       5,953,773
         Accrued interest..................................        33,446         483,435         373,222
         Preferred stock...................................     3,829,218              --              --
  Convertible preferred stock accretion (note 10)..........       231,911         257,666              --
                                                             ============    ============    ============
  Detachable warrants issued in conjunction with
    convertible debt and preferred stock (notes 8, 9 and
    10)....................................................       567,593         462,000         207,000
                                                             ============    ============    ============
  Conversion feature of debentures and stockholder notes
    payable issued (notes 8 and 9).........................       776,068       1,555,981       1,235,294
                                                             ============    ============    ============
  Common stock issued in connection with stockholder notes
    payable and preferred stock (notes 8 and 10)...........       656,103              --              --
                                                             ============    ============    ============
  Preferred stock converted to notes payable (note 10).....     1,185,496              --              --
                                                             ============    ============    ============
  Debentures and accrued interest converted to short- and
    long-term note payable (note 9)........................     1,035,205              --              --
                                                             ============    ============    ============
  Borrowings under capital lease obligations...............            --         194,064              --
                                                             ============    ============    ============
</TABLE>
 
          See accompanying notes to consolidated financial statements.
 
                                       F-5
<PAGE>   53
 
                      LASERTECHNICS, INC. AND SUBSIDIARIES
 
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                           DECEMBER 31, 1997 AND 1996
(1) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 
  (a) Company Organization and Basis of Presentation
 
     The accompanying consolidated financial statements include the accounts of
Lasertechnics, Inc. and its wholly owned subsidiaries Lasertechnics Marking
Corp. (LMC), its 96 percent owned subsidiary Sandia Imaging Systems Corporation
(Sandia), and Sandia's wholly owned French subsidiary Sandia Imaging Systems SA
(Sandia Europe) (collectively, the Company). All significant intercompany
accounts and transactions have been eliminated in consolidation.
 
     The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
 
  (b) Statements of Cash Flows
 
     The Company considers all highly liquid debt instruments with original
maturities of three months or less to be cash equivalents. The Company had cash
equivalents of $1,683,011 and $1,587,878 at December 31, 1997 and 1996,
respectively.
 
  (c) Inventory
 
     Inventory is valued at the lower of cost or market using the first-in,
first-out method.
 
  (d) Depreciation and Amortization
 
     Depreciation on property and equipment is calculated using the
straight-line method over the estimated useful lives of the respective assets.
Assets acquired under capital leases are amortized over the lesser of the term
of the lease or the estimated useful life of the asset using the straight-line
method.
 
  (e) Fair Value of Financial Instruments
 
     The carrying amount of cash equivalents, accounts receivable, accounts
payable, notes payable, customer advances, commissions payable and accrued
liabilities approximate fair value because of the short-term maturity of these
instruments.
 
     The outstanding borrowings under the Company's note payable to Xerox
Corporation (note 11) and the long-term note payable (note 9) bear interest at
current market rates, and therefore, the carrying amount of debt approximates
estimated fair value at December 31, 1997 and 1996.
 
     At December 31, 1996, the net carrying value of the March 1996 convertible
debentures (note 9) approximates fair value as such debentures are recorded
based on the current effective interest rate.
 
  (f) Income Taxes
 
     The Company accounts for income taxes under the asset and liability method.
Under this method, deferred tax assets and liabilities are recognized for the
future tax consequences attributable to differences between the financial
statement carrying amounts of existing assets and liabilities and their
respective tax bases. Deferred tax assets and liabilities are measured using
enacted tax rates expected to apply to taxable income in the years in which
those temporary differences are expected to be recovered or settled. Valuation
allowances are established when necessary to reduce deferred tax assets to the
amount more likely than not to
 
                                       F-6
<PAGE>   54
                      LASERTECHNICS, INC. AND SUBSIDIARIES
 
           NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
 
be realized. Income tax expense is the total of tax payable for the period and
the change during the period in deferred tax assets and liabilities.
 
  (g) Foreign Currency Translation
 
     The functional currency for the Company's foreign subsidiary is the
applicable local currency. Assets and liabilities of the foreign subsidiary are
translated to U.S. dollars at year-end exchange rates. Income and expense items
are translated at the average rates of exchange prevailing during the year. The
adjustments resulting from translating the financial statements of the foreign
subsidiary are reflected in stockholders' equity.
 
  (h) Net Loss Per Common Share
 
     In February 1997, the Financial Accounting Standards Board issued Statement
of Financial Accounting Standards No. 128, "Earnings Per Share" ("SFAS No.
128"). SFAS No. 128 revised the previous calculation methods and presentations
of earnings per share and requires that all prior-period earnings (loss) per
share data be restated to conform to SFAS No. 128. The Company adopted SFAS No.
128 in the fourth quarter of 1997 as required by this Statement. In accordance
with SFAS No. 128, the Company has presented basic loss per share, computed on
the basis of the weighted average number of common shares outstanding during the
year. Diluted earnings per share which includes the dilutive effect of options
and warrants has not been presented since, due to the net losses recorded by the
Company for all periods presented, their inclusion would be antidilutive.
 
     Net loss applicable to common stock is derived by adding to the
consolidated net loss the accretion of the discount recorded for the Company's
increasing rate preferred stock Series A, B and C, the annual accretion of
Series D, E and F Preferred Stock, the value of warrants issued to induce
conversions from Series F to Series G Preferred Stock during 1997 and in
connection with a 1997 standstill agreement and the intrinsic value of the
beneficial conversion feature of the Series D Preferred Stock (note 10).
 
  (i) Revenue Recognition
 
     The Company recognizes revenue on sales of its products either when the
products are shipped from the Company or received by the customer, depending on
shipping terms. Revenue related to product sales that require installation or
customer acceptance is recognized upon fulfillment of such requirements.
 
  (j) Warranty Costs
 
     The Company warrants its products against defects in material and
workmanship for periods ranging from 30 days to two years from the date of
installation. The Company provides for future warranty obligations in the period
product sales are recorded. The warranty reserve is reviewed quarterly and
adjusted based upon the Company's actual historical warranty costs and its
estimate of future costs.
 
  (k) Impairment of Long-Lived Assets and Long-Lived Assets to Be Disposed Of
 
     The Company adopted the provisions of SFAS No. 121, Accounting for the
Impairment of Long-Lived Assets and for Long-Lived Assets to Be Disposed Of, on
January 1, 1996. This Statement requires that long-lived assets and certain
identifiable intangibles be reviewed for impairment whenever events or changes
in circumstances indicate that the carrying amount of an asset may not be
recoverable. Recoverability of assets to be held and used is measured by a
comparison of the carrying amount of an asset to future net cash flows expected
to be generated by the asset. If such assets are considered to be impaired, the
impairment to be recognized is measured by the amount by which the carrying
amount of the asset exceeds the fair value of the assets. Assets to be disposed
of are reported at the lower of the carrying amount or fair value less costs to
sell.
 
                                       F-7
<PAGE>   55
                      LASERTECHNICS, INC. AND SUBSIDIARIES
 
           NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
 
Adoption of this Statement did not have a material impact on the Company's
financial position or results of operations.
 
  (l) Stock Compensation Plans
 
     On January 1, 1996, the Company adopted SFAS No. 123, Accounting for
Stock-Based Compensation, which permits entities to recognize as expense over
the vesting period the fair value of all stock-based awards on the date of
grant.
 
     Alternatively, SFAS No. 123 also allows entities to continue to apply the
provisions of Accounting Principles Board ("APB") Opinion No. 25, Accounting for
Stock Issued to Employees, and provide pro forma net income and pro forma
earnings per share disclosures for employee stock option grants made in 1995 and
future years as if the fair value-based method defined in SFAS No. 123 had been
applied. The Company has elected to continue to apply the provisions of APB
Opinion No. 25 and provide the pro forma disclosures of SFAS No. 123. Under APB
Opinion No. 25, compensation expense would be recorded on the date of grant only
if the current market price of the underlying stock exceeded the exercise price.
 
  (m) Reclassifications
 
     Certain reclassifications have been made to prior year consolidated
financial statements to conform to the current year presentation.
 
(2) RESTATEMENT
 
     The Company has restated its consolidated financial statements for the
years ended December 31, 1995 and 1996 to conform its accounting for beneficial
conversion features related to the issuance of convertible debentures in October
1995 and March 1996 and convertible preferred stock issued in July 1996 to the
Financial Accounting Standards Board's Emerging Issues Task Force Topic No. D-60
issued in March 1997 ("Topic No. D-60"). Topic No. D-60 requires that the
intrinsic value of beneficial conversion features of convertible debt securities
should be recognized as interest expense over the period from issuance to the
first date that conversion can occur. Previously, the Company was amortizing the
estimated fair value of the beneficial conversion feature to interest expense
over the life of the convertible debentures. Topic No. D-60 further states that
the intrinsic value of beneficial conversion features of convertible preferred
stock should be treated as a return to the preferred stockholder over the period
from issuance to the first date that conversion can occur. The Company had not
previously assigned a value to the beneficial conversion feature of its Series D
Convertible Preferred Stock.
 
     As a result of the aforementioned restatement, amounts were adjusted as
follows:
 
<TABLE>
<CAPTION>
                                                           YEAR ENDED      YEAR ENDED
                                                          DECEMBER 31,    DECEMBER 31,
                                                              1996            1995
                                                          ------------    ------------
<S>                                                       <C>             <C>
Interest expense, as previously reported................  $  1,541,001    $    968,790
Adjustment..............................................       369,918       1,051,961
                                                          ------------    ------------
Restated interest expense...............................     1,910,919       2,020,751
                                                          ============    ============
Restated net loss.......................................   (11,398,995)    (10,146,464)
Dividends, as previously reported.......................      (667,060)        (73,234)
Adjustment..............................................    (1,198,055)             --
                                                          ------------    ------------
Restated net loss attributable to common stockholders...   (13,264,110)    (10,219,698)
                                                          ============    ============
Basic and diluted loss per share, as previously
  reported..............................................         (0.34)          (0.33)
Restated basic and diluted loss per share...............         (0.39)          (0.37)
</TABLE>
 
                                       F-8
<PAGE>   56
                      LASERTECHNICS, INC. AND SUBSIDIARIES
 
           NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
 
     Unaudited quarterly financial data has also been restated from amounts
previously reported for the fiscal 1997 and 1996 quarterly results. See note 17.
 
(3) OPERATIONS, LIQUIDITY AND GOING CONCERN
 
     The Company's operations in 1997 continued to generate losses. The loss in
1997 significantly exceeded losses in either 1996 or 1995. Although, during
1997, the Company raised gross proceeds of approximately $11 million through
equity and debt transactions, the Company's operations, capital expenditures and
debt service requirements have utilized a significant portion of such proceeds
through February 1998. These factors raise substantial doubt about the Company's
ability to continue as a going concern.
 
     The Company's business plan for 1998 is predicated principally upon the
commencement of a new service center for outsourced card printing, significant
increases in sales for existing Sandia products, the successful introduction of
new products in both of its business segments, significant improvements in gross
margins and reductions in research and development expenditures. Because of the
anticipated timing of new product introductions and manufacturing cost
reductions, together with the necessity to prepay all or a portion of the
balance of its lease obligation financing, the Company may require additional
external financing to meet its 1998 requirements. However, there can be no
assurance that sufficient additional external financing could be obtained to
fund any increases in financing requirements resulting from delays in or
inability to significantly increase sales of existing Sandia products,
successfully introduce planned new products, or achieve gross margin
improvements. If the Company is unable to obtain such additional funds, it may
be necessary to either reduce or stop certain product development programs,
reduce its sales and marketing efforts, dispose of assets or undertake other
actions as may be appropriate.
 
(4) SIGNIFICANT CUSTOMERS
 
     One customer accounted for 10, 18 and 16 percent of consolidated revenues
in 1997, 1996 and 1995, respectively. Another customer accounted for 29 percent
of 1996 consolidated revenues. At December 31, 1997 and 1996, two customers
accounted for 29% and 27% of consolidated net accounts receivable, respectively.
 
                                       F-9
<PAGE>   57
                      LASERTECHNICS, INC. AND SUBSIDIARIES
 
           NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
 
(5) PROPERTY, PLANT AND EQUIPMENT
 
     Property, plant and equipment consists of the following:
 
<TABLE>
<CAPTION>
                                                    AMORTIZATION/
                                                     DEPRECIATION
                                                        PERIOD           1997           1996
                                                    --------------    -----------    -----------
<S>                                                 <C>               <C>            <C>
Property, plant and equipment under capital lease:
  Land (note 6)...................................                    $   336,396    $   336,396
  Building........................................      Lease term        923,550        923,550
  Machinery and equipment.........................      Lease term        127,411        127,411
  Research equipment..............................      Lease term         21,339         21,339
  Furniture and fixtures..........................      Lease term        530,913        530,913
                                                                      -----------    -----------
                                                                        1,939,609      1,939,609
Accumulated amortization..........................                       (695,084)      (648,131)
                                                                      -----------    -----------
  Property, plant and equipment under capital
     leases, net..................................                      1,244,525      1,291,478
                                                                      -----------    -----------
Other property, plant and equipment:
  Building........................................  14 to 45 years        311,955        311,955
  Leasehold improvements..........................      Lease term        158,311        165,679
  Machinery and equipment.........................    5 to 8 years      1,543,854      1,285,025
  Demonstration equipment.........................    2 to 3 years        830,258        933,363
  Research equipment..............................         3 years        179,796        136,005
  Furniture and fixtures..........................         5 years        657,963        781,851
                                                                      -----------    -----------
                                                                        3,682,137      3,613,878
                                                                      -----------    -----------
Accumulated depreciation and amortization.........                     (1,951,937)    (1,571,079)
                                                                      -----------    -----------
Other property, plant and equipment, net..........                      1,730,200      2,042,799
                                                                      -----------    -----------
     Total property, plant and equipment, net.....                    $ 2,974,725    $ 3,334,277
                                                                      ===========    ===========
</TABLE>
 
(6) LEASE OBLIGATIONS
 
     In 1983, the Company entered into a long-term capital lease agreement with
the City of Albuquerque, New Mexico for office, manufacturing and warehouse
facilities and equipment. In connection with the transaction, the City of
Albuquerque issued industrial development revenue bonds. The leased assets will
revert to the Company upon retirement of the lease obligations and payment of a
nominal amount.
 
     Pursuant to the original agreement, the bondholder has the right to call
the bonds starting in November 1993 and in each November thereafter. On October
1, 1993, the Company and bondholder entered into an agreement whereby the
Company increased the monthly lease payment by $8,000. This additional
prepayment amount started in April 1994 and was to be made for a 24 month
period. In exchange for the Company's agreement to make these prepayments, the
bondholder agreed to waive its right to call the bonds during this 24 month
period provided that the Company made its monthly payments on a timely basis and
remained in compliance with the agreement's debt covenants, which required the
Company to maintain a current ratio of not less than 1 to 1 and a debt to equity
ratio of not more than 3 to 1. During the fourth quarter of 1996, the bondholder
agreed to permanently waive the debt to equity ratio requirement and its right
to call the bond for redemption provided the lessee remains in compliance with
all other covenants. At December 31, 1997, the Company's current ratio was 0.9
to 1, which was in violation with the lease covenants, and accordingly, the
Company has classified the outstanding note payable pursuant to this agreement
as a current liability in the accompanying consolidated financial statements.
The Company intends to seek a waiver of non-compliance during 1998 relating to
this covenant violation. In addition to the covenants mentioned previously, the
agreement includes a provision whereby the debt can be called anytime the
bondholder reasonably believes itself to be insecure. No such call has occurred
as of February 1998 and management believes the likelihood that such
acceleration provisions will be exercised in 1998 is remote.
 
                                      F-10
<PAGE>   58
                      LASERTECHNICS, INC. AND SUBSIDIARIES
 
           NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
 
     Capital lease obligations are as follows:
 
<TABLE>
<CAPTION>
                                                                1997         1996
                                                              --------    ----------
<S>                                                           <C>         <C>
City of Albuquerque, New Mexico, due monthly (approximately
  $17,589 to maturity) including interest at 75% of the
  prime rate of Chase Manhattan Bank (6.38% at December 31,
  1997) but not less than 8% nor more than 14%, maturing
  September 2001............................................  $807,935    $  955,852
Other capital leases, due $6,601 monthly, with maturity
  dates through June 2002, including interest ranging from
  15.15% to 19.4%...........................................   114,845       197,235
                                                              --------    ----------
Total capital lease obligations.............................   922,780     1,153,087
Less:
  Current portion of capital leases.........................   807,935       225,676
                                                              --------    ----------
                                                              $114,845    $  927,411
                                                              ========    ==========
</TABLE>
 
     The annual aggregate lease payments under capital leases, assuming no
acceleration of lease payments due to the covenant violations discussed above,
are as follows:
 
<TABLE>
<CAPTION>
YEAR ENDING DECEMBER 31
-----------------------
<S>                    <C>                                                      <C>
        1998..................................................................  $  287,215
        1999..................................................................     257,879
        2000..................................................................     238,853
        2001..................................................................     229,829
        2002..................................................................      73,270
                                                                                ----------
                                                                                 1,087,046
        Less amount representing interest.....................................    (164,266)
                                                                                ----------
                                                                                $  922,780
                                                                                ==========
</TABLE>
 
(7) ACCRUED LIABILITIES
 
     Accrued liabilities consist of the following at December 31, 1997 and 1996:
 
<TABLE>
<CAPTION>
                                                                 1997          1996
                                                              ----------    ----------
<S>                                                           <C>           <C>
Customer advances...........................................  $    6,489    $  436,249
Commissions payable.........................................      33,970        65,249
Product warranty reserve....................................     645,055       516,783
Accrued payroll and payroll taxes...........................     167,415       265,928
Accrued vacation............................................     108,617       163,935
Preferred stock dividends...................................      60,916       356,182
Other.......................................................     812,139     1,153,199
Interest payable............................................     255,192            --
                                                              ----------    ----------
                                                              $2,089,793    $2,957,525
                                                              ==========    ==========
</TABLE>
 
(8) NOTES PAYABLE TO STOCKHOLDERS
 
     During the first quarter of 1997, the Company obtained a commitment for a
working capital bridge loan of up to $1,000,000 from Antiope Partners L.L.C.
(formerly Wolfensohn Partners L.P.) ("Antiope Partners"). The Company made draws
of $1,000,000 under this agreement during the first and second quarters of 1997.
Borrowings bore interest at 12% and were due on demand. The borrowings were
ultimately convertible into the Company's voting common stock. In June 1997,
borrowings under this agreement were
 
                                      F-11
<PAGE>   59
                      LASERTECHNICS, INC. AND SUBSIDIARIES
 
           NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
 
converted into an advance under the terms of a new bridge loan financing
provided to the Company by Antiope Partners and J.P. Morgan Investment
Corporation ("JPMIC") pursuant to a note purchase agreement dated June 25, 1997
(the "Note Purchase Agreement"). The Note Purchase Agreement provided the
Company with additional bridge financing up to a total of $3,000,000, to be
funded 60% by Antiope Partners and 40% by JPMIC. Under the Note Purchase
Agreement, the Company received additional fundings of $2,000,000 by September
1997. The Note Purchase Agreement provided for an interest rate of 10% per annum
for advances by Antiope Partners and 6.64% per annum for advances by JPMIC, with
a final maturity of December 31, 1997. In connection with the advances, the
Company issued to Antiope Partners and JPMIC an aggregate of 308,571 restricted
shares of the Company's common stock and warrants to purchase 600,000 shares of
the Company's common stock with a strike price of $0.70. In connection with the
restricted shares and warrants, the Company recorded a discount to equity of
approximately $287,000 ($91,000 for the warrants and $196,000 for the common
stock). Further, advances under the Note Purchase Agreement were convertible
into convertible debentures with terms similar to the currently outstanding
convertible debentures (see note 9), which were ultimately convertible into
common stock at a discount. The Company recorded a discount to equity of
approximately $688,000 for the intrinsic value of the beneficial conversion
feature. The discount attributable to the restricted shares, warrants and
conversion feature was fully accreted to interest expense during 1997. Advances
under the Note Purchase Agreement are secured by a pledge of all the capital
stock of the Company's LMC subsidiary held by the Company.
 
     In December 1997, JPMIC, Antiope Partners and Amphion Ventures L.P.
("Amphion"), an affiliate of Antiope Partners, extended the maturity of the Note
Purchase Agreement to December 31, 1998 in exchange for 112,942 restricted
shares of the Company's common stock and warrants to purchase 600,000 shares of
common stock at an exercise price of $0.25. The Company recorded a debt discount
of approximately $88,000 ($60,000 for warrants and $28,000 for the common stock)
representing the estimated fair value of the warrants and restricted stock
provided under this arrangement. The debt discount will be accreted to interest
expense through the extended maturity date of December 31, 1998.
 
     The Company borrowed additional funds of $4,138,575 from Amphion during
late September 1997 through early December 1997 under an informal borrowing
agreement. The advances accrued interest at a rate of 10% per annum. In
connection with these advances, the Company issued 425,681 restricted shares of
the Company's common stock and warrants to purchase 827,715 shares of the
Company's common stock at an exercise price of $.70. The Company recorded a debt
discount of approximately $316,000 ($121,000 for the warrants and $195,000 for
the common stock) representing the estimated fair value of the warrants and
restricted stock, which was fully accreted to interest expense as of December
31, 1997. In December 1997, the Company entered into an agreement whereby it
converted the advances under this informal borrowing agreement into Series G
Preferred Stock (see note 10).
 
     The effective interest rate associated with the borrowings from Antiope
Partners, Amphion and JPMIC was 71% including the beneficial conversion feature,
and 39% excluding the same.
 
     During June and July 1996, the Company obtained a 12% working capital
bridge loan totaling $1.7 million from Amphion. The loan principal and related
interest were paid in full in August 1996 with proceeds from the sale of Series
D Convertible Preferred Stock (note 9). In connection with these borrowings, a
five year warrant to purchase a total of 56,341 shares of Common Stock was
issued to Amphion.
 
     In 1994 and 1995, the Company borrowed $8,900,000 from JPMIC and Amphion
under notes payable which bore interest at 12% and were due on demand, or if no
demand was made, principal and interest became due at various dates in 1996. Of
the total amount borrowed, $6,210,000 plus accrued interest was converted into a
combination of common, nonvoting common and preferred stock. In conjunction with
these borrowings, Wolfensohn received detachable warrants to purchase 534,105
shares of Common Stock. The warrants were fully exercised in 1995 at an
aggregate price of $690,000, and an exercise price ranging from $1.01 to $1.76
per share. The value allocated to the warrants, $207,000, was reflected as a
discount on the convertible promissory
 
                                      F-12
<PAGE>   60
                      LASERTECHNICS, INC. AND SUBSIDIARIES
 
           NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
 
notes and was being amortized ratably over the one year stated term of the
notes. Amphion converted its debt during 1995, and the unamortized portion of
the discount was netted against additional paid-in capital as of the date of
conversion.
 
     The Company paid Amphion $2,000,000 of the amount borrowed with proceeds
from the October 1995 convertible debenture private placement (note 9). The
balance of borrowings outstanding were repaid when Amphion exercised all 534,105
warrants to purchase common stock of the Company.
 
(9) CONVERTIBLE DEBENTURES
 
     In October 1995, the Company completed a $7,000,000 private placement of 10
percent convertible debentures maturing in October 1998 (the "1995 Debentures").
The 1995 Debentures plus accrued interest were convertible by the holder into
unregistered Common Stock as follows: (a) between October 11, 1995 and November
25, 1995 at an exercise price of $2.34375, (b) between November 26, 1995 and
December 25, 1995, one-half of the 1995 Debentures could be converted at the
lesser of $2.34375 or 85 percent of the average five day closing bid price of
the Common Stock prior to conversion, and (c) after December 25, 1995, and
during the term of the 1995 Debentures, all 1995 Debentures could be converted
by the holder under the same terms described in (b). The Company had the right
to convert the 1995 Debentures at its own election subject to the terms of the
1995 Debenture agreement. The Common Stock issued upon conversion has
registration rights under certain circumstances. The Company recorded a debt
discount of approximately $1,235,000 for the intrinsic value of the beneficial
conversion feature of the 1995 Debentures. The consolidated financial statements
have been restated to reflect the accretion of the beneficial conversion feature
from issuance in October 1995 to the date of first available conversion of all
of the debentures, December 25, 1995 (see note 2). In 1995, $1,025,000 face
amount of 1995 Debentures plus $20,342 of accrued interest were converted into
658,570 shares of Common Stock. During 1996, all remaining 1995 Debentures,
having a face value of $5,975,000, plus $355,823 of accrued interest were
converted into 4,290,500 shares of Common Stock.
 
     In connection with the 1995 Debentures, a five year warrant to purchase
221,867 shares of Common Stock, priced at 20 percent above the $2.34375 closing
price, or $2.81 per share, was issued to the placement agent for the offering as
part of the placement fee.
 
     In March 1996, the Company completed a $5,500,000 private placement of 10
percent convertible subordinated debentures maturing March 1, 1999 (the "1996
Debentures"). The 1996 Debentures, plus accrued interest, were convertible into
the Company's unregistered common stock at the option of the holder as follows:
(a) between March 13, 1996 and May 11, 1996 at the fixed exercise price of $2.00
per share and (b) at the lesser of $2.00 per share or 85 percent of the average
five day closing bid price of the Common Stock prior to conversion for up to
one-fourth of the 1996 Debentures purchased beginning on each of these dates in
1996: May 12, June 11, July 11, and August 10. The Company had the right to
convert the 1996 Debentures at its own election at any time after March 1, 1997
utilizing the formula described above. The Company also has the right to redeem
the 1996 Debentures for cash upon notice of conversion by a holder or at any
time after March 1, 1997. The Common Stock issued upon conversion has
registration rights under certain circumstances. In connection with the 1996
Debentures, five year warrants to purchase 192,500 shares of Common Stock at
$2.20 per share were issued to the placement agent for the offering as part of
the placement fee. In addition, five year warrants to purchase 550,000 shares of
Common Stock at $2.00 per share were issued with the 1996 Debentures. The
Company recorded a debt discount of approximately $950,000 representing the
intrinsic value of the beneficial conversion feature of the 1996 Debentures and
approximately $606,000 for the estimated fair value of the 550,000 related
detachable warrants to purchase Common Stock. The consolidated financial
statements have been restated to reflect the accretion of the beneficial
conversion feature from issuance in March 1996 to the date of first available
conversion of all of the debentures (see note 2). The discount related to the
detachable warrants was being amortized ratably as an interest rate
 
                                      F-13
<PAGE>   61
                      LASERTECHNICS, INC. AND SUBSIDIARIES
 
           NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
 
adjustment over the life of the 1996 Debentures or until conversion. All
outstanding 1996 Debentures were to be automatically converted into Common Stock
prior to maturity. During 1996, $3,250,000 face amount of the 1996 Debentures
plus $127,612 of accrued interest were converted into 2,392,061 shares of Common
Stock.
 
     During 1997, $1,000,000 face amount of the 1996 Debentures plus $181,239
accrued interest were converted into 1,980,901 shares of the Company's common
stock. Additionally, in May 1997, the Company redeemed $600,000 principal of its
March 1996 Debentures with the proceeds from the private placement of $500,000
principal amount of the Series B 10% Convertible Debenture due March 1999 (the
"Series B Debenture") with substantially identical terms as the 1996 Debentures
and $100,000 in proceeds from the private placement of $500,000 of Series E
convertible preferred stock (see note 10). The Company recorded a debt discount
of approximately $88,000 representing the intrinsic value of the beneficial
conversion feature of the Series B Debenture. The discount was fully accreted to
interest expense during 1997. The Company redeemed an additional $50,000 face
amount of the 1996 Debentures during 1997.
 
     In July 1997, the holders of the 1996 Debentures, Series B Debenture,
Series D Preferred Stock and Series E Preferred Stock (the "Suspended
Securities") agreed to a ninety day suspension of conversion rights on 75% of
their holdings beginning July 14, 1997. From October 14, 1997 and thereafter,
the holders of the Suspended Securities can exercise the suspended portion at a
cumulative rate of 20% per month. In exchange for the standstill agreement, the
holders of the 1996 Debentures and the Series B Debenture received warrants to
purchase 271,875 shares of the Company's common stock at an exercise price of
$0.70. In connection with the issuance of these warrants, the Company recorded a
charge to interest expense of approximately $60,000, which represents the
estimated fair value of the warrants provided as an inducement to the holders of
the Suspended Securities.
 
     At December 31, 1997, as part of a series of transactions to convert
debentures and preferred stock into notes payable (the "December 1997
Restructuring"), the remaining $600,000 face amount of the 1996 Debentures were
converted into a 12% short-term note payable with $300,000 principal due in
January 1998 and three installments of $100,000 plus current interest due in
March, April and May 1998. Additionally, the Company converted the $500,000
principal amount of the Series B Debenture into an 8% long-term promissory note
due January 15, 2000. In connection with these conversions, the Company issued
to the holders warrants to purchase 600,000 shares of the Company's common stock
at an average exercise price of $0.42. In connection with the warrants issued,
the Company recorded a charge to interest expense of approximately $47,000,
which represents the estimated fair value of the warrants provided as a
conversion inducement.
 
(10) PREFERRED STOCK
 
  Series D Preferred Stock
 
     In July 1996, the Company completed an $8,350,000 private placement of 835
shares of a new class of preferred stock, Series D Convertible Preferred Stock,
par value $.01 per share ("Series D Preferred Stock"). Shares of Series D
Preferred Stock was convertible into Common Stock in increments of up to 1/3 of
Series D Preferred Stock purchased at the lesser of (i) $2.1406 per share or
(ii) (a) the average closing bid price of the Common Stock for the ten trading
days immediately prior to the conversion date multiplied by (b) a percentage
which is 90 percent from October 1, 1996 through November 29, 1996, 87.5 percent
from November 30, 1996 through January 28, 1997, and 85 percent thereafter. The
Company assigned a value of approximately $1,198,000 to the beneficial
conversion feature of the Series D Preferred Stock, which has been included as a
preferred stock dividend for purposes of calculating loss applicable to common
stockholders for the year ended December 31, 1996 in the accompanying
consolidated financial statements. See note 2. The Series D Preferred Stock did
not accrue dividends; however, each share possessed an 8 percent per annum
accretion rate prior to conversion which was payable in Common Stock upon
conversion or redemption at the conversion price then in effect. Any shares of
Series D Preferred Stock outstanding on August 2, 1999 were to
 
                                      F-14
<PAGE>   62
                      LASERTECHNICS, INC. AND SUBSIDIARIES
 
           NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
 
be subject to automatic conversion at the conversion rate then in effect. The
Company effected a Registration Statement on Form S-3 (Registration No.
333-10665), which registers up to 6,000,000 shares of Common Stock to be offered
by the holders of Series D Preferred Stock upon such holders' conversion of such
Series D Preferred Stock into Common Stock.
 
     In connection with the Series D Preferred Stock, a five year warrant to
purchase 195,039 shares of Common Stock at $2.1406 per share was issued to the
placement agent for the offering as part of the placement fee.
 
     During 1996, 250 shares of Series D Preferred Stock, having an aggregate
face value of $2,500,000, and an aggregate accretion value of $58,352, were
converted into 2,280,933 shares of Common Stock.
 
  Series E and F Preferred Stock
 
     In June 1997, the Company completed the private placement of $500,000
Series E Convertible Preferred Stock ("Series E Preferred Stock"). The Series E
Preferred Stock had substantially identical terms as the Series D Preferred
Stock. The proceeds of this placement were used to redeem $400,000 of Series D
Preferred Stock and a portion of the $600,000 principal amount of 1996
Debentures redeemed (see note 9). As discussed in note 10, in July 1997, the
holders of the 1996 Debentures, Series B Debenture, Series D Preferred Stock and
Series E Preferred Stock (the "Suspended Securities") agreed to a ninety day
suspension of conversion rights on 75% of their holdings beginning July 14,
1997. In exchange for the standstill agreement, the holders of the Series D and
Series E preferred stock received warrants to purchase 542,500 shares of the
Company's common stock at an exercise price of $0.70. The Company recorded a
discount of approximately $119,000 representing the estimated fair value of the
warrants provided for under this arrangement. These warrants provided as an
inducement to the holders of the Suspended Securities have been accounted for as
stock dividends to the Series D and E Preferred Stockholders. In connection with
the standstill agreement, the Company converted the outstanding shares of Series
D and Series E Preferred Stock into Series F Convertible Preferred Stock
("Series F Preferred Stock"). The Series F Preferred Stock had substantially
identical terms as the Series D and Series E Preferred Stock. Additionally, the
Company completed a private placement of $480,000 face amount of Series F
Preferred Stock in July 1997 with Antiope, the proceeds of which were used to
redeem $480,000 of existing Series D Preferred Stock from a stockholder.
 
     During 1997, the Company converted a total of $3,590,000 face amount plus
$239,218 in accreted dividends of Series D, E and F Preferred Stock into
5,753,014 shares of common stock and redeemed for cash a total $1,350,000 face
amount.
 
  Series G Preferred Stock and December 1997 Restructuring
 
     In December 1997, in connection with the December 1997 Restructuring, the
Company completed a $7,897,353 private placement of Series G Preferred Stock
with stockholders of the Company. Proceeds from the private placement were as
follows: cash of $931,000; a short-term note receivable of $1,158,684 (which was
repaid in full in January and February 1998); forgiveness of accrued dividends
payable of $708,620 on Series A, B and C Series Preferred Stock; conversion of
$4,138,575 principal and $63,121 accrued interest from the informal borrowing
agreement (see note 9); and conversion of $860,000 face amount plus $37,353 of
accreted dividends in Series F Preferred Stock. In connection with the Series F
to Series G Preferred Stock conversion, the Company issued 897,353 shares of
common stock to the Series F Preferred Stockholders with a fair value of
approximately $236,000 as a conversion inducement. This conversion inducement
has been accounted for as a stock dividend to the Series F Preferred
Stockholders.
 
     Additionally, in connection with the December 1997 Restructuring, $980,000
face amount of Series F Preferred Stock plus $112,768 in accrued dividends were
converted into a short-term note payable due in two installments in January and
September 1998. The remaining $75,000 face amount of Series F Preferred Stock
 
                                      F-15
<PAGE>   63
                      LASERTECHNICS, INC. AND SUBSIDIARIES
 
           NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
 
was converted into a 12% short-term note payable, with accrued interest at
December 31, 1997 of $17,759. In connection with these conversions, the Company
issued to the holders warrants to purchase 840,000 shares of the Company's
common stock at an exercise price of $0.50. The Company recorded a debt discount
of approximately $70,000 representing the estimated fair value of the warrants
provided for under this arrangement. This conversion inducement has been
accounted for as a stock dividend to the Series F Preferred Stockholders.
 
  Series A, B and C Preferred Stock
 
     The Company has three additional classes of convertible preferred stock,
Series A, B and C Convertible Preferred Stock, stated value $1.30, $1.42, and
$1.51, respectively. Each share of Series A, B, and C Convertible Preferred
Stock is convertible at the option of the holder into voting Common Stock on a
share for share basis and is entitled to vote as if converted into voting Common
Stock. The Company may redeem the preferred stock at anytime at stated value
plus accrued dividends.
 
     The Series A and B Preferred Stock accrue dividends at the following rates
per annum: 0 percent through December 31, 1995; 5 percent January 1, 1996
through March 31, 1996; 7.5 percent April 1, 1996 through June 30, 1996 and 10
percent thereafter. Series C Preferred Stock accrues dividends at 0 percent per
annum through December 31, 1995 and 10 percent per annum thereafter. Dividends
are payable within 15 days following each calendar quarter in cash or in
additional shares of preferred stock at the option of the Company through June
30, 1996 (September 30, 1996 for Series C Preferred Stock). After June 30, 1996
(September 30, 1996 for Series C Preferred Stock), dividends are payable in cash
or additional shares of preferred stock at the option of the stockholders. There
were no dividends in arrears at December 31, 1997 and 1996.
 
     A discount on the Series A, B, and C Convertible Preferred Stock was
recorded equal to the present value of the difference between the actual
dividends that would be paid and the 10 percent perpetual dividend amount,
calculated over the increasing dividend rate period. The discount was amortized
to provide a constant effective dividend rate. The 1996 and 1995 aggregate
discount amortization for all three series of preferred stock was $53,212, and
$73,234, respectively. The discount was fully amortized during 1996.
 
     All series of preferred stock rank senior in right of payment to the
Company's Common Stock as to dividends or upon a liquidation or dissolution of
the Company.
 
(11) NOTES PAYABLE
 
     On December 27, 1996, Sandia signed a $2,100,000 note payable to Xerox
Corporation ("Xerox") in connection with a license agreement for certain
technology. Initially, one-third of the note principal plus accrued interest was
due on December 15 of 1997, 1998 and 1999. The Company and Xerox have held
settlement discussions during the first quarter of 1998 in an effort to amicably
resolve their dispute. However, there can be no assurances that the Company will
prevail in any action or proceeding arising in connection with its dispute with
Xerox, or that an amicable resolution of such dispute would be possible. (See
note 18). Accordingly, the outstanding balance of $2,100,000 has been classified
as a current liability in the accompanying consolidated balance sheet.
 
     The license fee of $2,100,000 has been recorded as a deferred license fee
and is being amortized over the three year term of the license agreement.
Accordingly, the Company has reflected the unamortized balance of $1,400,000 as
a noncurrent asset. In years following 1999, upon license renewal the Company
will pay a minimum royalty. The royalty on annual sales in excess of $10,000,000
is to be calculated using a declining percentage ranging from 4.5% to 3%.
 
                                      F-16
<PAGE>   64
                      LASERTECHNICS, INC. AND SUBSIDIARIES
 
           NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
 
     The remaining balance in notes payable at December 31, 1997 includes short
term notes payable totaling $1,767,767 and long-term notes payable of $535,205
related to the December 1997 Restructuring transactions discussed at notes 9 and
10 and other, as follows:
 
<TABLE>
<S>                                                           <C>
Note payable issued to 1996 Debenture holder................  $  600,000
Notes payable issued to Series F Preferred stockholders.....   1,167,767
Xerox note payable..........................................   2,100,000
Other notes payable.........................................      74,728
                                                              ----------
          Total short-term notes payable....................  $3,942,495
                                                              ==========
Long-term note payable issued to Series B debenture
  holder....................................................  $  535,205
                                                              ==========
</TABLE>
 
(12) STOCK COMPENSATION PLANS
 
     At December 31, 1997, the Company has four stock-based compensation plans
that are described below. The Company applies APB Opinion 25 and related
Interpretations in accounting for its plans. Accordingly, no compensation cost
has been recognized related to stock option grants since the intrinsic value of
stock options awarded is zero at the date of grant. Had compensation cost for
the Company's four stock-based compensation plans been determined based on the
grant date fair value method in accordance with SFAS No. 123, the Company's net
loss and net loss per share would have increased to the pro forma amounts
indicated below:
 
<TABLE>
<CAPTION>
                                               1997            1996            1995
                                           ------------    ------------    ------------
<S>                                        <C>             <C>             <C>
Net loss applicable to common stock
  As reported (as restated -- see note
     2)..................................  $(13,892,830)   $(13,264,110)   $(10,219,698)
  Pro forma..............................   (14,140,970)    (13,359,439)    (10,268,031)
Basic and diluted net loss per common
  share
  As reported (as restated -- see note
     2)..................................  $      (0.31)   $      (0.39)   $      (0.37)
  Pro forma..............................         (0.32)          (0.34)          (0.33)
</TABLE>
 
     The fair value of each option grant is estimated on the date of grant using
the Black-Scholes option-pricing model with the following weighted-average
assumptions used for grants in 1995 and 1996, respectively: (i) expected
volatility of 90 and 92 percent, except that expected volatility is assumed to
be zero in the computation of fair value of the non-public subsidiary options
since such stock does not trade, (ii) risk-free interest of 6.5%, and (iii)
expected lives of 5 years for director options and 10 years for employee
options.
 
     The Company had a key employee stock option plan (the 1981 Plan) that
terminated on November 29, 1991. Under the 1981 Plan, 93,066 shares of Common
Stock have been reserved for the outstanding options, all of which are
exercisable at a price of $.66 per share through December 21, 2000, when they
expire.
 
     Under the Company's 1991 Employee Stock Option Plan, the Company may grant
up to 1,000,000 shares of Common Stock to its employees. The exercise price of
each option equals the market price of the Company's stock on the date of grant
and an option's maximum term is ten years. Options granted vest over a four year
period. In addition to employees, the Company has issued stock options to
various members of the Board of Directors and officers of the Company. The
exercise price of each option equals the average market price of the Company's
stock during the thirty trading days immediately prior to the date of grant and
the option term is five years. Options are generally granted each year and have
various vesting requirements.
 
                                      F-17
<PAGE>   65
                      LASERTECHNICS, INC. AND SUBSIDIARIES
 
           NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
 
     The Company also has separate Employee Stock Option Plans for each of its
subsidiary companies. The Sandia unit, under its 1994 Employee Stock Option
Plan, may grant up to 2,000,000 shares of its common stock to employees of
Sandia. The LMC unit, under its 1995 Employee Stock Option Plan, may grant
450,000 shares of its common stock to LMC employees. Under both plans, the
exercise price of each option equals or exceeds the estimated fair value of the
subsidiary's stock on the date of grant and an option's maximum term is 10
years. Options are generally granted each year and vest over a four year period.
In addition to employees, each subsidiary has issued stock to its Board of
Directors and officers. The exercise price of each option equals or exceeds the
estimated fair value of each subsidiary's stock on the date of grant and the
option's maximum term is five years.
 
<TABLE>
<CAPTION>
                                                                        WEIGHTED AVERAGE
                  LASERTECHNICS, INC.                       SHARES       EXERCISE PRICE
                  -------------------                     ----------    ----------------
<S>                                                       <C>           <C>
Balance outstanding at December 31, 1994................   2,624,743         $0.69
  Granted...............................................     127,587          1.42
  Exercised.............................................    (627,212)         0.73
  Forfeited.............................................  (1,417,956)         0.50
                                                          ----------         -----
Balance outstanding at December 31, 1995................     707,162          1.19
  Granted...............................................      70,000          1.80
  Exercised.............................................     (69,228)         1.06
  Forfeited.............................................     (92,374)         1.07
                                                          ----------         -----
Balance outstanding at December 31, 1996................     615,560          1.29
  Granted...............................................          --            --
  Exercised.............................................          --            --
  Forfeited.............................................     (61,595)         1.36
                                                          ----------         -----
Balance outstanding at December 31, 1997................     553,965         $1.29
                                                          ==========         =====
</TABLE>
 
     At December 31, 1997, 1996, and 1995, there were 518,965, 528,060 and
647,245 Lasertechnics, Inc. options exercisable, respectively. Weighted-average
fair values of Lasertechnics, Inc. options granted during the year ended
December 31, 1996 and 1995 were $1.60 and $1.20 per share, respectively.
 
<TABLE>
<CAPTION>
                                                                        WEIGHTED AVERAGE
                      SUBSIDIARIES                          SHARES       EXERCISE PRICE
                      ------------                         ---------    ----------------
<S>                                                        <C>          <C>
Balance outstanding at December 31, 1994.................    227,500         $0.09
  Granted................................................     40,000          0.50
  Exercised..............................................    (45,000)         0.01
  Forfeited..............................................    (45,000)         0.06
                                                           ---------         -----
Balance outstanding at December 31, 1995.................    177,500          0.20
  Granted................................................  1,260,675          0.97
  Exercised..............................................    (10,000)         0.01
  Forfeited..............................................   (153,000)         0.93
                                                           ---------         -----
Balance outstanding at December 31, 1996.................  1,275,175          0.88
  Granted................................................    515,000          1.00
  Exercised..............................................    (10,000)         0.01
  Forfeited..............................................   (455,100)         0.96
                                                           ---------         -----
Balance outstanding at December 31, 1997.................  1,325,075         $0.90
                                                           =========         =====
</TABLE>
 
                                      F-18
<PAGE>   66
                      LASERTECHNICS, INC. AND SUBSIDIARIES
 
           NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
 
     At December 31,1997, 1996 and 1995, there were 394,087, 249,747, and 95,208
subsidiary options exercisable, respectively. Weighted-average fair values of
subsidiary options granted during the years ended December 31, 1997, 1996 and
1995 were $0.35, $0.53 and $0.28 per share, respectively.
 
     The following table summarizes information about the stock options
outstanding at December 31,1997. Certain ranges of exercise prices overlap
because of the significant difference in contracted lives.
 
<TABLE>
<CAPTION>
                                                   OPTIONS OUTSTANDING             OPTIONS EXERCISABLE
                                           ------------------------------------   ----------------------
                                                          WT. AVE.
                                             NUMBER       REMAINING    WT. AVE.     NUMBER      WT. AVE.
                 RANGE OF                  OUTSTANDING   CONTRACTUAL   EXERCISE   OUTSTANDING   EXERCISE
             EXERCISE PRICES               AT 12/31/97   LIFE/YEARS     PRICE     AT 12/31/97    PRICE
             ---------------               -----------   -----------   --------   -----------   --------
<S>                                        <C>           <C>           <C>        <C>           <C>
Lasertechnics, Inc.
  $0.66 to $0.66..........................     93,066        3.0        $0.66        93,066      $0.66
  $1.00 to $1.29..........................     67,375        5.8         1.04        67,375       1.04
  $1.22 to $1.81..........................    322,624        1.3         1.44       310,124       1.42
  $1.58 to $1.79..........................     70,900        7.8         1.64        48,400       1.63
                                            ---------                               -------
  $0.66 to $1.81..........................    553,965        3.0         1.29       518,965       1.25
                                            =========                               =======
Subsidiaries
  $0.01 to $0.01..........................     75,000        0.9        $0.01        75,000      $0.01
  $1.50 to $1.00..........................  1,250,075        8.9         0.95       319,087       0.89
                                            ---------                               -------
  $0.01 to $1.00..........................  1,325,075        8.4         0.90       394,087       0.72
                                            =========                               =======
Consolidated
  $0.01 to $1.81..........................  1,879,040        6.8        $1.01       913,052      $1.02
                                            =========                               =======
</TABLE>
 
(13) COMMITMENTS AND CONTINGENCIES
 
     The Company has entered into license agreements that provide for royalty
payments based on various percentages of certain product sales. Royalty expense
under these agreements for the years ended December 31, 1997, 1996 and 1995 was
approximately $275,000, $126,000 and $151,000, respectively.
 
     On February 28, 1996, an investor group filed suit against the Company.
This lawsuit arises out of the Company's refusal to recognize the investor
group's attempt to exercise an option to purchase 1,400,000 shares of Common
Stock at $.495 per share. The option had been granted to the Company's former
President and CEO who attempted to transfer his option to the investor group on
the last day of the option term in September 1995. On that same day the investor
group attempted to exercise the option. The Company refused to recognize the
attempted transfer of the option to the investor group on the primary grounds
that the option was granted personally to the Company's former President and CEO
and was not transferable to third parties. The lawsuit seeks issuance and
registration of the 1,400,000 shares upon payment of the exercise price, or in
the alternative, monetary damages which the investor group alleges to be not
less than $2,800,000. The Company believes the claim is without merit and will
vigorously oppose it. At December 31, 1997, management estimates that the
ultimate outcome of this claim will not have a material adverse effect upon the
Company's financial position or results of operations. Management's estimates
could change depending upon the progress of the lawsuit.
 
     On March 15, 1996, LMC was notified about a potential future patent
infringement claim by a competitor relating to LMC's electronic code changing
device. LMC does not believe that its product infringes on the identified
patent, but it is in the process of investigating the merits of the asserted
claim. Management currently estimates that the ultimate outcome of this claim
will not have a material adverse effect upon the Company's financial position or
results of operations. Management's evaluation may change depending upon the
results of its investigation.
 
                                      F-19
<PAGE>   67
                      LASERTECHNICS, INC. AND SUBSIDIARIES
 
           NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
 
     The Company is also involved in various other claims and lawsuits which are
generally incidental to its business. The Company is vigorously contesting all
such matters and believes that their ultimate resolution will not have a
material adverse effect on its consolidated financial position, results of
operations or cash flows.
 
(14) TERMINATION OF MANUFACTURING AGREEMENT
 
     In 1993, the Company engaged Wolfensohn International, Inc., a subsidiary
of James D. Wolfensohn, Inc., which is an affiliate of a significant
stockholder, Wolfensohn Associates, L.P. (Wolfensohn), to provide advisory and
investment banking services with respect to a possible strategic alliance with a
third party to develop and manufacture the Company's products. On May 13, 1994,
Sandia and Singapore Precision Industries (SPI), a unit of Singapore Technology
Industrial Corporation, the technology manufacturing arm of the Singapore
government, entered into a contract manufacturing agreement and a distribution
agreement whereby SPI became a licensed distributor of Sandia products.
Concurrently, SPI purchased 826,447 shares of Common Stock for $1,000,000.
Pursuant to the agreement with Wolfensohn the Company paid Wolfensohn $50,000
during 1994 based upon the $1,000,000 SPI stock purchase transaction. The
Company does not anticipate that any additional fees will be paid to Wolfensohn
International, Inc. pursuant to this agreement.
 
     In the third quarter of 1995 the Company instructed SPI to discontinue
production, and subsequently began negotiations with SPI to terminate the
manufacturing agreement pursuant to the cancellation provisions of the contract.
The negotiations were not completed until the second quarter of 1996. In
settlement of all outstanding claims under this agreement, which included
payment for units already produced and parts inventory, the Company agreed to
pay $1,525,000 to SPI. As part of the settlement, the Company received plastic
card printers and parts having an estimated net realizable value of $525,000. As
a result, the Company recorded an expense of $1 million in the second quarter of
1996 as a cost of settling the dispute.
 
     The Company had previously paid SPI $465,000 for amounts due for units
produced. The remaining amount was paid in 1996 after completion of the
negotiations.
 
(15) INCOME TAXES
 
     Due to the Company's losses, no income tax expense was recorded for the
years ended December 31, 1997, 1996 and 1995. At December 31, 1997, the Company
had a net operating loss carryforward of approximately $46,000,000 for U.S.
federal income tax purposes, which will begin expiring in 1998. Of this federal
net operating loss carryforward approximately $9,125,000 is available for state
income tax purposes. The tax benefit (approximately $15,700,000) of the net
operating loss carryforward has been fully offset by a valuation allowance,
since the Company cannot currently conclude that it is more likely than not that
the benefit will be realized. The valuation allowance increased by approximately
$2,440,000 during 1997. Because of conversions of existing convertible debt, a
change in ownership, as defined for purposes of the Internal Revenue Code,
occurred in 1996 that limits the annual utilization of the U.S. federal net
operating loss carryforward under applicable Internal Revenue Service
regulations. The annual limitation, as defined under Internal Revenue Code (IRC)
Section 382, is computed pursuant to such IRC section and considers the fair
market value of the corporation on the ownership change dates and the federal
long-term tax exempt interest rate. Additionally, the Company had approximately
$400,000 of research and development carryforward. The carryforwards expire from
1998 to 2006. The credit carryforwards will also be restricted in their usage as
a result of the ownership change.
 
                                      F-20
<PAGE>   68
                      LASERTECHNICS, INC. AND SUBSIDIARIES
 
           NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
 
(16) SEGMENT INFORMATION
 
     Export sales totaled approximately $4,431,054, $9,409,624 and $5,333,443 in
1997, 1996 and 1995, respectively. Such export sales were to the following
geographic regions:
 
<TABLE>
<CAPTION>
                                                    1997          1996          1995
                                                 ----------    ----------    ----------
<S>                                              <C>           <C>           <C>
Europe.........................................  $  870,328    $1,692,523    $1,980,847
Asia-Pacific...................................   3,045,781     7,437,154     3,256,877
Other..........................................     514,945       279,947        95,719
                                                 ----------    ----------    ----------
                                                 $4,431,054    $9,409,624    $5,333,443
                                                 ==========    ==========    ==========
</TABLE>
 
  Business Segments
 
     The Company operates with its product groups organized into two business
segments: imaging and marking. Imaging operations involve the sale of plastic
card printers. Operations in marking involve the production and sale of laser
systems which mark products with a serial number, logo or bar code.
 
     Operating results and other financial data are presented in the information
which follows for the principal business segments of the Company for the years
ended December 31, 1997, 1996 and 1995. General corporate assets and expenses
are allocated to the respective business segments. Assets used by the respective
segments are located at the operating units of the respective segments and there
are no general corporate assets. General corporate expenses are allocated based
on the estimated usage of financial resources by the respective segments.
 
<TABLE>
<CAPTION>
                                           IMAGING          MARKING        CONSOLIDATED
                                          (SANDIA)           (LMC)           COMPANY
                                         -----------      -----------      ------------
<S>                                      <C>              <C>              <C>
1997:
  Sales................................  $ 4,353,318(a)   $ 6,765,021(b)   $ 11,118,339
  Loss from operations.................   (8,383,449)      (1,808,445)      (10,191,894)
  Identifiable assets(c)...............    8,934,768        5,750,644        14,685,412
  Capital expenditures.................      178,212         (109,953)           68,259
  Depreciation.........................      417,489           92,359           509,848
1996:
  Sales................................  $ 8,197,639(a)   $ 9,383,801(b)   $ 17,581,440
  Loss from operations.................   (8,642,620)        (981,376)       (9,623,996)
  Identifiable assets(c)...............    9,941,186        7,720,671        17,661,857
  Capital expenditures.................      654,832          128,962           783,794
  Depreciation.........................      459,860          265,999           725,859
1995:
  Sales................................  $ 3,121,577      $10,308,154      $ 13,429,731
  Loss from operations.................   (7,934,839)        (195,374)       (8,130,213)
  Identifiable assets(c)...............    5,844,770        8,797,832        14,642,602
  Capital expenditures.................      640,528          354,990           995,518
  Depreciation.........................      133,991          218,466           352,457
</TABLE>
 
---------------
 
(a)  Sales of imaging products to two customers were $688,198 and $722,000 in
     1997, which represents 16% and 17% of imaging sales for that year. Sales to
     the same two customers were $5,122,000 and $1,107,000 in 1996, which
     represents 63% and 14% of imaging sales for that year. Additionally, sales
     to another customer were $506,000, which represents 12% of imaging sales in
     1997.
 
(b)  Sales of marking products to a single customer were $1,139,000, $3,153,000
     and $2,171,000 in 1997, 1996 and 1995, which represents 17%, 34%, and 21%
     of marking sales, respectively.
 
                                      F-21
<PAGE>   69
                      LASERTECHNICS, INC. AND SUBSIDIARIES
 
           NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
 
(c)  Identifiable assets by business segment are those assets used in the
     Company's operations in each segment.
 
      GEOGRAPHIC SEGMENTS
 
          The Company operates primarily in the United States and France.
     Operating results and other financial data are presented in the information
     which follows for the principal geographic segments of the Company.
 
<TABLE>
<CAPTION>
                                      UNITED                          INTERCOMPANY
                                     STATES(G)         FRANCE         ACTIVITY(F)    CONSOLIDATED
                                    -----------      -----------      ------------   ------------
   <S>                              <C>              <C>              <C>            <C>
   1997:
     Sales........................  $10,953,416      $ 1,720,205      $(1,555,282)   $11,118,339
     Loss from operations.........   (8,291,174)      (1,674,849)                       (225,871)
     Identifiable assets(e).......   15,103,387        1,486,049       (1,904,024)    14,685,412
   1996:
     Sales........................  $18,320,335(a)   $ 7,143,779(b)   $(7,882,674)   $17,581,440
     Loss from operations.........   (6,989,549)      (1,927,536)        (706,911)    (9,623,996)
     Identifiable assets(e).......   17,470,744        2,535,828       (2,344,715)    17,661,857
   1995:
     Sales........................  $11,730,377(a)   $ 2,549,943         (850,589)    13,429,731
     Loss from operations.........   (6,565,747)      (1,557,388)          (7,078)    (8,130,213)
     Identifiable assets(e).......   12,356,388        2,520,500         (234,286)    14,642,602
</TABLE>
 
          Sales between geographic regions are recorded at amounts above cost in
     accordance with the rules and regulations of the governing tax authorities.
 
(e)  Identifiable assets by geographic segment are those assets used in the
     Company's operations in each segment.
 
(f)  Intercompany activity is eliminated in consolidation.
 
(g)  All corporate activity and assets are included in the United States
     geographic segment.
 
                                      F-22
<PAGE>   70
                      LASERTECHNICS, INC. AND SUBSIDIARIES
 
           NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
 
(17) QUARTERLY FINANCIAL DATA (UNAUDITED -- AS RESTATED (NOTE 2))
 
<TABLE>
<CAPTION>
                                                       QUARTER ENDED
                                   ------------------------------------------------------
                                    MARCH 31       JUNE 30     SEPTEMBER 30   DECEMBER 31
                                   -----------   -----------   ------------   -----------
<S>                                <C>           <C>           <C>            <C>
1997:
  Net revenues...................  $ 4,589,787   $ 2,591,537   $ 1,982,489    $ 1,954,526
  Operating income (loss)........  $(1,297,126)  $(2,202,775)  $(3,925,433)    (2,766,560)
  Net loss applicable to common
     stock.......................  $(1,630,226)  $(3,094,533)  $(4,459,747)   $(4,708,324)
  Basic and diluted net loss per
     share.......................  $     (0.04)  $     (0.07)  $     (0.10)   $     (0.10)
1996:
  Net revenues...................  $ 4,111,701   $ 3,454,222   $ 7,252,217    $ 2,763,300
  Operating income (loss)........  $(1,750,246)  $(3,230,530)  $(2,100,109)   $(2,543,111)
  Net loss applicable to common
     stock.......................  $(2,144,870)  $(4,406,255)  $(3,234,236)   $(3,478,749)
  Basic and diluted net loss per
     share.......................  $     (0.07)  $     (0.13)  $     (0.09)   $     (0.10)
1995:
  Net revenues...................  $ 3,266,475   $ 3,496,314   $ 3,181,409    $ 3,485,533
  Operating income (loss)........  $(1,652,719)  $(2,311,655)  $(1,613,883)   $(2,551,956)
  Net loss applicable to common
     stock.......................  $(1,775,527)  $(2,575,240)  $(1,866,174)   $(4,002,757)
  Basic and diluted net loss per
     share.......................  $     (0.07)  $     (0.10)  $     (0.07)   $     (0.15)
</TABLE>
 
(18) SUBSEQUENT EVENTS (UNAUDITED)
 
     (a) Nasdaq Listing.
 
          In August 1997, the Securities and Exchange Commission approved
     certain changes to the continued listing requirements of the Nasdaq
     SmallCap Market. Two such rule changes, which became effective February 22,
     1998, require an issuer to maintain a minimum bid price of $1 per share for
     its listed securities and to maintain a minimum of $2 million in net
     tangible assets. A special stockholders' meeting was held on March 31,
     1998, at which time the stockholders approved, among other things, a
     1-for-20 reverse split. As of April 2, 1998, the first full trading day
     after the Company gave notice to Nasdaq that the reverse stock split was
     approved by its stockholders, the closing bid price of the Common Stock was
     $5.00 per share, which is in excess of the minimum bid price of $1.00 per
     share established by the new Nasdaq listing requirements. Further, by
     letter dated April 15, 1998, Nasdaq advised the Company that it was in
     compliance with the new Nasdaq listing requirements and approved the
     Company's continued listing on Nasdaq. Subsequent to December 31, 1997,
     Antiope and Amphion purchased $1.9 million in Series G Preferred Stock.
     Additionally, Amphion committed to purchase up to an additional $5.5
     million of Series G or certain other new preferred stock to fund the
     Company's operations and provide for the continued maintenance of the
     Company's net tangible assets above the Nasdaq minimum requirement. As of
     February 28, 1998, the Company's net tangible assets were in excess of the
     $2 million Nasdaq requirement. While management believes that the Company
     will be able to preserve the listing of the Common Stock on the Nasdaq
     SmallCap Market, there can be no assurance that the Company will be able to
     do so.
 
                                      F-23
<PAGE>   71
                      LASERTECHNICS, INC. AND SUBSIDIARIES
 
           NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
 
     (b) Name Change.
 
          At a special meeting of stockholders held on March 31, 1998, the
     stockholders approved a proposal to amend the Company's Certificate of
     Incorporation to change the Company's name to AXCESS Inc. Further, in
     connection with the name change, the Company changed its trading symbol on
     the Nasdaq SmallCap Market to "AXSI."
 
     (c) Xerox Settlement.
 
          The Company and Xerox have entered into a settlement agreement
     pursuant to which the Company has agreed to pay Xerox $1.47 million of a
     license fee for certain technology and issue Xerox 120,000 (post reverse
     split) shares of Common Stock. Xerox has agreed not to sell any of these
     shares until December 1999, at which time shares may be subject to certain
     limitations. The Company will fund the payment to Xerox from proceeds
     received from Amphion Ventures under the terms of a two-year loan which
     bears interest at the rate of 10% per annum. In addition, Amphion Ventures
     will receive, as a loan origination fee, (i) 15,120 shares of restricted
     Common Stock and (ii) 3-year warrants to purchase 14,700 shares of Common
     Stock with an exercise price of $5.00 per share.
 
                                      F-24
<PAGE>   72
 
                                  SCHEDULE II
                      LASERTECHNICS, INC. AND SUBSIDIARIES
 
                       VALUATION AND QUALIFYING ACCOUNTS
                  YEARS ENDED DECEMBER 31, 1997, 1996 AND 1995
 
<TABLE>
<CAPTION>
                                                             ADDITIONS
                                                BALANCE AT   CHARGED TO                   BALANCE AT
                                                BEGINNING    COSTS AND                      END OF
                 DESCRIPTION                    OF PERIOD     EXPENSES    DEDUCTIONS        PERIOD
                 -----------                    ----------   ----------   -----------     ----------
<S>                                             <C>          <C>          <C>             <C>
For the year ended December 31, 1997:
  Reserves and allowance deducted from asset
     accounts-allowance for doubtful
     accounts.................................   $357,136    $1,058,572   $(1,034,797)(a)  $380,911
                                                 ========    ==========   ===========      ========
  Product Warranty Reserve....................   $516,783    $  382,795   $  (254,523)(b)  $645,055
                                                 ========    ==========   ===========      ========
For the year ended December 31, 1996:
  Reserves and allowance deducted from asset
     accounts-allowance for doubtful
     accounts.................................   $278,263    $  248,489   $  (169,616)(a)  $357,136
                                                 ========    ==========   ===========      ========
  Product Warranty Reserve....................   $256,003    $  639,606   $  (378,826)(b)  $516,783
                                                 ========    ==========   ===========      ========
For the year ended December 31, 1995:
  Reserves and allowance deducted from asset
     accounts-allowance for doubtful
     accounts.................................   $170,010    $  115,375   $    (7,122)(a)  $278,263
                                                 ========    ==========   ===========      ========
  Product Warranty Reserve....................   $261,138    $  338,250   $  (343,858)(b)  $256,003
                                                 ========    ==========   ===========      ========
</TABLE>
 
---------------
 
(a)  Charge-Offs
 
(b)  Actual costs incurred
 
                                       S-1
<PAGE>   73
                                  EXHIBIT INDEX

<TABLE>
<CAPTION>
            EXHIBIT
            NUMBER                           EXHIBIT
            -------                          -------
              <S>    <C>
              3.1    --Certificate of Incorporation of the Company. Incorporated
                     herein by reference to Exhibit 3.1 to the Company's
                     Registration Statement on Form S-1 (Registration No.
                     2-80946).

              3.2    --By-laws of AXCESS. Incorporated herein by reference to
                     Exhibit 3.2 to the Company's Registration Statement on Form
                     S-1 (Registration No. 2- 80946).

              3.3    --First Amendment to Certificate of Incorporation of AXCESS
                     dated June 6, 1986. Incorporated herein by reference to
                     Exhibit 3.3 to the Company's Annual Report on Form 10-KSB
                     for the year ended December 31, 1987.

              3.4    --Second Amendment to Certificate of Incorporation of
                     AXCESS, dated May 27, 1987. Incorporated herein by
                     reference to Exhibit 3.4 to the Company's Annual Report on
                     Form 10-KSB for the year ended December 31, 1987.

              3.5    --Third Amendment to Certificate of Incorporation of
                     AXCESS, dated November 11, 1994. Incorporated herein by
                     reference to Exhibit 4.4 to the Company's Registration
                     Statement on Form S-3 (Registration No. 333- 10665).

              3.6    --Fourth Amendment to Certificate of Incorporation of
                     AXCESS, dated July 28, 1995. Incorporated herein by
                     reference to Exhibit 4.5 to the Company's Registration
                     Statement on Form S-3 (Registration No. 333- 10665).

              3.7    --Fifth Amendment to Certificate of Incorporation of
                     AXCESS, dated June 17, 1996. Incorporated herein by
                     reference to Exhibit 4.6 to the Company's Registration
                     Statement on Form S-3 (Registration No. 333-10665).

              3.8    --Sixth Amendment to Certificate of Incorporation of AXCESS
                     dated March 31, 1998. Incorporated herein by reference to
                     Exhibit 99.1 to the Company's Report on Form 8-K dated
                     April 13, 1998.

              3.9    --Seventh Amendment to Certificate of Incorporation of
                     AXCESS dated March 31, 1998. Incorporated herein by
                     reference to Exhibit 99.2 to the Company's Report on Form
                     8-K dated April 13, 1998.

              3.10   --Eighth Amendment to Certificate of Incorporation of
                     AXCESS dated April 9, 1998. Incorporated herein by
                     reference to Exhibit 99.3 to the Company's Report on Form
                     8-K dated April 13, 1998.

              4.1    --Certificate of Designation of the Company's Series A, B
                     and C Preferred Stock, dated December 27, 1995.
                     Incorporated herein by reference to Exhibit 4.7 to the
                     Company's Registration Statement on Form S-3 (Registration
                     No. 333-10665).
</TABLE>



<PAGE>   74





<TABLE>
<CAPTION>
            EXHIBIT
            NUMBER                           EXHIBIT
            -------                          -------
              <S>    <C>
              4.2    --Certificate of Designation of the Company's Series D
                     Preferred Stock. Incorporated herein by reference to
                     Exhibit 4.1 to the Company's Quarterly Report on Form
                     10-QSB for the period ended June 30, 1996.

              4.3    --Certificate of Designation of the Company's Series E
                     Preferred Stock. Incorporated by reference to Exhibit 4.3
                     to the Company's Quarterly Report on Form 10-QSB for the
                     period ended September 30, 1997.

              4.4    --Certificate of Designation of the Company's Series F
                     Preferred Stock and Certificate of Correction. Incorporated
                     by reference to Exhibit 4.4 to the Company's Quarterly
                     Report on Form 10-QSB for the period ended September 30,
                     1997.

              4.5    --Certificate of Designation of AXCESS Series G Preferred
                     Stock. Incorporated herein by reference to Exhibit 4.5 to
                     the Company's Annual Report on Form 10-KSB for the year
                     ended December 31, 1997.

              10.1   --License agreement, dated June 30, 1988, between the
                     Company and Patlex Corporation. Incorporated herein by
                     reference to Exhibit 10.17 to the Company's Annual Report
                     on Form 10-KSB for the year ended December 31, 1988.

              10.2   --Employment agreement dated August 31, 1989, between Louis
                     F. Bieck, Jr. and AXCESS Inc. as amended. Incorporated
                     herein by reference to Exhibit 10.17 the Company's Form
                     10-KSB for the year ended December 31, 1990.

              10.3   --1991 Incentive Stock Option Plan, dated August 14, 1991.
                     Incorporated herein by reference to Exhibit 10.10 to
                     Lasertechnics' Annual Report on Form 10-KSB for the year
                     ended December 31, 1991.

              10.4   --Purchase Agreement between Sandia Europe and Jean-Luc
                     Poutchnine, Alain Quilleau and Philippe Bonnevie, dated
                     March 4, 1994. Incorporated herein by reference to Exhibit
                     10.15 to the Company's Annual Report on Form 10-KSB for the
                     year ended December 31, 1994.

              10.5   --Letter confirming sale of shares of AXCESS Common Stock
                     to Singapore Precision Industries PTE LTD, dated May 12,
                     1994. Incorporated herein by reference to Exhibit 10.16 to
                     the Company's Annual Report on Form 10- KSB for the year
                     ended December 31, 1994.

              10.6   --Advisory and investment banking services agreement
                     between AXCESS and Wolfensohn International, Inc., dated
                     May 19, 1993. Incorporated herein by reference to Exhibit
                     10.18 to the Company's Annual Report on Form 10-KSB for the
                     year ended December 31, 1994.

              10.7   --Purchase of Common Stock and Convertible Note Agreement
                     between the Company and J.P. Morgan Investment Corporation,
                     dated July 8, 1994. Incorporated herein by reference to
                     Exhibit 10.19 to the Company's Annual Report on Form 10-KSB
                     for the year ended December 31, 1994.
</TABLE>


<PAGE>   75




<TABLE>
<CAPTION>
            EXHIBIT
            NUMBER                           EXHIBIT
            -------                          -------
              <S>    <C>

              10.8   --OEM License Agreement between Sandia and Xerox
                     Corporation, dated January 6, 1995. Incorporated herein by
                     reference to Exhibit 10.20 to the Company's Annual Report
                     on Form 10-KSB for the year ended December 31, 1994.

              10.9   --Demand Promissory Note issued to J.P. Morgan Investment
                     Corporation, dated December 19, 1994. Incorporated herein
                     by reference to Exhibit 10.21 to the Company's Annual
                     Report on Form 10-KSB for the year ended December 31, 1994.

              10.10  --Demand Promissory Note issued to J.P. Morgan Investment
                     Corporation, dated December 31, 1994. Incorporated herein
                     by reference to Exhibit 10.22 to the Company's Annual
                     Report on Form 10-KSB for the year ended December 31, 1994.

              10.11  --Amendment to the OEM License Agreement between Sandia and
                     Xerox Corporation, dated December 27, 1996. Incorporated by
                     reference to Exhibit 10.12 to the Company's Annual Report
                     on Form 10-KSB for the year ended December 31, 1996.

              10.12  --Demand Promissory Note issued to Wolfensohn Associates
                     L.P., dated March 27, 1997. Incorporated by reference to
                     Exhibit 10.13 to the Company's Quarterly Report on Form
                     10-QSB for the period ended September 30, 1997.

              10.13  --Warrant to purchase shares of the Company's Common Stock
                     issued to Wolfensohn Associates L.P., dated March 27, 1997.
                     Incorporated by reference to Exhibit 10.14 to the Company's
                     Quarterly Report on Form 10- QSB for the period ended
                     September 30, 1997.

              10.14  --Note Purchase Agreement dated June 25, 1997, by and among
                     AXCESS, J.P. Morgan Investment Corporation and Wolfensohn
                     Associates L.P. Incorporated by reference to Exhibit 10.15
                     to the Company's Quarterly Report on Form 10-QSB for the
                     period ended September 30, 1997.

              10.15  --Intellectual Property Transfer Agreement dated January 8,
                     1998, by and between XL Vision, Inc. and Sandia Imaging
                     Systems Corporation. Incorporated herein by reference to
                     Exhibit 10.15 to the Company's Annual Report on Form 10-KSB
                     for the year ended December 31, 1997.

              10.16  --Amendment to Notes and Note Purchase Agreement dated
                     December 31, 1997, by and among the Company, Antiope
                     Partners L.L.C. and J.P. Morgan Investment Corporation.
                     Incorporated herein by reference to Exhibit 10.16 to
                     Amendment No. 1 to the Company's Annual Report on Form
                     10-KSB for the year ended December 31, 1997.

              10.17  --Series G Preferred stock Purchase Agreement dated
                     December 29, 1997, by and among the Company and Amphion
                     Ventures L.P. Incorporated herein by reference to Exhibit
                     10.17 to Amendment No. 1 to the Company's Annual Report on
                     Form 10-KSB for the year ended December 31, 1997.
</TABLE>



<PAGE>   76

<TABLE>
<CAPTION>
            EXHIBIT
            NUMBER                           EXHIBIT
            -------                          -------
              <S>    <C>
              10.18  --Pledge Agreement dated August 18, 1997, by and among the
                     Company, Antiope Partners L.L.C. and J.P. Morgan Investment
                     Corporation. Incorporated herein by reference to Exhibit
                     10.18 to Amendment No. 1 to the Company's Annual Report on
                     Form 10-KSB for the year ended December 31, 1997.

              10.19  --Preferred Stock Exchange Agreement dated January 8, 1998,
                     by and among the Company, Antiope Partners L.L.C. and H.T.
                     Ardinger. Incorporated herein by reference to Exhibit 10.19
                     to Amendment No. 1 to the Company's Annual Report on Form
                     10-KSB for the year ended December 31, 1997.

              10.20  --Form of Warrant to purchase shares of the Company's
                     Common Stock issued to Antiope Partners L.L.C. and Amphion
                     Ventures L.P. Incorporated herein by reference to Exhibit
                     10.20 to Amendment No. 1 to the Company's Annual Report on
                     Form 10-KSB for the year ended December 31, 1997.

              10.21  --Settlement Agreement dated as of April 21, 1998, by and
                     between the Company and Xerox Corporation. Incorporated
                     herein by reference to Exhibit 10.21 to Amendment No. 1 to
                     the Company's Annual Report on Form 10-KSB for the year
                     ended December 31, 1997.

              21     --Subsidiaries of the Company. Incorporated herein by
                     reference to Exhibit 21 to the Company's Annual Report on
                     Form 10-KSB for the year ended December 31, 1997.

              23     --Consent and Report on Schedule of KPMG Peat Marwick LLP.*

              27     --Financial Data Schedule. Incorporated herein by reference
                     to Exhibit 27 to the Company's Annual Report on Form 10-KSB
                     for the year ended December 31, 1997.
</TABLE>

     -----------------
     *Filed herewith.